MAY 4, 1998

U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-SB
GENERAL FORM FOR REGISTRATION OF SECURITIES OF SMALL
BUSINESS ISSUERS

TORVEC, INC.

(NAME OF SMALL BUSINESS ISSUER IN ITS CHARTER)

                                                       16-1509512
               NEW YORK

    (STATE OR OTHER JURISDICTION OF        I.R.S. EMPLOYER IDENTIFICATION NO.
     INCORPORATION OR ORGANIZATION)



             3740 ROUTE 104
          WILLIAMSON, NEW YORK                           14587

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES                (ZIP CODE)

ISSUER'S TELEPHONE NUMBER, INCLUDING AREA CODE: (716) 248-8549

SECURITIES REGISTERED PURSUANT TO SECTION 12(B) OF THE EXCHANGE ACT:

NONE

SECURITIES REGISTERED PURSUANT TO SECTION 12(G) OF THEEXCHANGE ACT

$.01 PAR VALUE COMMON VOTING STOCK

DOCUMENTS INCORPORATED BY REFERENCE: NONE

PAGE 1 OF ______ PAGES CONTAINED IN THE SEQUENTIAL NUMBERING SYSTEM. THE

EXHIBIT INDEX MAY BE FOUND ON PAGE 42 OF THE SEQUENTIAL NUMBER SYSTEM.

                                  TABLE OF CONTENTS
                                                                         PAGE
                                                                      NUMBER

PART I
           ITEM 1.  DESCRIPTION OF BUSINESS                              3

           ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN        13

                    OF OPERATION

           ITEM 3.  DESCRIPTION OF PROPERTY                             16

           ITEM 4.  SECURITY OWNERSHIP OF CERTAIN BENEFICIAL            17

                    OWNERS AND MANAGEMENT

           ITEM 5.  DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND        18

                    CONTROL PERSONS

           ITEM 6.  EXECUTIVE COMPENSATION                              20

           ITEM 7.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS      23

           ITEM 8.  DESCRIPTION OF SECURITIES                           24


PART II

           ITEM 1.  MARKET PRICE OF AND DIVIDENDS ON THE COMPANY'S      25

                    COMMON EQUITY AND OTHER STOCKHOLDER MATTERS

           ITEM 2.  LEGAL PROCEEDINGS                                   25

           ITEM 3.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS       25

                    ON ACCOUNTING AND FINANCIAL DISCLOSURE

           ITEM 4.  RECENT SALES OF UNREGISTERED SECURITIES             25
           ITEM 5.  INDEMNIFICATION OF DIRECTORS AND OFFICERS           29


PART F/S            FINANCIAL STATEMENTS                             F-1


PART III

           ITEM 1.  INDEX TO EXHIBITS                                   42

PART I

ITEM 1. DESCRIPTION OF BUSINESS.

(A) BUSINESS DEVELOPMENT AND SUMMARY

Upon its creation in September, 1996, TORVEC, Inc. ("the Company") acquired numerous patents, inventions and know-how developed for more than ten years by Vernon E. Gleasman and members of his family. The Company presently is a development company specializing in automotive technology. The Company owns many U.S. and international patent properties developed by the Gleasmans protecting important inventions relating to five different areas of automotive technology, i.e., (i) steering drive for tracked vehicles, (ii) infinitely- variable transmission (IVT), (iii) hydraulic pump and motor, (iv) CV (constant velocity) joint and (v) spherical gearing. Its new type of automotive transmission (IVT) is less complicated and is manufactured at a lower cost than automatic transmissions. It will be used to significantly increase fuel mileage and, at the same time, reduce one of the world's more serious air pollution problems (all as described below). The primary inventor and the management team of the Company have the pertinent business experience outlined below:

VERNON E. GLEASMAN _ INVENTOR
Mr. Gleasman is considered a world's leading authority on gear technology. He is co-inventor (with sons, James A. and Keith E. Gleasman) of the all-gear GSD-10 (a hydro-mechanical steering system for track vehicles); conceived and engineered the FasTrack_ vehicle (discussed below); and is inventor of the TorsenR differential now used in many passenger automobiles around the world such as: Porsche, Audi Quattro's, 8 car lines of Toyota (i.e., Lexus, Supra and RAV4), Mazda Miata and RX7, Chevrolet Camero, Pontiac Firebird, Oldsmobile Achieva, Suzuki, and the U.S. Army HMMWV (Hummer). Mr. Gleasman was the winner of the Society of Automotive Engineers' 1983 Schwitzer Award for Most Innovative New Product at the Indianapolis 500; is listed in Who's Who in American Inventors 1990 Edition; and he has been nominated to the National Inventors Hall of Fame. His work is featured in the Theory of Machines and Mechanisms, McGraw-

Hill, 1995 (Mr. Gleasman's TorsenR Differential is pictured on the jacket cover). He has been granted over 20 patents on gearing, differentials, and machine tools over the past 30 years, and he is the principal inventor on over 100 U.S. patents (as well as corresponding foreign patents), primarily automotive-related. Examples (U.S. patent numbers in parenthesis): hydraulic clutch transmission (2177213); hydraulic clutch for transmission (2226309); Bendix fuel direct engine injector valve and Bendix diesel engine starter (2450129); hydraulic variable-speed hydrostatic transmission (2471031); Vane- type fluid drive (2552167), hypoid differential (2628508); fluid transmission (2668417); White Motor Co. tilting cab (2838126), assigned to White Motor; hydro-vector fuel-injector advance mechanism; catalytic converter for diesel trucks. He is also the inventor of non-freeze water meter, machine tools and other products. Early career: engineer at Bendix; and vice president manufacturing at White Motor, where engineering and management experience included designing and planning White's plant for manufacture of White 9000 heavy truck and organizing manufacturing and production of aircraft components for White's Aircraft division. Later, Mr. Gleasman founded his own companies, including Triple-D, Inc., sold to Gleason Corporation, Rochester, New York.
DR. HERBERT H. DOBBS _ CHAIRMAN OF THE BOARD OF DIRECTORS Dr. Dobbs, Ph.D., P.E., has worked at every level from design engineer to technical director of an Army Major Commodity Command at the two-star level. He has worked as a hands-on engineer and scientist in industry and government, commanded field units, managed Army R & D programs and laboratories and currently has his own practice as a consultant engineer. He has the broad background needed to guide the Company's growth and development. During his career he has:
. Worked as a manufacturing engineer.
. Worked as a design engineer in the aircraft and missile industry.
. Managed Army laboratories as a captain, lieutenant colonel and colonel.
. Organized, implemented and operated the theater-wide "Red Ball Express" quick response supply system in Vietnam to get disabled weapons and other critical equipment repaired and back into combat as rapidly as possible.
. Done basic research on multi-phase turbulent fluid dynamics supporting development of the gas turbine primary power system now used in the M1 Abrams Main Battle Tank (MBT).
. Managed advanced development of the laser guided 155mm-artillery shell now known as the "Copperhead".
. Served in Taiwan as a member of the U.S. Military Assistance Advisory Group (MAAG) working with the Republic of China Army General Staff.
. Served as liaison officer between the Army and Air Force for development of the laser seeker for the Hellfire missile.
. Guided development of a new family of tactical vehicles for the Army, including the High Mobility Multipurpose Wheeled Vehicle (HMMWV) now known as the "Hummer", which uses Vernon Gleasman's TorsenR differential.
. Served as Technical Director of U.S. Army Tank-Automotive Command (TACOM), which employs some 6,400 people and is responsible for all support of U.S. military ground vehicles (a fleet of 440,000) from development to ultimate disposal with a budget of nearly $10 billion a year. He was also responsible for negotiation and management of military automotive R&D agreements with the French and German Ministries of Defense. At the end of 1985, Herbert H. Dobbs left government service and started his own consulting practice and began working with the Gleasmans to develop and market Vernon Gleasman's inventions. Herbert H. Dobbs holds a Ph.D. in Mechanical Engineering from the University of Michigan and is a registered professional engineer in Michigan. He holds several patents of his own and, among many affiliations, is a member of SAE, ASME, NSPE, AAAS, Sigma XI, AUSA, ADPA and the U.S. Army Science Board. The last named organization is a small group of senior technical and managerial people chosen from industry and academia to provide direct advice to the Secretary of the Army, the Chief of Staff, and the Department of the Army concerning issues of policy, budgets, doctrine, organization, training and technology. Its advice rarely is ignored and usually is acted on.

LEE E. SAWYER _ DIRECTOR
Over a 30-year career Mr. Sawyer has worked on the wholesale side of the automotive industry for Ford in technical training and Toyota in sales, marketing, motorsports and service. During the last ten years, he was part of the start-up teams that successfully launched Hyundai and Kia Motors America focusing on parts, service, quality assurance, fleet sales, public relations and consumer affairs policy, procedures and systems. During his career he has worked with these automakers as follows:

Ford Motor Company:
. As Ford's first field service engineer.
. Managed expanded Training Center with Ford, Lincoln-Mercury car and heavy truck classrooms, and taught Ford Shelby high performance curriculum.

Toyota Motor Sales USA:
. Established 12 service Training Centers.
. Computerized the national warranty system and established an expense control audit program.
. Managed sales, parts and service field force during a period in which sales increased 300%
. In 1979, introduced the TorsenR differential to Toyota
. Started Motorsports - hired factory race teams, coordinated race engine development, and conducted Long Beach Grand Prix and Pro-Celebrity Match Race. Results: 14 national championships.

Hyundai Motor America:
. Started national Service Department: warranty, quality assurance, consumer affairs, technical and management training.
. Managed public relation's activities, product introduction press previews, press releases and media interviews.

Kia Motors America:
. Consulted with Kia Korea re: establishing a car company in the USA.
. Started service department: warranty, quality assurance, consumer affairs, service training and publication.

Mr. Sawyer is a start-up specialist with the operations, management, communications and problem solving skills required to launch the Company successfully. He holds a B.A. in Industrial Technology and attended USC School of Business-International Relations, Ford Marketing Institute, Toyota Management Training, American Management Association Training, Interpersonal skills training, and U.S. Coast Guard Leadership and Diesel Engine schools.
MORTON A. POLSTER _ DIRECTOR; SECRETARY
Partner in the intellectual property law firm of Eugene Stephens & Associates. Formerly, General Patent Counsel and, thereafter, Secretary and Corporate Counsel for Gleason Corporation (1969 - 1989) and prior to that, Patent Counsel for Eastman Kodak Corporation (1960 _1969). While with Gleason Corporation, Mr. Polster represented Gleason when the latter purchased the Gleasman's Triple D, Inc., and exclusive rights to the Gleasman patents relating to the design and manufacture of the Torsen differential. He was part of the management team overseeing the operation of the Gleason Power Systems Division, which was created to manufacture and sell the Torsen differential. Also, he represented Gleason when the latter sold its Power Systems Division and its rights to the Torsen Differential to Diesel Kiki, Ltd. of Japan (now Zexel Corporation). While in private practice, since 1989, Mr. Polster represented Zexel Torsen, Inc., (subsidiary of Zexel Corp.), which was created to manage the manufacture and sale of Torsen Differentials. Mr. Polster has been patent counsel to the Gleasmans since 1989 and has been in charge of the preparation and execution of their U.S. and international patent protection.

TORVEC'S TRACKED VEHICLE

BACKGROUND
The infrastructure of most of Asia, Africa, South and Central America is very similar to the U.S. in the early 1900's. At that time U.S. demographics were as follows: eighty percent of the population lived in rural areas; income was low; and transportation was limited to walking, bicycles, push carts and animal pulled vehicles. Roads, when they existed, were dirt and at times impassable due to terrain or inclement weather. Even with the advent of automobiles, commerce remained inhibited because paved roads were only found in the cities. Similarly, the wheeled vehicles of the developing country today can only traverse the rural dirt roads during certain seasons of the year. When roads are in rough condition (e.g., muddy, blocked by snow or ice, etc.), there is little difference in travel time between an animal drawn cart; a man on foot or bicycle; or a wheeled car. If they are able to travel at all, even four- wheeled drive vehicles are usually limited to 4_5 mph under these conditions. The idealized vehicle would be a vehicle that could travel at higher speeds (25- 50 mph.), regardless of the terrain, significantly shortening the travel time between rural areas and the primary marketplaces in the city. A tracked vehicle, in effect, "brings its own road with it".

TORVEC'S FASTRACK VEHICLE
The Company's FasTrack prototype vehicle (see cover) is a new type of vehicle, that steers as easily as a car (using a steering wheel), has rubber tracks and bridges an important gap between wheeled and tracked vehicles that manufacturers have been trying to span for decades. This new vehicle combines the high-speed capabilities of trucks and cars with the high-traction capabilities of tracked vehicles. Unlike most "new generation" vehicles (e.g., the Model T, for which Henry Ford had to design and build almost every part), the FasTrack can be made from existing automotive components, and lends itself to formation of joint ventures for assembly in the developing country. FasTrack vehicles are rubber-tracked vehicles which, by design, are environmentally sensitive since their low ground pressure (less than 2 lbs. per sq. in.) does not damage paved road surfaces or leave ruts or cause potholes on unpaved surfaces. This tracked vehicle can traverse almost any terrain at higher speeds. The tracks could be made by Goodyear; a corporation dedicated to supporting original equipment manufacturers (OEMs). Goodyear states, "Based on product testing and feedback from our customers, in most situations, Goodyear rubber track has been seen to last 3 to 5 times longer than a set of standard utility tires used in the same application." An additional feature of the FasTrack vehicle is its alternator, which will be modified to permit the vehicle to also serve as a mobile power plant with a 2 HP (approximately 1400 watts) electrical generator for running a myriad of electrical items, which can contribute to rural electrification. FasTrack vehicles perform as they do because of their unique steering mechanism, which is protected by several patents in Europe and Japan as well as the following U.S. patents: Multi-Axle Vehicle Steer Drive system (4732053), No-slip imposed Differential Reduction Drive (4776235), No- slip imposed differential (4776236), Steer-Driven Reduction Drive System (4895052). The FasTrack also uses TORVEC's Orbital Transmission (U.S. patent 5186692), an infinitely-variable transmission (IVT). Different from the multi- shifting automatic transmission used on passenger vehicles, TORVEC's IVT contributes to increased fuel mileage and significantly lower emissions (see next section below).

TORVEC'S TRANSMISSION

BACKGROUND
Environmental scientists agree that "global warming" is one of the world's primary concerns, and the President of the United States has assured an international environmental conference that our country acknowledges the importance of this problem. In addition, the President has recently stated "The answer lies in promoting new energy-efficient technologies and not imposing steep energy price increases to encourage efficiency" (Associated Press- 10/7/97). It is well recognized that carbon dioxide (C02) emissions from automotive vehicles are presently a major contributor to this world problem and, further, that the use of automotive vehicles is projected to increase more than 400% over the next few decades. The Society of Automotive Engineers (SAE paper #930941) notes that the 1992 RIO conference targeted pollution as one of the three major challenges which must be met by the International Community and it states: "The forecast demographic and economic changes will lead to the production of 250 million vehicles per year and a world motor vehicle fleet of 2.5 billion vehicles within the next 50 years as compared with today's production of 50 million vehicles per year and a fleet of 550 million vehicles." It is also well recognized that diesel engines emit much less CO2.
Unfortunately, as presently used in trucks, busses and cars, diesel engines emit other undesirable pollutants (e.g., NOx , hydrocarbons, and particulates). In addition, (SAE paper #930126) "The World Health Organization has concluded that diesel particulate is a probable human carcinogen." Such undesirable pollutants are emitted by diesel engines primarily during those periods of operation when the speed of the diesel engine is being changed significantly (e.g., during start-up, acceleration from gear to gear, and rapid slow down). However, when diesel engines run at steady-state speeds, their emission levels are very low. Further, diesel engines can exhibit approximately 30% improvement in fuel economy over gasoline engines, diesel fuel is cheaper to produce and its manufacture results in less air pollution than does the manufacture of gasoline.
Therefore, during the past several years, the world's vehicle manufacturers and their suppliers have been engaged in major efforts to reduce the pollutants from operating diesel engines. In recent years, punitive fines have been imposed upon manufacturers and end-users throughout the world with the intent of creating special incentives for such efforts to reduce diesel pollution. [NOTE:

Especially restrictive diesel regulations are scheduled to go into effect in the U.S. in California and eleven other states sometime in 1998.] An example of such an incentive is a recently proposed EPA fine to be imposed on bus companies for any bus emitting pollutants that don't meet the standards. As quoted from Clean Air Today (July 7, 1997), "Under the EPA program, transit agencies that do not install a [filter] retrofit kit designed to meet strict particulate matter standards are subject to a noncompliance penalty of $25,000 per bus. According to EPA, the kit will cost about $7,940 for an urban bus. More than 110,000 urban buses are located in various metropolitan areas throughout the United States." (This indicates an estimated cost of $880,000,000 for the retrofit kits alone, not including installation and maintenance costs.) The filter (catalytic purifier) just referred to above, is one of many recent attempts to help solve the diesel problem, most of which are directed primarily to "engine management" remedies such as fuel and exhaust filters, controls relating to turbo compression of the air being delivered to the engine's cylinders, etc. As indicated by the example above, government environmental regulators, such as the EPA, indicate that they intend to enforce stricter air standards as soon as proven technology permits vehicles to meet such desired safer air standards (refer to SAE paper #920142). According to Monetary & Economic Review, (September, 1997):

"Ford Motor Company, in a June 5 letter to all of its local dealers, warned of 'a major policy issue that will greatly affect the auto business,' impacting the kinds of vehicles that can be sold, the costs of driving and overall vehicle affordability. The letter cited legally binding caps and cuts on energy use for developed countries that would be enforced by a UN agency. 'These caps and cuts are expected to be finalized in December of this year in Kyoto [Japan],' the letter stated.
Continuing, the letter read, 'Such a treaty would necessitate major gasoline price increases and likely would lead to other measures, including higher CAFE and restrictions on vehicle use. Many countries in Europe already are implementing such measures in anticipation of the agreement... and the UN would be in charge of monitoring compliance."

THE TORVEC_ IVT

The TORVEC prototype transmission is an infinitely variable transmission (IVT), meaning it provides an uninterrupted drive through an infinite number of geared speed ratios, allowing ideal torque flow to propel the vehicle while permitting the engine to run at optimum efficiency. In sharp contrast to other work being done in relation to diesel/gasoline engine management, the Company's new TORVEC transmission does not require any change, costly or otherwise, to the manufacture or operation of existing diesel/gasoline engines. Instead, it permits present automotive diesel/gasoline engines to operate in a steady-state mode, with dramatically reduced pollution, at most times during normal operation, i.e., under the starting, stopping, acceleration and deceleration of normal urban traffic. For instance, such a steady-state optimum condition may match the usual engine setting when the vehicle is being driven at its top urban speed (e.g., 35-45 miles per hour). It should be noted that this optimum urban cruising speed may be only approximately twice the normal idling speed of the engine, and that this steady-state setting is relatively low in comparison to the normally required engine speed of three, four or five times idling speed that must be attained by the same diesel/gasoline engine each time the vehicle accelerates between each of the conventional forward gears (e.g., when shifting from first gear to second gear, then from second to third, etc.). [NOTE: Because it is an infinitely variable transmission and changes its ratios extremely quickly, the TORVEC IVT can accelerate a diesel-powered vehicle as quickly as a gasoline-powered vehicle. The Torvec IVT also may be able to significantly improve the performance of electric drive vehicles. There are a number of kinds of electric motors that can be chosen to drive a vehicle. Their performance and physical characteristics vary considerably. Weight (for a given power level), zero-speed torque, useful speed range, efficiency-vs.-motor-speed, and control characteristics are among these, and there are conflicts in making the best choice for a given vehicle application. A transmission of some sort commonly is needed to resolve these. The performance characteristics of the Torvec IVT make it a promising candidate for such applications.]

In addition to having the potential of remarkably reducing particulates, the TORVEC transmission is less complicated and has approximately 1/3 fewer parts when compared to a conventional four or five speed automatic transmission, making it smaller in size, lighter in weight and, therefore, further improving fuel economy. The TORVEC transmission, which will be simpler and less expensive to manufacture, should provide the automotive industry with a higher performing product at a lower cost.

In view of the above, and because all vehicles currently have transmissions, the Company believes that the TORVEC transmission will permit substantial reductions in diesel/gasoline engine pollutants and that such significant environmental benefits will be achieved without an economic penalty. Further, it is believed that the TORVEC transmission will not be in direct competition with companies who provide other diesel/gasoline engine pollution remedies and that the latter may even be interested in working with the Company to explore possible synergistic effects with the TORVEC transmission.

ADDITIONAL TORVEC PRODUCTS

HYDRAULIC PUMP/MOTOR, CV JOINT, AND SPHERICAL GEARING

The Company's patented TORVEC transmission incorporates a hydraulic pump/motor machine and, although it can be operated with commercially-available pump/motors, it is most effectively used in combination with the Company's patented TORVEC hydraulic pump/motors (5,513,553) which, like the TORVEC transmission, are significantly simpler, smaller and lighter than other commercially available pump/motors having comparable performance specifications. The key feature of the TORVEC pump/motors is their swash-plate mounting arrangements that utilize a new form of spherical gearing which is also proprietary to the Company (5,647,802). Further, this spherical gearing has been incorporated in yet another TORVEC product, which has been developed to replace CV (constant velocity) joints used, among other places, in all front- wheel drive vehicles. The TORVEC CV Joint (5,613,914) is a remarkable departure from known designs, and its efficiency and weight savings should provide a significant competitive advantage in the annual CV-joint market of 180,000,000 units per year.

BUSINESS PLAN

The Company's present business strategy relating to its TORVEC products is
(1) to provide developing country FasTrack vehicle models for marketing to potential Asian, African, South and Central American joint venture partners; (2) to complete the installation of TORVEC transmissions into diesel-powered trucks for appropriate testing by national and state environmental agencies in the U.S. and other countries to quantify exact fuel savings and emissions levels and to determine its potential effect on the worldwide problem of diesel engine pollutants; (3) to complete the installation of the TORVEC transmission into the best selling automobile of a major U.S automaker that has an agreement with the Company for an exclusive "first look" at the TORVEC transmission for gasoline engine passenger cars, providing data on gasoline engine fuel mileage and emission levels, and the Company expects these results will create joint- venture/licensing opportunities; (4) to promote worldwide use of TORVEC transmissions for reducing diesel/gasoline engine pollution; (5) to enter into appropriate licensing/joint working arrangements for all TORVEC products (the FasTrack vehicle, IVT Transmission, Hydraulic Pump/Motor, CV Joint, and Spherical Gearing); (6) to obtain a Website for marketing, sales, education and information relating to the TORVEC products; 7) to obtain patent protection on at least four new developments and improvements related to the Torvec products described above.

(B) BUSINESS OF ISSUER

GENERAL

Preceding the formation of the Company, its principal shareholders, Vernon E. Gleasman, James A. Gleasman and Keith E. Gleasman started a research program that required more than 10 years of time and capital of approximately $3 million. As a family, the Gleasmans have operated and sold their own innovative products and companies over the last 30 years. It is this knowledge base (of the automotive industry and its trends), that was the basis of the various research projects that are now the properties of the Company. A review of Vernon Gleasman's first 100 plus inventions indicates that almost all of them are improvements of other companies' technology, and most of Vernon Gleasman's inventions were created either while he was employed by various companies, or while he was acting as a consultant to these other companies. Therefore, the past income of Vernon Gleasman and family does not reflect a remuneration proportionate to the economic impact of the products he invented (e.g., the hydraulic multi-disc clutch patent which was invented by Vernon Gleasman in the late 30's and has been used in most automatic transmissions produced over the last 60 years).

Unlike Vernon Gleasman's earlier inventions, the Torsena differential produced more revenue for the Gleasman family, because the Gleasmans themselves manufactured and produced these differentials (from the mid 1960's - 1982) through a family-owned corporation. Their primary customers were the U.S. Air Force and U.S. Army, with some further sales for after-market, high-performance vehicles. In 1982, as a result of the expanding need for larger production facilities to meet orders for Toyota and the U.S. Army HMMWV vehicle, the company was sold to Gleason Corp., Rochester, New York for cash, stock and a royalty package.

Historically, the major impediments to the incorporation of Gleasman products into other companies' vehicles has been the "not invented here" syndrome and the problems relating to enforcement of licensing agreements by an independent inventor. It is next to impossible to sell an idea that is merely on paper. Therefore, it is necessary to fully engineer and develop a highly refined prototype. Thousands of hours and millions of dollars have to be invested before a new product can be sold to an OEM (original equipment manufacturer). A highly refined prototype of the FasTrack_ vehicle (described immediately below) has been engineered and the Company will use a portion of the net proceeds of this Offering to explore joint ventures to produce this vehicle. In addition, the Company will use a portion of the net proceeds of this Offering to engineer and develop highly refined prototypes of the infinitely variable transmission (IVT), the hydraulic pump/motor, spherical gearing and CV Joint (also described below) to serve as critical components of the FasTrack vehicle as well as for direct commercialization.

TRACKED VEHICLE STEERING (GSD-10) AND HYDRAULIC PUMP/MOTOR

In response to requests from the David Taylor Marine Research Department of the U.S. Navy for a new generation of assault vehicles using off-the-shelf componentry, the Gleasman steering mechanism for tracked vehicles (GSD-10) was conceived and developed. For over 60 years an adequate, economical mechanism for steering tracked vehicles has been sought. Because they are difficult to steer precisely, tracked vehicles generally have been cumbersome and limited to low speed. While wheeled trucks and cars have been able to travel at higher speed on prepared roads, they have lacked the ability to traverse truly difficult terrain. Having developed the GSD-10 steer drive, and seeking the best way to market it, led the Company to a new direction for commercializing the Gleasman inventions. In contrast to the Gleasmans' past procedures of selling their products for another company's use, the decision was made to incorporate the new steer drive into a new type of vehicle designed as a specific product that could be sold directly to the consumer, thereby providing a foundation upon which the Company can propose joint ventures with countries, automobile producers, and/or component manufacturers for producing this vehicle. Rather than hiring a design studio in California or Michigan, costing in excess of tens of millions of dollars, the Gleasmans designed and fully engineered a vehicle manufactured from high-volume purchased parts. That major investment of time, know-how and capital has resulted in the prototype FasTrack vehicle illustrated on the cover and described in the Registration Statement Summary.

The GSD-10 steer drive can best be described in engineering terms as a hydro-mechanical steering mechanism. The "mechanical" portion is manufactured from conventional, high-volume gearing, while the "hydro" portion is the Company's patented hydraulic pump and motor. Conventional hydraulic pumps and motors are large, noisy, and inefficient at low RPM. For over 100 years, as reflected in SAE papers and a large number of issued patents, engineers and companies have sought a solution to these problems which have continued to be inherent in automotive hydraulic pump and motor designs. Therefore, because tests have indicated that the recently patented Torveca hydraulic pump/motors have substantially solved these heretofore inherent problems, the Company believes the GSD-10 steer drive is most effective when used with these novel Torveca pump/motors.

INFINITELY VARIABLE TRANSMISSION (IVT)

The long quest for a perfect automotive transmission, which began almost simultaneously with the invention of the automobile, is described in a 1987 Ford News Release (paper 87/45) entitled A History of Automatics (Car transmission systems through the years). This same Ford document states: "Ford began investigations into CVT (Continuously Variable Transmission) concepts in 1969 and started detailed engineering work in 1976 on a new design, known as the Ford CTX (Continuously variable Transaxle), developed jointly with Van Doorne and Fiat. In late 1983, a formal programme for CTX was initiated, at a total cost of $120 million. Using some Ford components (castings and differentials) the CTX will be produced by Van Doorne Transmissie as the first stage in the build- up to mass production at Ford's Bordeaux transmission plant in France." The transmission described in this Ford document is limited to very small engines (1.6 liter). While the CVT is a step toward the IVT (Infinitely Variable Transmission), it does not perform the same or as well as an IVT. In addition, unlike the Torvec_ IVT, which can be built to accommodate every size engine, the CVT used by Ford and other companies is only viable when used in conjunction with very small engines. In order to increase its ability to work with larger engines (e.g., 2 liters and above), a torque converter must be used with the CVT, adding weight and cost, increasing size, and reducing the efficiency of the transmission. Like the GSD-10 steer drive, the Torvec IVT incorporates the new Torvec hydraulic pump and motor, which is remarkably smaller in weight and size when compared to standard pump/motors that would otherwise be needed for the Torvec IVT. For example, conventional pumps/motors for the IVT could weigh as much as 400 lbs. In comparison, the Torvec hydraulic pump/motor weighs less than 100 lbs. In effect ,the Company's products appear to meet the essential criteria for needed automotive innovation as expressed in a recent statement by the Chief Executive Officer of Honda: "We must begin to make cleaner cars that people actually want to buy_with more performance, safety and comfort and vehicles that also use less fuel, produce fewer emissions, and yet don't cost much more" (SAE Automotive Engineering, 10/97). Transmissions are needed by all of the 50 million vehicles produced annually throughout the world. Therefore, the Company's potential could be substantial in view of the proven weight, cost, and size reductions of its products coupled with their potential to increase fuel efficiency.

SPHERICAL GEARING

The compact size and full power start-up torque of the Torvec hydraulic pump/motors are made possible through the invention of a revolutionary new form of gearing based on the geometry of spheres rather than conventional gear geometry of cylinders and cones. This new "spherical" gear is perhaps the most important and creative Gleasman invention to date, surpassing the "impossible geometry" of the Torsena differential gearing.

The Gleasman spherical gears have been used to form a geared ball-and- socket coupling in which driving tooth contact is maintained continuously while, at the same time, permitting the coupling to be flexed at 40 degrees to either side of center. The potential versatility of the Company's spherical gears may open the door to many yet unknown solutions and products yet to be discovered. This new gearing paradigm is found in the swash-plate mechanism of the Torvec hydraulic pump and motor, and it has also been used to create a constant velocity (CV) joint that is fully engineered as a working prototype and is ready for installation in a car. The Torvec CV joint is designed to be interchangeable in over 40 existing car models. It is notably lighter, less costly to manufacture, and potentially more durable than the CV joints presently being used in all front-wheel drive vehicles. In contrast, conventional automotive CV joints, like the conventional automotive pump/motors discussed above, have defied major improvements over the last 60 years in spite of the large expenditure of time and money by individuals and corporations. Further, in spite of severe mechanical and design limitations, the CV joints currently in use are manufactured at the rate of over "180 million units annually" according to the 1994 Annual Report of GKN (the world's largest producer of CV joints).

THE COMPANY'S ASSETS
The Company owns the exclusive right, title and interest in and to the following patent properties:
1. U.S. Patent No.: 4,732,053 Title: Multi-Axle Vehicle Steer Drive System

2. U.S. Patent No.: 4,776,235 Title: No-Slip, Imposed Differential Reduction Drive

3. U.S. Patent No.: 4,776,236 Title: No-Slip, Imposed Differential

4. U.S. Patent No.: 4,895,052 Title: Steer-Driven Reduction Drive System

5. U.S. Patent No.: 5,186,692 Title: Hydro-Mechanical Orbital Transmission

6. U.S. Patent No.: 5,440,878 Title: Variable Hydraulic Machine

7. U.S. Patent No.: 5,513,553 Title: Hydraulic Machine with Gear-Mounted Swash-Plate

8. U.S. Patent No.: 5,647,802 Title: Variable-Angle Gears

9. U.S. Patent No.: 5,613,914 Title: Universal Coupling

10. U.S. Patent Application (application number not yet assigned) Title: Method for Shaping the Teeth of Spherical Gears

11. European Pat. 0 160 671:


Title: No-Slip, Imposed Differential

Validated in: France, Germany, Sweden, United Kingdom

12. Japanese Pat. No. 200255 Title: No-Slip, Imposed Differential

13. Australian Patent No. 681528 Title: Variable-Angle Gear System and Constant Velocity Joint

14. Australian Patent No. 681534 Title: Hydraulic Machine with Gear-Mounted Swash-Plate

15. International Application No. PCT/US95/06538 Title: Variable-Angle Gear System and Constant-Velocity Joint Corresponding Regional/National applications:

Europe      95 921372.9
Brazil      PI 9507908-4
Canada      2,191,701
China       95 1 94440.1
Japan       501004/96
Korea       96-706840
Mexico      96 05859

16. International Application No.: PCT/U595/08732 Title: Hydraulic Machine with Gear Mounted Swash-Plate Corresponding Regional/National applications:

Europe      95 926258.5
Brazil      PI 9508276-0
Canada      2,194,963
China       95 1 95044.4
Japan       505116/96
Korea       97-700152
Mexico      9700288

In addition, the Company owns the exclusive right, title and interest in and to the following prototypes, automotive parts, engineering documentation, computer-readable data and other technological assets relating to the development and testing of the drive mechanisms for tracked vehicles, transmission, hydraulic pump/motors, a unique form of gearing, universal joints and constant-velocity joints disclosed and found in the above-referenced patent properties:
1. 1997 Ford Taurus 4-door sedan.
2. FasTrack tracked vehicle (Dimensions: length - 142", width - 68", height - 72"; weight: 4100 lbs; Engine: Ford, gasoline 2.3 liter; Transmission: Ford A4lLd; Steering system: Gleasman Steer Drive (GSD- 10).
3. Scale Model designs for various FasTrack vehicles.
4. Prototype of Gleasman Steer Drive (GSD-10).
5. Ford automotive parts: 4 engines; transmissions; differentials; worm gears; body parts; windshields; dashboards; and seats.
6. 3 prototypes of Gleasman Orbital (IVT) Transmission
7. One year of test results relating to testing of Gleasman IVT's at Alfred State University.
8. Right to use laboratory equipment at Alfred State University (equipment donated to University by Gleasmans); 250 hp eddy current dynamometer; lebow torque sensor; strain gauge shaft sensor; various transducers; Datatronic data acquisition system; and 1 Ford V-
6 (3 liter) engine.
9. Complete CAD/CAM design for Gleasman Ortibal (IVT) Transmission re- engineered to adapt as retrofit for existing vehicle of a major U.S. automaker.
10. Engineering data for adapting Gleasman Orbital (IVT) Transmission for retrofit on U.S. Army's existing HMMWV ("Hummer" vehicle).
11. Prototype Gleasman hydraulic pump/motors.
12. Off-the-shelf automotive hydraulic pump/motors made by other manufacturers (used for comparison testing).
13. Various prototypes of Gleasman "special" gears with supporting technical data.
14. Parts (gears, housing, shafts) and supporting technical data, relating to designs of Gleasman CV-joint apppropriate for retrofit in existing vehicle of a major U.S. automaker.
15. Engineering CAD/CAM files (representing 2,000 hours of development work) for Gleasman CV-joint designs.
16. Isuzu Commercial Vehicle NPR-Diesel

(C) SPECIAL RISK FACTORS ASSOCIATED WITH BUSINESS

The present and intended business operations of the Company must be considered to be highly speculative and involve substantial risks, and an investment in the Common Stock should only be considered by those persons who can bear the economic risk of their entire investment. Among the risk factors to be considered are the following:

DEVELOPMENT STAGE; NO OPERATING HISTORY

Since its incorporation on September 25, 1996, the Company's activities have consisted primarily of continuing the development of and designing specific applications for the inventions patented by Vernon E. Gleasman and Keith E. Gleasman as independent inventors during a period of more than ten years. See "Business of Issuer." The Company as yet has not manufactured nor entered into any arrangements to manufacture its prototypes as commercially available products and therefore has no operating history. To date, operations have been funded exclusively from sales of its Common Stock, including sales made pursuant to the terms of a Confidential Placement Memorandum, dated November 8, 1996. The Company is subject to all of the business risks associated with a new enterprise, including, but not limited to, risks of unforeseen capital requirements, failure of market acceptance, failure to establish business relationships, and competitive disadvantages as against larger and more established companies. The Company's ability to succeed may be hampered by the expenses, difficulties, complications and delays frequently encountered in connection with the formation and commencement of operations of a new business, including, but not limited to management's potential underestimation of initial and ongoing costs associated with the enterprise, overestimation of gross receipts and market penetration, the adverse impact of competition, as well as the adverse impact on the Company, and its cash flow, of the Company's inability to promote the worldwide use of Torvec_ products.

ABILITY OF COMPANY TO CONTINUE AS A GOING CONCERN

The Company's Financial Statements (contained elsewhere herein) were prepared assuming that the Company will continue as a going concern. The Company's independent auditors, in its report regarding the Company's Financial Statements, has expressed the fact that the Company is experiencing net losses and is not generating cash flows from operating activities to sustain its operations which raises substantial doubt the Company's ability to continue as a going concern. The Company is planning to offer up to 1,500,000 shares of its Common Stock at $5.00 per share in the near future to generate sufficient capital to effectuate its "Plan of Operation" described herein.

NO ASSURANCE OF COLLABORATIVE AGREEMENTS, JOINT VENTURES OR LICENSES

The Company's business strategy is based upon entering into collaborative joint working arrangements, formal joint venture agreements and/or licensing agreements with domestic and/or foreign governments, automotive industry manufacturers and suppliers in order to promote the use of the Torvec products. No such arrangements and/or licenses have been consummated to date and there is no assurance that the Company will be able to enter into definitive joint working arrangements or joint venture collaborative agreements with prospective working partners or others, or that such agreements, if entered into, will be on terms and conditions that are sufficiently attractive to the Company to enable it to generate profits.

In addition to seeking commercially attractive collaborative working arrangements or joint ventures, the Company may license one or more of its Torvec products to unaffiliated third parties. There is no assurance that the Company will be able to enter into such license arrangements or that such licenses will produce any income to the Company. See "Plan of Operation. "

UNCERTAINTY OF MARKET ACCEPTANCE

The Company's ability to generate revenue and become profitable is dependent, in part, upon the automotive industry's acceptance of certain of its products, such as the steering drive for tracked vehicles, the infinitely- variable transmission (IVT), the hydraulic pump and motor, the CV (constant velocity) joint and spherical gearing. The Company's growth and future financial performance will depend on demonstrating the advantages of such products over existing technologies to an automotive industry which has committed substantial resources to product systems utilizing old technology. In addition, despite management's belief that its products are superior, the Company will have to overcome the "not invented here" attitude that permeates the industry.

The Company's future development is also dependent upon consumer acceptance of certain other of its products, for example, the FasTrack_ vehicle especially in the Asian, African, South and Central American markets. While the potential domestic and international market is great, see "Business of Issuer", the Company faces considerable obstacles in introducing the FasTrack in these markets and there can be no assurance that it will be able to do so successfully.

POTENTIAL NEED FOR ADDITIONAL FINANCING; OUTSOURCING-COST AND TIMING

The Company is not currently generating revenues to fund its operations for the twelve months immediately following the effectiveness of this Registration Statement. See "Plan of Operation-Liquidity and Capital Resources." Accordingly, the Company has embarked and is implementing plans to raise additional capital, including an offering for up to 1,500,000 shares of its Common Stock at $5.00 per share. This proposed offering may not be successful. In addition, the Company currently does not have a manufacturing facility and its present intention is not to manufacture any of its products itself. Should the Company find that it is desirable to do so, this decision would require significant additional capital. The Company presently intends to outsource its requirements through collaborative working agreements, joint venture arrangements, licenses or a combination of all three. The Company may not be able to control the terms and conditions of such outsourcing arrangements, including the costs of labor, component parts and manufacturers' mark-up as well as the time involved for the manufacture and/or delivery of the products it outsources. The Company, therefore, very likely will be faced with the need for additional financing of a capital nature in order to successfully commercialize its products.

The Company intends to satisfy any such additional capital requirements through debt and/or future equity financing. There can be no assurance that such financing will be available or, if available, that it will be on favorable terms. If adequate financing is not available, the Company may be required to delay, scale back or eliminate certain of its research and development programs, to relinquish rights to certain of its technologies, or to license third parties to commercialize technologies that the Company would otherwise seek to develop itself. See "Plan of Operation."

UNPREDICTABILITY OF PATENT PROTECTION AND PROPRIETARY TECHNOLOGY

The Company currently has the United States and foreign patent properties listed on Page 9 of this Registration Statement. The Company's success depends, in part, on its ability to enforce the patents which it owns, maintain trade secrecy protection and operate without infringing on the proprietary rights of third parties. All of the pending applications are based upon technology that has already been patented in the United States, and therefore, the Company is optimistic that these applications will mature into appropriate protection. However, there can be no assurance that any of the Company's pending patent applications will be approved, that the Company will develop additional proprietary technology that is patentable, that any patents issued to the Company will provide the Company with competitive advantages or will not be challenged by third parties or that the patents of others will not have an adverse effect on the Company's ability to conduct its business. Furthermore, there can be no assurance that others will not independently develop similar or superior technologies, duplicate any of the Company's automotive technologies, or design around the Company's patented automotive technologies. It is possible that the Company may need to contest the validity of issued or pending patents of third parties relating to its automotive technologies. There can be no assurance that the Company would prevail in any such contest. In addition, the Company could incur substantial costs in defending itself in suits brought against the Company on its patents or in bringing patent suits against other parties.

In addition to patent protection, the Company also relies on trade secrets, proprietary know-how and technology which it seeks to protect, in part, by confidentiality agreements with its prospective working partners and collaborators, employees and consultants. There can be no assurance that these agreements will not be breached, that the Company would have adequate remedies for any breach, or that the Company's trade secrets and proprietary know-how will not otherwise become known or be independently discovered by others. See "Business; Certain Proceedings Involving Stockholders."

COMPETITION

The Company believes that its patented technology is superior to similar products manufactured in the automotive industry and in some instances represent a true paradigm shift with respect to presently known technology. However, once the Company commences operations, it will be marketing products that are provided by companies in the automotive industry that have significantly greater financial, marketing and operating resources than the Company.

DEPENDENCE ON KEY MANAGEMENT AND OTHER PERSONNEL

To date, the Company has been dependent upon and for the foreseeable future, it will be dependent upon the efforts of its management and scientific staff, including Herbert H. Dobbs, Lee E. Sawyer, Morton A. Polster, Vernon E. Gleasman, Keith E. Gleasman, and James A. Gleasman. Therefore, the loss of the services of any one or more of such persons may have a material adverse effect on the Company. However, the Company's negotiations and communications with others is quite well documented, and the technology relating to the Company's FasTrack vehicle, orbital transmission, hydraulic pump/motor, CV-Joint, and spherical gears has all (a) been quite thoroughly documented, by engineering drawings and on CAD computer disks, and (b) already undergone considerable applied development and testing. The Company believes that Messrs. Dobbs, Sawyer and Polster should be capable of continuing the further development and marketing of the Company's products supported by this just-identified technology.

Consequently, the Company's future success will depend in large part upon its ability to attract and retain skilled scientific, management, operational and marketing personnel. The Company faces competition for hiring such personnel from other companies, government entities and other organizations. While there can be no assurance that the Company will be successful in attracting and retaining such personnel in the future, the Company feels quite fortunate that its management presently includes non-family individuals with skills and experience remarkably pertinent to the Company's present needs.

CONTROL BY EXISTING STOCKHOLDERS; POSSIBLE DEPRESSIVE EFFECT ON THE COMPANY'S COMMON STOCK

The Company's existing stockholders are able to elect all of the Company's directors, dissolve, merge or sell all of the Company's assets and otherwise control the Company. Such concentration of control of the Company may also have the effect of delaying, deferring or preventing a third party from acquiring control of the Company, may discourage bids for the Company's Common Stock at a premium over the market price and may adversely affect the market price of the Common Stock. See "Security Ownership of Certain Beneficial Owners and Management."

NO DIVIDENDS

The Company has never paid any dividends on its Common Stock, and has no plans to pay dividends on its Common Stock in the foreseeable future. Future dividend policy will depend upon the Company's earnings, capital requirements, financial condition and other factors considered relevant by the Company's Board of Directors. See "Market Price of and Dividends on the Company's Common Equity and Other Stockholder Matters."

FUTURE SALES OF RESTRICTED SECURITIES; REGISTRATION RIGHTS

The Company has 20,673,496 shares of Common Stock outstanding. These shares of Common Stock (the "Restricted Shares") outstanding were sold by the Company in reliance on exemptions from the registration requirements of the Securities Act, are "restricted securities" as defined in Rule 144 promulgated under the Securities Act and may not be sold in the absence of registration under the Securities Act unless an exemption therefrom, including an exemption afforded by Rule 144, is available. Under Rule 144 (and subject to the conditions thereof), 20,453,594 of the Restricted Shares will become eligible for sale beginning 90 days after the date of this Registration Statement, and substantially all of the remaining 219,902 Restricted Shares will become eligible for sale as of January 30, 1999. In addition, the holders of 1,000,000 of the Restricted Shares have certain registration rights. The sale of a substantial number of shares of Common Stock or the availability of Common Stock for sale could adversely affect the market price of the Common Stock prevailing from time to time. See "Shares Eligible for Future Sale;" "Certain Transactions."

EFFECT OF PREVIOUSLY ISSUED OPTIONS AND WARRANTS ON STOCK PRICE

The Company has reserved from the authorized, but unissued, Common Stock, 455,000 shares of Common Stock for issuance upon exercise of outstanding options granted under the Company's 1998 Stock Option Plan, 1,545,000 shares for issuance upon exercise of options available for future grant under the Plan and 500,000 shares reserved for issuance upon the exercise of Consulting Warrants granted to LT Lawrence & Co., Inc. The existence of these options and warrants may prove to be a hindrance to future financings, since the holders of such securities may be expected to exercise them at a time when the Company would otherwise be able to obtain additional equity capital on terms more favorable to the Company. In addition, the holders of these securities have certain registration rights, and the sale of the shares issuable upon exercise of such securities or the availability of such shares for sale could adversely affect the market price of the Common Stock. See "Shares Eligible for Future Sale;" "Certain Transactions."

NO ASSURANCE OF PUBLIC TRADING MARKET; POSSIBLE VOLATILITY OF COMMON STOCK PRICES; MARKET MAKERS' POTENTIAL INFLUENCE ON THE MARKET

There is no public market for the Common Stock, and there can be no assurance that an active trading market for any of the Shares will develop or, if developed, be sustained. Upon the effectiveness of this Registration Statement, the Company intends to make appplication to have its Common Stock traded on the "Electronic Bulletin Board" of the National Association of Securities Dealers, Inc. ("NASD").

The market price for the Company's Common Stock may be highly volatile as has been the case with the securities of other small capitalized companies. Factors such as the Company's financial results, the introduction of the Company's products, its ability to enter into joint venture or licensing agreements and various factors effecting the automotive industry may have a significant impact on the market price of the Company's Common Stock. Additionally, in recent years, the stock market has experienced a high level of price and volume volatility and market prices for the stock of many companies, particularly of small capitalization companies the Common Stock of which trade in the over-the-counter market, have experienced wide price fluctuations which have not necessarily been related to the operating performance of such companies. The Company is seeking the services of one or more market makers to make a market in the Company's Common Stock. Such activities may exert a dominating influence on the market during their duration and such activities may be discontinued at any time.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained or incorporated by reference in this Registration Statement, including without limitation, statements containing the words "believes," "anticipates," "intends," "expects," "plans" and words of similar import, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward- looking statements. Such factors include, among others, the risks identified above under "Special Risk Factors." Given these uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements. The Company disclaims any obligation to update any such factors or to publicly announce the result of any revision to any of the forward-looking statements contained herein to reflect future events or developments.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

PLAN OF OPERATION

12-MONTH BUSINESS STRATEGY
During the twelve months immediately following the effectiveness of this Registration Statement, the Company intends to focus its efforts upon the following strategies:

1. TO PROVIDE DEVELOPING COUNTRY FASTRACK_ VEHICLE MODELS FOR MARKETING TO POTENTIAL ASIAN, AFRICA, SOUTH AND CENTRAL AMERICAN JOINT VENTURE PARTNERS. On January 7, 1998, the Company entered into a Service and Space Agreement with Joseph L. Neri, Sr. (a shareholder) and Joseph Neri Chevrolet-Oldsmobile-Pontiac pursuant to which the Company is entitled to lease the premises described below for 1 year with an option to renew for an additional 5 years and will be provided with labor and certain services which will enable the Company to construct, assemble and install the Company's products into various vehicles, including FasTrack. The Agreement will become effective upon completion of the Company's planned initial public offering of up to 1,500,000 shares at $5.00 per share. The facility is located at 3740 Route 104, Williamson, New York (approximately 20 minutes from downtown Rochester). The facility is approximately 17,000 sq. ft., situated on 8 acres of land. The agreement includes the facility, all utilities (including telephone system with an after-hour answering service), computer system, service department, specialized equipment and tools with above-ground lifts (D.E.C. approved) one of which has a 28,000 lb. capacity for trucks and buses, an 8 bay body shop, complete with a paint room and Kansas Jack straightening machine, a two floor parts department and a 30 member staff (sales, managers, office staff, mechanics and a computer programmer). The annual rental for the 8 acre facility, cost of labor and services aggregate to $630,000 (payable in 12 monthly installments). This facility is sufficient to construct all necessary FasTrack vehicles as well as assemble and install all Torvec products. Keith Gleasman shall have the primary responsibility to train the employees provided to the Company under the agreement with support from other Company executives. CAD/CAM design work will be needed and will be contracted with independent companies for approximately $2,000 weekly.

Adjacent to this property is 80 acres which fronts Route 104 and is ideal for demonstrating the Company's vehicles. This acreage has ponds, swamps and woods and will require only minor changes to construct a course that would be similar to developing country roads. Nominal bulldozing will enable the Company to construct the course. Under the lease/service contract, the 80 acres will be transferred and deeded to the Company for a cost of $350,000 on the last day of the the first year of the lease term. This tract of land, which is approximately 1.5 miles from the premises, is appropriate for testing all of the Company's products.

The cost of parts for building the FasTrack vehicle (windows, doors, engines, etc.) can range from $10,000-$40,000 per vehicle, depending on the vehicle design and size. The Company has already ordered appropriate diesel-powered truck parts for three FasTrack vehicles (one such set of parts has already been received from Isuzu Motors and the parts for the other two have been promised for delivery at the end of May 1998 by Kia Motors). IVTs will be built for the FasTrack using parts already designed (e.g., for the Taurus, etc.) at an estimated cost of $50,000. An additional $100,000 will be used to build a Torvec_ steer drive. For the latter, an outside contractor will provide the suspension components, material and frame, while Goodyear has agreed to supply the rubber track elements.
Upon completion of the Company's planned offering to raise needed capital, Lee E. Sawyer will commence dialogue and discussions with various automotive manufacturers to provide a business plan to supply parts to the Company on a purchase or joint-venture basis. After the parts suppliers have been identified and agreements executed, the FasTrack demonstration vehicles will be designed using the parts supplier's components. In this regard, Kia Motors has already indicated that it is interested in being a parts supplier for the FasTrack and that Kia has capacity to supply parts for as many as 80,000 vehicles per year. (Note: See appendix for correspondence from Kia Motors.) Concurrently, Herbert H. Dobbs, Chairman of the Board of Directors, assisted by Vernon and Keith Gleasman, will work together to finalize the design and engineering of the demonstration vehicles. At the same time, Herbert H. Dobbs and James Gleasman will be opening dialogue with potential developing country joint-venture partners in order to market the FasTrack.

2. TO COMPLETE THE INSTALLATION OF A TORVEC TRANSMISSION INTO DIESEL- POWERED TRUCKS FOR APPROPRIATE TESTING BY NATIONAL AND STATE ENVIRONMENTAL AGENCIES IN THE U.S. AND OTHER COUNTRIES TO QUANTIFY EXACT FUEL SAVINGS AND EMISSIONS LEVELS AND TO DETERMINE ITS POTENTIAL EFFECT ON THE WORLDWIDE PROBLEM OF DIESEL ENGINE POLLUTANTS. The basic engineering layout of the Torvec IVT has already been completed. The drawings will be submitted to a CAD/CAM contractor for the final engineering evaluation and detailing of parts. The cost of the trucks will be approximately $80,000, in addition to $150,000 to complete the Torvec IVT design and manufacturing. Alfred State College has tested Torvec IVT's in the past and is equipped for emission and fuel economy testing. The Gleasman family, prior to the formation of the Company, had donated most of the dynamometer test equipment to Alfred via a grant. In addition, Toyota donated the emission test equipment. Although negotiations have not yet been finalized, the Company expects to contract with Alfred State College, Alfred, New York to obtain emission and fuel economy results. The Company expects to spend $100,000-200,000 to obtain emission and fuel economy results, depending on the requirements of the United States Environmental Protection Agency. (Note: Re: Testing - see appendix for correspondence to the White House Climate Change Task Force from Yogendra B. Jonchhe of Alfred State College.)

3. A MAJOR U.S. AUTOMAKER, FORD MOTOR COMPANY HAS AN AGREEMENT WITH THE COMPANY FOR AN EXCLUSIVE "FIRST LOOK" AT THE IVT FOR GASOLINE-ENGINE PASSENGER CARS. The engineering drawings for the Taurus IVT are in the final stages of detailing and should be ready during the next business quarter. From these drawings the parts will be manufactured, subject to the schedule of the suppliers. When complete, the IVT will be installed into a Ford Taurus, owned by the Company. This car, equipped with the IVT, will be used to document emission levels and fuel economy. The vehicle and test results will be used to establish joint-venture/licensing opportunities with major car manufacturers around the world. To complete the above, a budget of approximately $350,000 has been established. (Note: Installation of the IVT into the Taurus is more complicated than the installation into the diesel trucks because the Taurus has a gasoline engine and also has a more complex front-wheel drive transaxle configuration, electronic controls and tight packaging.)

4. TO PROMOTE WORLDWIDE USE OF IVT'S FOR REDUCING DIESEL/GASOLINE ENGINE POLLUTION:
This will be accomplished with public relations, electronic and print news media and auto magazines. Included in the budget will be transportation of the vehicles, travel for the Company's support personnel, spare componentry, and promotional material. In addition, the Company will create displays for trade shows, SAE meetings, and other interested parties. The estmated budget to accomplish the above will be approximately $600,000.

5. TO ENTER INTO APPROPRIATE LICENSING COLLABORATIVE JOINT WORKING ARRANGEMENT WITH ALL TORVEC PRODUCTS (THE FASTRACK VEHICLE, IVT TRANSMISSION, HYDRAULIC PUMP/MOTOR, CV JOINT, AND SPHERICAL GEARING):
The Torvec CV joint for a front wheel drive Ford Taurus has been detailed by a contracted manufacturer, which has started to produce parts from the Company's CAD/CAM files. Assuming the parts are manufactured to specification, the completed Torvec CV joint will be installed in the Company's Taurus for evaluation, (durability, handling, etc.) If the results are satisfactory, the Company will present the CV Joint to the auto industry for their appraisal. The budget for completing the above will be approximately $100,000.
6. TO OBTAIN A WEBSITE FOR MARKETING, SALES, EDUCATION AND INFORMATION RELATING TO THE TORVEC PRODUCTS:
The Company will enter into arrangements with one or more companies to produce and manage Torvec's website. The beginning stages of the design are underway and will be ready as soon as practicable. The budget for production and management of the website is estimated to be $50,000.

7. TO OBTAIN PATENT PROTECTION ON AT LEAST FOUR NEW DEVELOPMENTS AND IMPROVEMENTS RELATED TO THE TORVEC PRODUCTS DESCRIBED ABOVE:
The budget, from past experience, is estimated to be approximately $130,000 for these patents.

LIQUIDITY AND CAPITAL RESOURCES

The Company's operations to date have been funded exclusively through the sale of 658,496 shares of Common Stock to a limited number of investors for an aggregate purchase price of approximately $1,400,000. These shares were sold at varying prices ranging from $1.50 to $3.00 per share. The Company does not presently anticipate that it will be able to generate significant operating revenues during the twelve months immediately following the effectiveness of this Registration Statement and therefore, the Company is presently planning to offer up to 1,500,000 shares of its Common Stock at $5.00 per share to generate sufficient capital to fund its continuing testing, development and other working capital requirements during the next twelve months. The Company anticipates, based on its currently proposed plans and assumptions relating to its operations (including assumptions regarding the nature and extent of its testing program, the ability of the Company to secure adequate manufacturing and distribution relationships and market acceptance of the Company's products) that if such offering is successful, the Company shall have sufficient capital to meet the Company's contemplated capital requirements for the next twelve months. However, if the Company's plans change or its assumptions change or prove to be incorrect, the Company could be required to seek additional financing. In addition, the Company may have to raise substantial additional capital to fund its operations, upon completion of its first year's operations. There can be no assurance that additional financing will be available when needed on terms acceptable to the Company, or at all.
If the Company successfully completes its planned offering of 1,500,000 shares, it will utilize the net proceeds of said offering as follows:

APPROXIMATE
DOLLAR AMOUNT

Named Executive Officers' salaries (1)                $600,000
Consultant's fees(2)                                  $450,000
Service and Space Agreement
  3740 Route 104, Williamson, New York (3)            $630,000
Purchase of 80 Acre Tract
  3740 Route 104, Williamson, New York (4)            $350,000
CAD/CAM Design Work (5)                               $104,000
IVT for FasTrack_ (6)                                $  50,000
Torvec_ Steer Drive (7)                               $100,000
Diesel Trucks (8)                                    $  80,000
IVT Design and Manufacturing (9)                      $150,000
Emission and Fuel Economy Testing (Alfred State) (10) $200,000
Installation of IVT into Taurus (11)                  $350,000
Promotion of Worldwide Use of IVT (12)                $600,000
Collaborative Joint Working Arrangements (13)         $100,000
Website (14)                                         $  50,000
New Patents (15)                                      $130,000
Legal and Accounting Expenses                         $250,000
Miscellaneous Costs of Public Offering, Including
Registration Fees and Printing Costs                  $150,000
Working Capital and General Corporate Purposes      $3,156,000

Total                                               $7,500,000

(1) See Page 21 of this Registration Statement for a description of the Company's employment agreements with its Named Executive Officers.
(2) See Page 22 of this Registration Statement for a description of the Company's consulting agreements with Keith, James and Vernon Gleasman.
(3) On January 7, 1998, the Company executed a Service and Space Agreement with Jospeh L. Neri, Sr. and Joseph L. Neri Chevrolet- Oldsmobile-Pontiac, Inc. pursuant to which the Company shall lease the premises located at 3740 Route 104, Williamson, New York 14589, rent equipment on premises and shall utilize Neri's personnel to construct, assemble and install the Company's products into vehicles. See "Plan of Operation." The agreement is for a term of one year, effective upon the completion of this Offering, and may be renewed, at the Company's option, for up to four additional one-year periods. The annual fee for facility, equipment and personnel is $630,000.
(4) Under the Space and Service Agreement, the Company has agreed to purchase, unless it would violate zoning laws or restrictions, an 80 acre tract of land adjacent to the premises located at 3740 Route 104 which acreage contains ponds, swamps and wood suitable for testing vehicles containing Company products. See "Plan of Operation." The purchase price is $350,000 and closing is to take place one year from the effective date of the agreement.
(5) See "Plan of Operation", Strategy 1.
(6) See "Plan of Operation", Strategy 1.
(7) See "Plan of Operation", Strategy 1.
(8) See "Plan of Operation", Strategy 2.
(9) See "Plan of Operation", Strategy 2.
(10) See "Plan of Operation", Strategy 2.
(11) See "Plan of Operation", Strategy 3.
(12) See "Plan of Operation", Strategy 4.
(13) See "Plan of Operation", Strategy 5.
(14) See "Plan of Operation", Strategy 6.
(15) See "Plan of Operation", Strategy 7.

The foregoing represents the Company's best estimate of its expenses during the 12 months immediately following the effectiveness of this Registration Statement. This estimate is based on certain assumptions, including that testing, development and marketing efforts relating to the Company's products can be completed at budgeted costs. Projected expenditures are estimates or approximations only. Future events, including the problems, delays, expenses, difficulties and complications frequently encountered by companies in an early stage of development, changes in economic or competitive conditions or in the Company's planned business, and the success or lack thereof of the Company's development and marketing efforts during the next twelve months may make shifts in the allocation of funds and curtailment of certain planned expenditures necessary or desirable. Any such shifts will be at the discretion of the Company. See "Plan of Operation."

Proceeds not immediately required for the purposes described above will be invested principally in short-term interest bearing securities, money market funds, certificates of deposit or direct or guaranteed obligations of the United States government.

IMPACT OF INFLATION

Inflation has not had a significant impact on the Company's operations to date and management is currently unable to determine the extent inflation may impact the Company's operations during the twelve months immediately following the effectiveness of this Registration Statement.

QUARTERLY FLUCTUATIONS
As of the date of this Registration Statement, the Company has not engaged in operations. Once the Company actually commences operations, the Company's operating results may fluctuate significantly from period to period as a result of a variety of factors, including product returns, purchasing patterns of consumers, the length of the Company's sales cycle to key customers and distributors, the timing of the introduction of new products and product enhancements by the Company and its competitors, technological factors, variations in sales by product and distribution channel, and competitive pricing. Consequently, once the Company actually commences operations, the Company's product revenues may vary significantly by quarter and the Company's operating results may experience significant fluctuations.

ITEM 3. DESCRIPTION OF PROPERTY.

See the Company's "Plan of Operation," Strategy 1 for a narrative description of the Company's Lease/Service Agreement, with respect to the Company's leasehold interest in plant and equipment located at 3740 Route 104, Williamson, New York 14587. See "Business of Issuer-The Company's Assets" for a narrative of the Company's patented inventions and other properties.

ITEM 4. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

(A) SECURITY OWNERSHIP

The following table sets forth as of the date of this Registration Statement certain information with respect to the beneficial ownership of the Common Stock of the Company by (i) each person known by the Company to own more than 5% of the outstanding shares of the Common Stock of the Company, each director, each executive officer, each consultant and (ii) all directors, executive officers and named consultants of the Company as a group. Unless otherwise indicated, the owners have sole voting and investment power with respect to their respective shares.

NAME AND ADDRESS OF                               NUMBER OF         PERCENT OF
  BENEFICIAL OWNER         POSITION              SHARES OWNED(1)   SHARES OWNED


Herbert H. Dobbs          Chairman of the Board    400,000(2)             1.93%
448 West Maryknoll Road   of Directors
Rochester Hills, MI 48309

Keith E. Gleasman         Dir.; President and    5,493,134(3)            26.56%
11 Pond View Drive        Consultant to Torvec,
Pittsford, NY 14534       Inc.

Lee E. Sawyer             Director                 357,000(4)             1.72%
16 Williamsburg Lane
Rolling Hills, CA 90274

Morton A. Polster         Director; Secretary of   275,600(5)             1.33%
c/o Eugene Stephens       Torvec, Inc.
& Associates
56 Windsor Street
Rochester, NY 14605

James A. Gleasman         Director; Consultant   5,480,133(6)            26.50%
11 Pond View Drive        to Torvec, Inc.
Pittsford, NY  14534

Vernon E. Gleasman        Consultant to          5,493,133(7)            26.56%
11 Pond View Drive        Torvec, Inc.
Pittsford, NY  14534

Samuel M. Bronsky         Chief Financial Officer    1,000            Less Than
6653 Main Street                                                        1%
Williamsville, NY  14221

All Executive Officers                          17,500,000(8)            84.60%
and Directors as a Group
(7 persons)

1. Except as indicated in the footnotes to this table, the Company believes that all the persons named in the table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to community property laws where applicable. In accordance with the rules of the Commission, a person or entity is deemed to be the beneficial owner of securities that can be acquired by such person or entity within 60 days from the date of this Registration Statement upon the exercise of options or warrants. Each beneficial owner's percentage ownership is determined by assuming that options and warrants that are held by such person (but not those held by any other person) and which are exercisable within 60 days of the date of this Registration Statement have been exercised. The inclusion herein of such shares listed as beneficially owned does not constitute an admission of beneficial ownership. Percentages herein assume a base of 20,673,496 shares of Common Stock outstanding as of the date of this Registration Statement.
2. Includes 20,000 shares which may be purchased through the exercise of an option granted in connection with his employment agreement, exercisable at $5.00 per share. In May, 1998, Mr. Dobbs entered into option agreements pursuant to which related parties have the right to purchase 360,000 shares of the Company's Common Stock from him at an exercise price of $5.00 per share at any time during a ten year option term.
3. Includes 5,000 shares which may be purchased through the exercise of an option granted in connection with his consulting agreement, exercisable at $5.00 per share. In December, 1997, Mr. Gleasman entered into option agreements pursuant to which related parties have the right to purchase 300,000 shares of the Company's Common Stock from him at an exercise price of $5.00 per share at any time during a ten year option term.
4. Includes 36,000 shares which may be purchased through the exercise of an option granted in connection with his employment agreement, exercisable at $5.00 per share.
5. Includes 20,000 shares which may be purchased through the exercise of an option granted in connection with his employment agreement, exercisable at $5.00 per share.
6. Includes 5,000 shares which may be purchased through the exercise of an option granted in connection with his consulting agreement, exercisable at $5.00 per share. In November, December 1997, Mr. Gleasman entered into option agreements pursuant to which related parties have the right to purchase 364,000 shares of the Company's Common Stock from him at an exercise price of $5.00 per share at any time during a 10 year option term.
7. Includes 5,000 shares which may be purchased through the exercise of an option granted in connection with his consulting agreement, exercisable at $5.00 per share. In December, 1997, Mr. Gleasman entered into option agreements pursuant to which related parties have the right to purchase 2,000,000 shares of the Company's Common Stock from him at an exercise price of $5.00 per share at any time during a 10 year option term.
8. Includes an aggregate 91,000 shares which may be purchased through the exercise of options granted in connection with employment and consulting agreements, exercisable at $5.00 per share.

ITEM 5. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS.

IDENTIFICATION OF DIRECTORS, EXECUTIVE OFFICERS AND CONSULTANTS

The following table sets forth certain information about the current directors, executive officers of the Company and its consultants.

                                               DATE OF       DATE OF
                                            ELECTION OR    TERMINATION
NAME                  AGE    POSITIION      DESIGNATION   OR RESIGNATION

Herbert H. Dobbs      66   Chairman of the     02/20/98          *
48 West Maryknoll Rd       Board of Directors
Rochester Hills, MI
48309

Keith E. Gleasman     50   Director; President      09/26/96          *
11 Pond View Drive         and Consultant to
Pittsford, NY 14534        Torvec, Inc.

Lee E. Sawyer         56   Director                 09/27/96          *
16 Williamsburg Lane
Rolling Hills, CA 90274

Morton A. Polster     70   Director; Secretary of   09/27/96          *
c/o Eugene Stephens &      Torvec, Inc.
Associates
56 Windsor Street
Rochester, NY 14605

James A. Gleasman     57   Director; Consultant to  02/20/98          *
11 Pond View Drive         Torvec, Inc.
Pittsford, NY 14534

Vernon E. Gleasman    86   Consultant to Torvec,    12/01/97          *
11 Pond View Drive         Inc.
Pittsford, NY 14534

Samuel M. Bronsky     36   Chief Financial Officer  04/01/98          *
6653 Main Street

Williamsville, NY 14221

*CHANGES IN CONTROL

To the knowledge of the Company's management, there are no present arrangements or pledges of the Company's Common Stock which may result in a change of control of the Company. The members of the Board of Directors shall serve until the next annual meeting of shareholders and until their successors are elected or appointed and shall have qualified, or until their prior resignation or termination.

(B) BUSINESS EXPERIENCE
The business experience of Messrs. Dobbs, Sawyer, Polster and Vernon E. Gleasman is provided on Pages 3 and 4 of this Registration Statement.
The following sets forth the business experience of Messrs. James A. and Keith E. Gleasman:

1. JAMES A. GLEASMAN - CONSULTANT
. Life-long entrepreneur.
. Skilled in management, finance, strategic planning, organizing and marketing.
. Co-inventor of the Gleasman GSD-10 steer drive.
. Established manufacturing of the TorsenR Differential in Argentina, Brazil, etc.
. Principal at two of the family companies, raised capital, negotiated international, military and automotive contracts.
. Set business strategies for small company's dealings with large companies, including sale of family company to Gleason Corp., New York.
. Joint venture partner with Clayton Brokerage Co. of St. Louis, MO.
. Owned financial-consulting business.
. Negotiated with numerous Asian Corporations (including Mitsubishi and Mitsui).
. Educated in Asian philosophy, business practices and culture.

2. KEITH E. GLEASMAN - CONSULTANT

Co-Inventor with Vernon E. Gleasman on all Torvec patents, Mr. Gleasman's strengths include his extensive marketing and sales executive experience, in addition to his design and development knowledge. His particular expertise has been in the area of defining and demonstrating the products to persons within all levels of the automotive industry, race crew members, educators and students.

. As Vice President of Sales for Gleason Corporation (Power Systems Division), designed and conducted seminars on vehicle driveline systems for engineers at the U.S. army tank automotive command.
. Designed a complete nationwide after-market program for the Torsen Differential, which included trade show participation for the largest after-market shows in the U.S.,SCORE and SEMA.
. Extensive after-market experience including pricing, distribuiton, sales catalogs, promotions, trade show booths designs and vehicle sponsorships.
. Responsible for over 300 articles in trade magazines highlighting the Torsen Differential (e.g., Popular Science, Auto Week, Motor Trend, Off-Road, and Four Wheeler).
. Designed FasTrack_ vehicle prototype, (from concept to asssembly).
. Assisted in developing engineering and manufacturing procedures for the Torsen Differential and for all of the Torvec prototypes.
. Instructed race teams on use of the Torsen Differential (Indy cars, Formula 1, SCCA Trans-Am, IMSA, GTO, GTU, GT-1, NASCAR, truck pullers and off-road racers).
. Has been trained for up-to-date manufacturing techniques such as NWH, statistical process control and MRP II. Mr. Gleasman has extensive technical and practical experience, covering all aspect of the Company's products such as, promotion, engineering and manufacturing.

3. SAMUEL M. BRONSKY - CHIEF FINANCIAL OFFICER

Owner of a Certified Public Accounting firm specializing in small to medium-sized businesses. Services include audits, reviews, compilations, and consulting services, including among other items, business valuations, computer applications, assisting in debt acquisition and consolidation, purchasing and selling of businesses and related tax ramifications, and general business assistance for clients. In addition, Mr. Bronsky has worked with various government agencies in a variety of audit contexts, including sales tax audits, IRS examinations. Mr. Bronsky is a member of the New York State Society of CPAs and the American Institute of CPAs. He is a director of the East Buffalo Credit Union and the Erie Community College Foundation and is the treasurer of the East Buffalo Credit Union. Mr. Bronsky is past treasurer and director of the Amherst Chamber of Commerce.

(C) FAMILY RELATIONSHIPS

Vernon E. Gleasman is the father of James A. and Keith E. Gleasman. There are no other family relationships between any directors or executive officers of the Company, either by blood or by marriage.

(D) CERTAIN PROCEEDINGS INVOLVING STOCKHOLDERS
1. On August 29, 1997, McElroy Manufacturing, Inc. of Tulsa, Oklahoma, and two of its employees (collectively "MMI"), initiated a lawsuit against Vernon and Keith Gleasman in the United States District Court for the Northern District of Oklahoma. The Company is not a party to this litigation. The plaintiffs seek money damages against the Gleasmans in the amount of $750,000 representing amounts MMI allegedly contributed to the development of hydraulic pump/motor prototypes and also allege that the two MMI employees should have been named as co-inventors on three patents.

In responding to the MMI complaints, the Gleasmans requested dismissal of the complaint on the grounds that the claims relate to an Agreement dated October 10, 1991, entered into by MMI and the Gleasmans under which the parties agreed to arbitrate "any controversy or claim arising out of or relating to this Agreement." The Gleasmans also requested dismissal of the complaint on the additional grounds that the two individuals were not co-inventors and, even if they were, that pursuant to the Agreement the individuals and MMI assigned any and all interest they may have had in such patents and prototypes to the Gleasmans.

On February 6, 1998, the Court stayed all aspects of the litigation pending arbitration in New York State. In the opinion of the Gleasmans, MMI's claims are without merit.

As indicated above, the Company is not a party to this MMI litigation. The litigation sets forth claims which do not effect the validity of the patents, but could impact the Company's exclusive ownership of three patents listed among the future products of the Company on Page 9 of this Registration Statement, namely the Hydraulic Pump/Motor, CV-Joint, and Spherical Gearing thus, enabling MMI to commercialize such patents. The claims are based upon the allegations that (1) the products were not included within the Agreement between the parties and therefore not assigned to the Gleasmans which fact is disputed by the Gleasmans and is one of the subjects of the arbitration, and (2) the plaintiffs are co-inventors of the invention with the Gleasmans, which allegation is contrary to every fact known by the Gleasmans. In the opinion of the Company, if the plaintiffs are successful, this will not effect the development and marketing of the FasTracka. Two of the three products are not used in the FasTrack. The third will be used by the Company, but a non-exclusive interest in that product, which is all that the plaintiffs could win, will not enable them to build the FasTrack which relies heavily on other Company patents, particularly the steer-drive patents.

2. In 1993, James A. Gleasman, after a dramatic reduction in income, suffered financial reverses and filed for protection under Chapter 11 of the United States Bankruptcy Code in United States Bankruptcy Court for the Western District of Texas. The reorganization was completed within 14 months and all allowed claims were paid in full.

ITEM 6. EXECUTIVE COMPENSATION.

EXECUTIVE COMPENSATION

SUMMARY COMPENSATION TABLE

Pursuant to the terms of the Company's employment agreements with Messrs. Herbert H. Dobbs, Lee E. Sawyer and Morton A. Polster (as more fully described below), such persons shall assume the capacities of Chief Executive Officer, President and Chief Operating Officer, and Secretary, Legal and Patent Counsel, respectively, on the first day of the month in which the Company completes its planned initial public offering of 1,500,000 shares of its Common Stock at $5.00 per share. The following table sets forth the aggregate compensation to be paid or accrued by the Company for services rendered in such capacities during the twelve month period beginning on the first day of the month following completion of such offering by Herbert H. Dobbs, Lee E. Sawyer and Morton A. Polster (together, the "Named Executive Officers").

                                                             LONG TERM
                                                        COMPENSATION AWARDS

                                                   NUMBER OF SHARES         
                                                  OF COMMON STOCK
                               ANNUAL               UNDERLYING        ALL OTHER
                            COMPENSATION              OPTIONS        COMPENSATION
NAME AND PRINCIPAL                      BONUS    _________________   ____________
                     SALARY
POSITION


Herbert H. Dobbs    $150,000 (1)        $ -0-       100,000 (2)           $0
Lee E. Sawyer       $240,000 (1)        $60,000     180,000 (2)           $0
Morton A. Polster   $150,000 (1)        $ -0-       100,000 (2)           $0

(1) Prior to the date of this Registration Statement, the Company did not pay cash compensation to the Company's Chief Executive Officer or to the Company's other Named Executive Officers. The Named Executive Officers and the consultants named below have performed services to the Company to date in exchange for receipt of shares of Common Stock in the Company and in the case of the Gleasmans, a cash reimbursement in the amount of $365,000 for expenses incurred prior to the Company's formation with respect to the Company's inventions and patent properties. See "Security Ownership of Management and Certain Security Holders"; "Certain Transactions." It is not anticipated that such personnel will receive additional shares for such past services. The Company has executed employment agreements with its Named Executive Officers and consulting agreements with its consultants, the salient terms and conditions of which are described below. See "Employment Agreements;" "Consulting Agreements."

(2) In 1998 380,000 stock options have been granted to the Named Executive Officers in connection with their employment agreements exercisable in cumulative increments at the rate of 20% annually.

AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION
VALUES

The following table sets forth certain information for the Named Executive Officers with respect to the exercise of options to purchase Common Stock during the fiscal year ended December 31, 1997 and the number and value of securities underlying unexercised options held by the Named Executive Officers as of April 15, 1998.

                                 NUMBER OF UNEXERCISED     VALUE OF UNEXERCISED
                SHARES                OPTIONS AT           IN-THE-MONEY OPTIONS
               ACQUIRED    VALUE     APRIL 15, 1998        AT APRIL 15, 1998(1)
  NAME        ON EXECISE REALIZED EXERCISAB(2) UNEXERCISAB EXERCISAB UNEXERCISAB

Herbert H. Dobbs     0      0      20,000       80,000        $0         $0
Lee E. Sawyer        0      0      36,000      144,000        $0         $0
Morton A. Polster    0      0      20,000       80,000        $0         $0

(1) Calculated on the basis of the planned initial public offering price of the the Common Stock of $5.00 per share, minus the per share exercise price multiplied by the number of shares underlying the option.
(2) At December 31, 1997 the options indicated as exercisable were included in the unexercisable column.

EMPLOYMENT AGREEMENTS

On February 6, 1998, the Company entered into a 3 year employment agreement with Herbert H. Dobbs, commencing on the first day of the month in which the Company receives the proceeds from the completion of its planned initial public offering of up to 1,500,000 shares at $5.00 per share, under which he is obligated to devote substantially all of his business and professional time to the Company and its Plan of Operation in the capacity as Chairman and Chief Executive Officer of the Company. Under such agreement, Herbert H. Dobbs is entitled to receive a salary of $150,000 during the first year of the agreement, $150,000 during the second year and $150,000 during the last year. He is also entitled to certain employee benefits normally associated with employment such as vacation, health and disability insurance and was granted an option to purchase 100,000 shares of the Company's Common Stock pursuant to the Company's 1998 Stock Option Plan conditioned upon shareholder approval of the 1998 Stock Option Plan. The agreement is automatically renewable for an additional 3 years and may be terminated earlier by the employee upon 12 months notice or by the Company upon payment of a severence of 12 months base pay, except if the termination is for cause.

On February 6, 1998, the Company entered into a 3 year employment agreement with Lee E. Sawyer, commencing on the first day of the month in which the Company receives the proceeds from the completion of its planned initial public offering of up to 1,500,000 shares at $5.00 per share, under which he is obligated to devote substantially all of his business and professional time to the Company and its Plan of Operation in the capacity as President and Chief Operating Officer of the Company. Under such agreement, Mr. Sawyer is entitled to receive a salary of $240,000 during the first year of the agreement, $252,000 during the second year and $264,000 during the last year and a minimum bonus of $15,000 per quarter during the agreement's term, with bonus increases determined by the Board of Directors depending upon such factors as performance, profitability and the financial condition of the Company. He is also entitled to certain employee benefits normally associated with employment such as vacation, health and disability insurance and was granted an option to purchase 180,000 shares of the Company's Common Stock pursuant to the Company's 1998 Stock Option Plan conditioned upon shareholder approval of the 1998 Stock Option Plan. The agreement is automatically renewable for an additional 3 years and may be terminated earlier by the employee upon 12 months notice or by the Company upon payment of a severence of 12 months base pay and minimum bonus, except if the termination is for cause.

On February 6, 1998, the Company entered into a 3 year employment agreement with Morton A. Polster, commencing on the first day of the month in which the Company receives the proceeds from the completion of its planned initial public offering of up to 1,500,000 shares at $5.00 per share, under which he is obligated to devote substantially all of his business and professional time to the Company and its Plan of Operation in the capacity as Secretary and Legal and Patent Counsel of the Company. Under such agreement, Mr. Polster is entitled to receive a salary of $150,000 during the first year of the agreement, $150,000 during the second year and $150,000 during the last year. He is also entitled to certain employee benefits normally associated with employment such as vacation, health and disability insurance and was granted an option to purchase 100,000 shares of the Company's Common Stock pursuant to the Company's 1998 Stock Option Plan conditioned upon shareholder approval of the 1998 Stock Option Plan. The agreement is automatically renewable for an additional 3 years and may be terminated earlier by the employee upon 12 months notice or by the Company upon payment of a severence of 12 months base pay, except if the termination is for cause.

CONSULTING AGREEMENTS

On December 1, 1997, the Company entered into a 3 year consulting agreement with Vernon E. Gleasman, under which he is obligated to devote substantially all of his business and professional time to the Company and its Plan of Operation in the capacity of Consultant to the Company. Under such agreement, Mr. Vernon Gleasman shall receive an annual consulting fee of $150,000 and was granted an option to purchase 25,000 shares of the Company's Common Stock pursuant to the Company's 1998 Stock Option Plan conditioned upon shareholder approval of the 1998 Stock Option Plan.

On December 1, 1997, the Company entered into a 3 year consulting agreement with James A. Gleasman, under which he is obligated to devote substantially all of his business and professional time to the Company and its Plan of Operation in the capacity of Consultant to the Company. Under such agreement, Mr. James A. Gleasman shall receive an annual consulting fee of $150,000 and was granted an option to purchase 25,000 shares of the Company's Common Stock pursuant to the Company's 1998 Stock Option Plan conditioned upon shareholder approval of the 1998 Stock Option Plan.

On December 1, 1997, the Company entered into a 3 year consulting agreement with Keith E. Gleasman, under which he is obligated to devote substantially all of his business and professional time to the Company and its Plan of Operation in the capacity of Consultant to the Company. Under such agreement, Mr. Keith E. Gleasman shall receive an annual consulting fee of $150,000 and was granted an option to purchase 25,000 shares of the Company's Common Stock pursuant to the Company's 1998 Stock Option Plan conditioned upon shareholder approval of the 1998 Stock Option Plan.

Each of the employment agreements and each of the consulting agreements contain customary covenants prohibiting the employee or the consultant, as the case may be, from disclosure of confidential information regarding the Company, its inventions and its products, and provisions confirming that all inventions conceived, made or developed by the employee or the consultant, as the case may be, and relating to the business of the Company constitutes the sole property of the Company. Each of the consulting agreements contains covenants restricting the consultant from engaging in any activities competitive with the business of the Company during the terms of such agreements and for a period of two years after termination. Each of the consulting agreements also contain a provision that the benefits provided thereunder continue even if the consultant were to become unable to perform services for the Company during its term.

1998 STOCK OPTION PLAN

On December 1, 1997, the Company's Board of Directors adopted the Company's 1998 Stock Option Plan pursuant to which officers, directors, key employees and/or consultants of the Company may be granted incentive stock options and/or non-qualified stock options to purchase up to an aggregate of 2,000,000 shares of the Company's Common Stock. The Company intends to submit its 1998 Stock Option Plan to existing shareholders prior to the effective date of this Registration Statement.

With respect to incentive stock options, the Plan provides that the exercise price of each such option must be at least equal to 100% of the fair market value of the Common Stock on the date that such option is granted (110% of fair market value in the case of shareholders who, at the time the option is granted, own more than 10% of the total outstanding Common Stock), and requires that all such options have an expiration date not later than the date which is one day before the tenth anniversary of the date of the grant of such options (or the fifth anniversary of the date of grant in the case of 10% shareholders). However, in the event that the option holder ceases to be an employee of the Company, such option holder's incentive options immediately terminate. Pursuant to the provisions of the Plan, the aggregate fair market value, determined as of the date(s) of grant, for which incentive stock options are first exercisable by an option holder during any one calendar year cannot exceed $100,000.

With respect to non-qualified stock options, the Plan permits the exercise price to be less than the fair market value of the Common Stock on the date the option is granted and permits Board discretion with respect to the establishment of the terms of such options. Unless the Board otherwise determines, in the event that the option holder ceases to be an employee of the Company, such option holder's non-qualified options immediately terminate.

In connection with their employment agreements, the Company's Board of Directors granted stock options under the 1998 Stock Option Plan to the Company's Named Executive Officers entitling them to purchase an aggregate of 380,000 shares of Common Stock, all of which provide for an exercise price of $5.00 per share, are exercisable on a cumulative basis at the rate of 20% per year beginning on January 1, 1998 and provide that the right to exercise the option in accordance with its terms shall survive the executive's termination of employment. Each option expires on December 31, 2007 and is conditioned upon shareholder approval of the Plan. In connection with their consulting agreements, the Board of Directors granted stock options under the 1998 Stock Option Plan to the Company's consultants entitling them to purchase an aggregate of 75,000 shares of Common Stock, all of which provide for an exercise price of $5.00 per share, are exercisable on a cumulative basis at the rate of 20% per year beginning on December 1, 1997 and provide that the right to exercise the option in accordance with its terms shall survive the consultant's termination of services. Each option expires on November 30, 2007 and is conditioned upon shareholder approval of the Plan.

ITEM 7. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.

CERTAIN TRANSACTIONS

As stated elsewhere in this Registration Statement, during the ten plus years prior to the incorporation of the Company, Vernon E., Keith E. and James
A. Gleasman invented and patented numerous improvements relating to drive mechanisms for tracked vehicles, transmissions, hydraulic pumps/motors, a unique form of gearing, universal joints, and constant velocity joints as disclosed in such patents. Upon the Company's incorporation, the Gleasmans assigned all their right, title and interest to and in such inventions and patents to the Company in exchange for the issuance of 16,464,400 shares of the Company's Common Stock and the agreement of the Company to pay the Gleasmans the sum of $365,000 for expenditures in the development of these inventions and products, the Gleasmans having agreed to waive and release the Company from payment of any other expenses that they incurred in the development of these inventions and products. The Board of Directors of the Company concluded that the value of the inventions, patents and patent applications assigned to the Company, as well as the value of the services rendered, had a value in excess of the par value of the number of shares transferred to the assignors and service providers, respectively. Shares issued are fully paid and nonassessable.

Mr. Morton A. Polster, a director of the Company and its Secretary, has been Patent Counsel to the Gleasman family since 1989 and has been in charge of the preparation and execution of the Gleasmans' and now the Company's U.S. and international patent protection. Mr. Polster received 291,600 shares of the Company's Common Stock at the inception of the Company.

See Page 13 of this Registration Statement for a discussion of the lease/service contract entered into between the Company and Joseph L. Neri, Sr., who owns 95,000 shares of the Common Stock of the Company.

On February 11, 1997, the Company entered into a consulting agreement to retain LT Lawrence & Co., Inc. on a nonexclusive basis as a financial consultant for a period of three years. Under the agreement, the consultant will assist the Company in developing, studying and evaluating financing, merger and acquisition proposals, assist the Company in obtaining short and long-term financing and serve as a liaison between the Company and individuals and financial institutions in the investment community, such as security analysts, portfolio managers and market makers. As compensation, the Company issued an aggregate 1,000,000 shares of its Common Stock to the consultant's principals and granted the same persons 500,000 Consulting Warrants exercisable for a period of 5 years, commencing upon the consummation of this Offering, at an exercise price equal to the initial public offering price. If 50% or more of the Company's assets or Common Stock is acquired by a third party during the 5 year Consulting Warrant term, the exercise price shall be $1.50. In the event that the Representative originates an acquisition or merger transaction to which the Company is a party, LT Lawrence & Co., Inc. will also be entitled to receive a finder's fee in consideration for origination of such transaction.

The Company has agreed to register, at the request of the holders of a majority of the 1,000,000 shares and/or the 500,000 Consulting Warrants and at Company expense, the shares and/or the shares of Common Stock underlying the Consulting Warrants under the Securities Act on one occasion during the Consulting Warrant term and to include such underlying shares in any registration statement that is filed by the Company during the Consulting Warrant term and for two years after its expiration.

Each of consultant's principals have agreed not to offer, sell, assign, pledge or transfer any of such shares of Common Stock or the shares of Common Stock underlying the Consulting Warrants for a period of 12 months from the date of this Registration Statement.

Certain officers, directors and consultants may engage in transactions with the Company in the ordinary course of the business of the Company. It is expected that the terms and conditions of such transactions will be substantially the same as similar transactions with unrelated parties.

Other than as described herein, and other than as described in Part I, Item 6, there have been no material transactions, series of similar transactions or currently proposed transactions to which the Company was or is a party, in which the amount invested exceeds $60,000 and in which any director or executive officer, or any security holder who is known to the Company to own of record or beneficially more than five percent of the Company's Common Stock, or any member of the immediate family of any of the foregoing persons, had a material interest.

ITEM 8. DESCRIPTION OF SECURITIES.

COMMON STOCK
The Company is authorized to issue 40,000,000 shares of Common Stock, $.01 par value per share, of which 20,673,496 shares are currently issued and outstanding. Once issued for consideration, the shares of Common Stock are not subject to assessment or call. The following summary description of the Common Stock is qualified in its entirety by reference to the Company's Certificate of Incorporation, as amended, a copy of which is included as an exhibit to the Company's Registration Statement.

The holders of Common Stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders. There is no cumulative voting with respect to the election of directors, which means that the holders of more than 50% of the outstanding shares of Common Stock can elect all of the Company's directors if they choose to do so and, in such event, the holders of the remaining shares would not be able to elect any directors. Holders of Common Stock are entitled to receive ratably such dividends as may be declared by the Board of Directors out of funds legally available therefor and, in the event of the liquidation, dissolution or winding up of the Company, are entitled to share ratably in all assets remaining after payment of all liabilities. Holders of the Common Stock do not have subscription, redemption or conversion rights, nor do they have any preemptive rights. In the event the Company were to elect to sell additional shares of its Common Stock following this Offering, investors in this Offering would have no right to purchase such additional shares. As a result, their percentage equity interest in the Company would be diluted. All of the outstanding shares of Common Stock are, and the shares to be outstanding upon completion of this Offering will be, duly authorized, validly issued, fully paid and nonassessable. The Board of Directors is authorized to issue additional shares of Common Stock, not to exceed the amount authorized by the Company's Certificate of Incorporation as amended from time to time, and to issue options and warrants for the purchase of such Common Stock, on such terms and conditions and for such consideration as the Board of Directors may deem appropriate without further stockholder action.

OUTSTANDING WARRANTS

The Company has outstanding Consulting Warrants granting the holders the right to purchase up to an aggregate of 500,000 shares of Common Stock at a purchase price equal to the initial public offering price per share. The Consulting Warrants may be exercised on the date the Registration Statement filed with the Commission of which this Registration Statement is a part is declared effective by the Commission and shall expire five years thereafter. The Consulting Warrant holders are entitled to one demand and unlimited piggyback registration rights with respect to the underlying shares. See "Certain Transactions."

SHARES ELIGIBLE FOR FUTURE SALE

As of the effective date of the Registration Statement, the Company will have issued and outstanding 20,673,496 shares of Common Stock. Of such shares, all 20,673,496 shares of Common Stock are restricted securities within the meaning of Rule 144 under the Securities Act and, in general, if held for at least one year, will be eligible for sale in the public market in reliance upon and subject to the limitations of Rule 144.

In general under Rule 144 as currently in effect, a person (or persons whose shares are aggregated), including a person who may be deemed to be an affiliate of the Company as that term is defined under the Securities Act, is entitled to sell, within any three-month period, a number of shares beneficially owned for at least one year that does not exceed the greater of (i) one percent of the number of the then outstanding shares of Common Stock or (ii) the average weekly trading volume in the Common Stock during the four calendar weeks preceding such sale. Sales under Rule 144 are also subject to certain requirements as to the manner of sale, notice and the availability of current public information about the Company. Furthermore, a person who is not deemed to have been an affiliate of the Company during the ninety days preceding a sale by such person and who has beneficially owned such shares for at least two years is entitled to sell such shares without regard to the volume, manner of sale, public information or notice requirements. Under Rule 144 (and subject to the conditions thereof), of the 20,673,496 shares of Common Stock outstanding as of the date of this Registration Statement, 20,453,594 will become eligible for sale beginning 90 days after the date of this Registration Statement and substantially all of the remaining 219,902 shares will become eligible for sale as of January 30, 1999. In addition, the Company has granted certain registration rights with respect to 1,000,000 shares of Common Stock issued to certain principals of the LT Lawrence & Co., Inc. and with respect to the 500,000 shares of Common Stock underlying the Representative's Warrants and the Consulting Warrants, respectively. See "Certain Transactions."

There has been no public market for the Company's securities. The Company cannot predict the effect, if any, that market sales of the Common Stock, or the availability of such shares for sale, will have on the market price prevailing from time to time. Nevertheless, sales by the existing stockholders of substantial amounts of Common Stock in the public market could adversely affect prevailing market prices for the Company's securities. In addition, the availability for sale of substantial amounts of Common Stock acquired through the exercise of options or warrants could adversely affect prevailing market prices for the Common Stock.

No prediction can be made as to the effect, if any, that sales of Common Stock and of Common Stock underlying outstanding options or warrants or the availability of such shares for sale in the public market will have on the market price for the Common Stock prevailing from time to time. Nevertheless, sales of substantial amounts of Common Stock in the public market and/or upon the exercise of outstanding options and warrants after the restrictions described above lapse, or in the case of LT Lawrence & Co., Inc. after the exercise of its registration rights, could adversely effect prevailing market prices for the Common Stock and impair the ability of the Company to raise capital through an offering of its equity securities in the future.

PART II

ITEM 1. MARKET PRICE OF AND DIVIDENDS ON THE REGISTRANT'S COMMON EQUITY AND

OTHER SHAREHOLDER MATTERS.

(A) MARKET INFORMATION

Since the Company's incorporation in September, 1996, there has been no public market for the Company's Common Stock. The Company anticipates that upon the effectiveness of this Registration Statement, it will apply to have its Common Stock traded on the "Electronic Bulletin Board" of the National Association of Securities Dealers, Inc. ("NASD") and it is anticipated that upon such event, high and low bid and asked prices for the Company's Common Stock as reported by NASD will become available.

(B) HOLDERS

As of April 15, 1998, the Company had 113 shareholders of record.

(C) DIVIDEND POLICY

The Company has not paid any dividends to its shareholders since its inception. The declaration or payment of dividends, if any, to its shareholders is within the discretion of the Board of Directors of the Company and will depend upon the Company's earnings, capital requirements, financial condition and other relevant factors. The Board of Directors does not currently intend to declare or pay any dividends in the foreseeable future and intends to retain any earnings to finance the growth of the Company.

(D) REPORTS TO SHAREHOLDERS

The Company intends to furnish its shareholders with annual reports containing audited financial statements and such other periodic reports as the Company may determine to be appropriate or as may be required by law. Upon the effectiveness of this Registration Statement, the Company will be required to comply with periodic reporting, proxy solicitation and certain other requirements of the Securities Exchange Act of 1934.

(E) TRANSFER AGENT AND REGISTRAR

Continental Stock Transfer & Trust Company has been appointed as the Company's Transfer Agent and Registrar for its Common Stock.

ITEM 2. LEGAL PROCEEDINGS.

The Company is not a party to any pending , material legal proceeding. To the knowledge of management, no federal, state or local governmental agency is presently contemplating any proceeding against the Company. See "Management- Certain Proceedings Involving Consultants."

ITEM 3. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS.

None, not applicable

ITEM 4. RECENT SALES OF UNREGISTERED SECURITIES.

The following table provides information with respect to the sale of all "unregistered" and "restricted" securities sold by the Company since its incorporation in September, 1996, which were not registered under the Securities Act of 1933, as amended:

                        DATE OF       NO.        AMOUNT PAID
NAME OF STOCKHOLDER      SALE       SHARES

Gleasman, Keith E.    9-27-96           1.0    Founder's Shares

Gleasman, Vernon E.   9-27-96   5,488,133.0    Founder's Shares

Gleasman, Keith E.    9-27-96   5,488,133.0    Founder's Shares

Gleasman, James A.    9-27-96   5,488,133.0    Founder's Shares

Vogt, James M.        9-27-96     380,000.0           60,845.00

Polster, Morton A.    9-27-96     291,600.0           46,691.00

Oppenheimer, Robert   9-27-96      95,000.0           15,211.00

Jackson Investment    9-27-96     190,000.0           30,423.00

Sawyer, Lee           9-27-96     285,000.0           45,634.00

Cleaver, Derek        9-27-96     285,000.0           45,634.00

Martindale, Michael   9-27-96     190,000.0           30,423.00

Gleasman, David       9-27-96      95,000.0           15,211.00

Smith, Tim            9-27-96      47,500.0            7,607.00

McCracken, Peter      9-27-96      47,500.0            7,607.00

Neri, Joseph          9-27-96      95,000.0           15,211.00

Neri, Gerard J.       9-27-96     154,000.0           24,658.00

Dobbs, Herbert        9-27-96     380,000.0           60,845.00

Post, John A. II       1-7-97       3,000.0            4,500.00

Kettle, John           1-7-97       2,000.0            3,500.00

Testa, David R.        1-7-97       4,000.0            6,000.00

Jordan, William E.     1-7-97      10,000.0           15,000.00
and Janis

Bauer, Gerard R.       1-7-97       2,800.0            4,200.00
and Barbara

Post, Jack E.          1-7-97      10,000.0           15,000.00

Resch, David P.        1-7-97      13,000.0           19,500.00

Lawson, Alfred C.      1-7-97       6,000.0            9,000.00
and Audrey

Gale, Diane L.         1-7-97      10,000.0           15,000.00

Bonn, Kenneth Sr.      1-7-97       5,000.0            7,500.00

Liberty Systems        1-7-97       5,000.0            7,500.00

Warner, Greg           1-7-97      20,000.0           30,000.00

Husser, John D.        1-7-97       5,000.0            7,500.00

Bauer, Kimberly A.     1-7-97       2,000.0            3,000.00

Tallo, Gerard A.       1-7-97       4,500.0            6,750.00
and Sandra

Woodworth, Richard L.  1-7-97       3,334.0            5,001.00
and Essie M.

Cook, Clark            1-7-97      66,660.0          100,000.00

Brenner, Lloyd M.      1-7-97       3,333.3            5,000.00
and Wyllo

Miller, Gregory        1-7-97       2,500.0            3,750.00
and Mary Ann

Ellison, Deborah M.    1-7-97       3,333.0            5,000.00

Millet, Carol S.       1-7-97       1,000.0            1,500.00

Millet, David J.       1-7-97       7,000.0           10,500.00

Maker, Christine M.    1-7-97       2,000.0            3,000.00

Hampton, William R.    1-7-97       6,666.0           10,000.00
and Shirley

DeManincor, Daniel     1-7-97       6,667.0           10,000.00
and Donna

Visconte, Joseph J.    1-7-97       9,334.0           14,001.00
and Diane M.

Visconte, Joseph D.    1-7-97       6,667.0           10,000.00
and Irene M.

                                DATE OF SALE     NO. SHARES    AMOUNT PAID
NAME OF STOCKHOLDER

Lyles, James and Nancy              2-5-97       5,000.0      7,500.00

Webster, Odgen H.                   2-5-97       6,667.0     10,000.50

Gysel, Charles P. and Jeri          2-5-97       3,333.3      5,000.00

Dailey, Kenneth P. and Marcia       2-5-97       6,666.0     10,000.00

Radford, Gary                       2-5-97       4,000.0      6,000.00

Schmidt, Stephen and Patricia       2-5-97       4,600.0      6,900.00

Case, Theodore D.                   2-5-97       4,000.0      6,000.00

Mihevc, Mayda                       2-5-97      10,000.0     15,000.00

Hanson, James R. and Portia P.      2-5-97      10,000.0     15,000.00

Williams, Fred                      2-5-97       2,000.0      3,000.00

Miller, Michael T.                  2-5-97       2,000.0      3,000.00

Galusha, Gloria                     2-5-97       5,000.0      7,500.00

Weinstein, Eugene A.                2-5-97       4,000.0      6,000.00

Nygard, Kirsten Erica               2-5-97         700.0      1,050.00

Hubbard, Gary A.                   2-24-97       3,334.0      5,001.00

Schmidt, Stephen and Patricia      2-24-97       1,666.0      2,500.00

Schmidt, Pete W. and Lorraine J.   2-24-97       4,666.0      7,000.00

Gerace, Vincent J.                 2-24-97       4,000.0      6,000.00

Warner, W. Greg                    2-24-97      20,000.0     30,000.00

Warner, W. Greg                    2-25-97      20,000.0     30,000.00

Sevene, Paul H. Jr.                2-25-97       1,334.0      2,001.00
and Dalessando Paul

Marvek Investments, Inc.           2-25-97      10,667.0     16,000.50

Principato, Lawrence               4-15-97     250,000.0         10.00

Roberti, Todd                      4-15-97     250,000.0         10.00

Paone, Richard J.                  4-15-97     250,000.0         10.00

Gold, Joel                         4-15-97     125,000.0         10.00

Toto, James                        4-15-97     125,000.0         10.00

Resch, David P.                     6-1-97      15,000.0     22,500.00

Marvek Investments                  6-1-97      15,000.0     22,500.00

Post, Jack E.                       6-1-97       5,000.0     15,000.00

Lawson, Alfred C. and Audrey F.     6-1-97       2,500.0      7,500.00

Canan, Patricia L.                  6-1-97       2,500.0      7,500.00

Martin, Henry A. and Annabelle V.   6-1-97       2,000.0      6,000.00

Polster, Keith A. and Theresa       6-1-97      16,000.0     48,000.00

Polster, Evan D.                    6-1-97       2,000.0      6,000.00

Polster, Mark S.                    6-1-97       1,000.0      3,000.00

Runberg, Jon E.                     6-1-97         500.0      1,500.00

Sharpe, Joanne L.                   6-1-97         500.0      1,500.00

Sharpe, Larissa M.                  6-1-97         500.0      1,500.00

Hampton, William R. and Shirley     6-1-97       1,667.0      5,000.00

Martindale, Michael and Dorothy     6-1-97      16,000.0     48,000.00

Miller, Michael T. and              6-1-97       1,000.0      3,000.00
Elizabeth J.

Stendardo, Joseph G. and Ellicot,   6-1-97       3,500.0     10,500.00
Laurie B.

Cook, Clark W.                      6-1-97       1,000.0      3,000.00

                                      DATE OF SALE     NO. SHARES    AMOUNT PAID
NAME OF STOCKHOLDER

Ramsey, Christine E.                      6-1-97       1,000.0       3,000.00

Ramsey, Donald W. and Suzanne M.          6-1-97       1,000.0       3,000.00

Miller, Gregory J. and Mary Ann           6-1-97       1,000.0       3,000.00

Weinstein, Eugene                         6-1-97       2,000.0       6,000.00

Post, John A.                             6-1-97       2,500.0       7,500.00

Radford, G. Gary and Patricia M.          6-1-97       1,000.0       3,000.00
(Living Trust)

Millet, David J.                          6-1-97       3,000.0       9,000.00

Runberg, Jon and Janet                    6-1-97       1,000.0       3,000.00

Maker, Christine                          6-1-97       1,000.0       3,000.00

Siconolfi, Samuel A. and Mary            7-25-97       1,667.0       5,001.00

Siconolfi, Gary A.                       7-25-97       6,667.0      20,000.00

Flammia, James M. Sr.                    7-25-97       1,667.0       5,001.00

Lunn, Robert J. and Paul L.              7-25-97       1,667.0       5,001.00

Alberti, Joseph                          7-25-97       1,667.0       5,001.00

Gabel, Donald W. and Dora N.             7-25-97       5,000.0       7,500.00

R.L.T. Associates, Inc.                  7-25-97       5,000.0       7,500.00

Elting, Arthur S. and Marilyn M.         7-25-97       1,000.0       3,000.00

Dreyer, Charles                          7-25-97       1,000.0       3,000.00

Pastore, Carl P.                         7-25-97       1,000.0       3,000.00

Dickinson, Jerry B.                      7-25-97       1,000.0       3,000.00

Bradia, David Jr                          8-1-97      12,000.0      36,000.00

Toscano, Joseph                           9-1-97       1,667.0       5,001.00

Ray, Larry G. and Rebecca M.              9-1-97       2,000.0       6,000.00

Rogers, Mark                              9-1-97       1,500.0       4,500.00

Abelove, David                            9-1-97      20,000.0      60,000.00

Hopson, Bradford J.                       9-1-97       1,700.0       5,100.00

Giosio, Angelo                            9-1-97       1,700.0       5,100.00

Howard Norvasel Trust                     9-1-97      20,000.0      60,000.00

MLPF&S f/b/o M. Mihevc                    9-1-97      10,000.0      30,000.00

Richter, Douglas C. and Jean S.          10-1-97       2,000.0       6,000.00

Miller, Russell S.                       10-1-97       2,000.0       6,000.00

Whitehead, James A. and Susan S          10-1-97       1,000.0       3,000.00

Gleasman, Jason                          10-1-97         500.0       1,500.00

Gleasman, Patricia                       10-1-97         500.0       1,500.00

Gleasman, Howard and Patricia            10-1-97       1,000.0       3,000.00

Kane, Clifford and Jill                  10-1-97       2,000.0       3,000.00

Paul, James R.                           10-5-97       1,000.0       3,000.00

Dolan, Brendan                           10-5-97       1,000.0       3,000.00

Bunner, Robert B. IRA                   12-30-97      10,000.0      30,000.00

Horton, Robert C.                       12-30-97     100,000.0     300,000.00

Bronsky,Samuel M.                        3-13-98       1,000.0       3,000.00

Management believes all of the foregoing persons were either "accredited investors" as that term is defined under applicable federal and state securities laws, rules and regulations, or were persons who were by virtue of background, education and experience, either alone or through the aid and assistance of a personal representative, could accurately evaluate the risks and merits accordant to an investment of the securities of the Company. Further, all such persons were provided with access to all material information regarding the Company, prior to the offer or sale of these securities, and each had an opportunity to ask of and receive answers from directors, executive officers, attorneys and accountants for the Company. The offers and sales of the foregoing securities are believed to be exempt from the registration requirements of Section 5 of the 1933 Act pursuant to Section 4(2) thereof, and pursuant to and in accordance with Regulation D, Rule 505 promulgated thereunder, and from similar states' securities laws, rules and regulations requiring the offer and sale of securities by available state exemptions from such registration.

ITEM 5. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

The Certificate of Incorporation of the Company provides for elimination or limitation of personal liability of directors to the Company or its shareholders for money damages for conduct as a director, except that in accordance with New York law, a director's liability cannot be eliminated or limited for conduct which constitutes a breach of the director's duty of loyalty to the Company or its shareholders, acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, or for any unlawful distribution or transaction involving improper personal benefit.

The Certificate of Incorporation of the Company further provides for indemnification of officers and directors for expenses incurred in connection with any proceeding to which a person is made a party by reason of the fact that the person was serving as an officer or director of the Company or any of its subsidiaries, or of any other entity at the request of the Company, provided that such person acted in good faith, did not engage in intentional misconduct, and, with respect to any criminal action, did not know the conduct was unlawful.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

PART F/S

         I
Index to Financial Statements
                                                  Page
                                                  ----
   Independent Auditors' Report                    F-2
Financial Statements
Balance sheet as of December 31, 1997              F-3
Statements of operations for the year ended        F-4
December 31, 1997 and for the periods from
September 25, 1996 (inception) through December
31, 1996 and September 25, 1996 (inception)
through December 31, 1997
Statements of changes in stockholders' equity for  F-5
the year ended December 31, 1997 and for the
period from September 25, 1996 (inception)
through December 31, 1996
Statements of cash flows for the year ended        F-6
December 31, 1997 and for the periods from
September 25, 1996 (inception) through December
31, 1996 and September 25, 1996 (inception)
through December 31, 1997
Notes to financial statements                      F-7

INDEPENDENT AUDITORS' REPORT
Board of Directors and Stockholders

Torvec, Inc.

We have audited the accompanying balance sheet of Torvec, Inc., (a development stage company), as of December 31, 1997, and the related statements of operations and cash flows for the year ended December 31, 1997 and for the periods from September 25, 1996 (inception) through December 31, 1996 and September 25, 1996 (inception) through December 31, 1997 and changes in stockholders' equity for the year ended December 31, 1997 and the period from September 25, 1996 (inception) through December 31, 1996. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion. In our opinion, the financial statements enumerated above present fairly, in all material respects, the financial position of Torvec, Inc. as of December 31, 1997 and the results of its operations and its cash flows for the year ended December 31, 1997 and for the periods from September 25, 1996 through December 31, 1996 and from September 25, 1996 through December 31, 1997 in conformity with generally accepted accounting principles.
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note A to the financial statements, the Company has incurred net losses and is not generating cash flows from operating activities to sustain its operations which raises substantial doubt about its ability to continue as a going concern. Management's plans in regard to these matters are described in Note A. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

As described in Note G(3), the principal stockholders are involved in an arbitration proceeding relating to certain technology which they contributed to the Company at its formation.

/S RICHARD A. EISNER & COMPANY, LLP

Richard A. Eisner & Company, LLP
New York, New York
March 4, 1998

TORVEC, INC.
(a development stage company)

       Balance Sheet
       December 31, 1997


   ASSETS                                                  
Current assets:
Cash                                                    $147,000
Other current assets (Note G(1))                          53,000
Subscriptions receivable (Note F(4))                     180,000
                                                        --------
Total current assets                                     380,000
                                                        --------
Equipment (Note B(1)):
Office equipment                                           5,000
Transportation equipment                                  24,000
                                                        --------
                                                          29,000
Less accumulated depreciation                             (3,000)
                                                        --------
Net equipment                                             26,000
                                                        --------
Other Assets:
  Deposits (Note G(1))                                   111,000
  Deferred offering costs (Note F(3))                     60,000
                                                        --------
                                                         171,000
                                                        --------
                                                        $577,000
                                                        ========
LIABILITIES
Current liabilities:
Accounts payable and accrued expenses (Note E)           $73,000
                                                         -------
Commitments and other matter (Note G)
STOCKHOLDERS' EQUITY
Common stock, $.01 par value, 40,000,000 shares
authorized, 20,672,496 issued and
outstanding                                              207,000
Additional paid-in capital                             2,991,000
Unearned compensatory stock options                   (1,283,000)
Deficit accumulated during the development stage      (1,411,000)
                                                      ----------
Total stockholders' equity                               504,000
                                                      ----------
                                                        $577,000
                                                      ==========

See notes to financial statements

TORVEC, INC.
(a development stage company)

Statements of Operations
                                                    September     September
                                              25, 1996      25, 1996
                                              (Inception)  (Inception)
                                  Year Ended  Through      Through
                                  December    December     December
                                  31, 1997    31, 1996     31, 1997
Cost and expenses:
Research and development           $201,000     $22,000       $223,000
General and administrative          721,000     467,000      1,188,000
Net loss                          $(922,000)  $(489,000)   $(1,411,000)

Basic and diluted loss per           $(0.05)     $(0.03)
common share


Weighted average number of
shares of common
stock - basic and diluted        20,320,000  18,668,000
(Note B(4))

                                                                                       Deficit       
                                                                        Unearned       Accumulated
                                                            Additional  Compensatory   During the      Total
                                      Common Stock          Paid-in     Stock and      Development   Stockholders'
                                  Shares        Amount      Capital      Options       Stage         Equity
Issuance of shares
to founders                     16,464,400        $165,000 $(165,000)                                       $0
Issuance of stock
for services                     2,535,600          25,000    381,000                                  406,000
Sale of common stock -              64,600           1,000     96,000                                   97,000
November
($1.50 per share)
Sale of common stock -             156,201           1,000    233,000                                  234,000
December
($1.50 per share)
Distribution to founders                                      (27,000)                                 (27,000)
(Note A)
Net loss                                                                              $(489,000)     (489,000)
                                                                                       ---------      --------
Balance - December 31, 1996     19,220,801         192,000    518,000                  (489,000)       221,000
Issuance of compensatory stock   1,000,000          10,000  1,490,000 $(1,500,000                            0
(Note C(1))                                                                      )
Issuance of stock for services      12,000                     18,000                                   18,000
Sale of common stock - January      58,266           1,000     86,000                                   87,000
($1.50 per share)
Sale of common stock - February     75,361           1,000    112,000                                  113,000
($1.50 per share)
Sale of common stock - May          30,000                     45,000                                   45,000
($1.50 per share)
Issuance of stock for services       2,000                      6,000                                    6,000
Sale of common stock - June         73,166           1,000    219,000                                  220,000
($3.00 per share)
Sale of common stock - July         13,335                     40,000                                   40,000
($3.00 per share)
Sale of common stock - August       60,567           1,000    181,000                                  182,000
($3.00 per share)
Sale of common stock -September     10,000                     30,000                                   30,000
($3.00 per share)
Sale of common stock - October       7,000                     21,000                                   21,000
($3.00 per share)
Sale of common stock - November     10,000                     30,000                                   30,000
($3.00 per share)
Sale of common stock - December    100,000           1,000    299,000                                  300,000
($3.00 per share)
Issuance of compensatory                                      234,000     (234,000)                           0
options to consultants (Note F(2))
Compensatory stock and options                                             451,000                     451,000
earned
Distributions to founders                                   (338,000)                                (338,000)
(Note A)
Net loss                                                                               (922,000)     (922,000)
                                                                                        --------      --------


Balance - December 31, 1997     20,672,496        $207,000 $2,991,000  $(1,283,000)   $(1,411,000)      $504,000

       Statements of Cash Flows



TORVEC, INC.
(a development stage company)
Notes to Financial Statements
December 31, 1997

                                                   September    September
                                                    25, 1996     25, 1996
                                                  (Inception)   (Inception)
                                    Year Ended     Through       Through
                                    December 31,   December 31,  December 31,
                                       1997         1996           1997
Cash flows from operating
activities:
Net loss                            $(922,000)    $(489,000)    $(1,411,000)
Adjustments to reconcile net loss
to net cash used in
operating activities:
Depreciation and amortization            3,000                         3,000
Common stock issued for services                     406,000         406,000
Contribution of services                24,000                        24,000
Compensation expense attributable
to common
stock options                          451,000                       451,000
Changes in:
Other assets                         (164,000)                     (164,000)
Accounts payable and accrued            59,000                        59,000
expenses
Net cash used in operating           (549,000)      (83,000)       (632,000)
activities                            --------       -------        --------
Cash flows from investing
activities:
Purchase of equipment                 (29,000)                      (29,000)
                                       -------                       -------
Cash flows from financing
activities:
Net proceeds from sales of common      888,000       331,000       1,219,000
stock
Distributions                        (338,000)      (27,000)       (365,000)
Offering cost expenditures            (46,000)                      (46,000)
                                       -------                       -------
Net cash provided by financing         504,000       304,000         808,000
activities
Net increase (decrease) in cash       (74,000)       221,000         147,000
Cash at beginning of period            221,000

Cash at end of period                 $147,000      $221,000        $147,000


Supplemental disclosure of noncash
investing and
financing activities:
Accrued offering costs                 $14,000                       $14,000

TORVEC, INC.
(a development stage company)

Notes to Financial Statements
December 31, 1997

NOTE A - THE COMPANY

TORVEC, INC. (THE "COMPANY") WAS INCORPORATED IN NEW YORK ON SEPTEMBER 25, 1996. THE COMPANY WHICH IS IN THE DEVELOPMENT STAGE, SPECIALIZES IN AUTOMOTIVE TECHNOLOGY. IN SEPTEMBER 1996, THE COMPANY ACQUIRED NUMEROUS PATENTS, INVENTIONS AND KNOW-HOW (THE "TECHNOLOGY") CONTRIBUTED BY VERNON E. GLEASMAN AND MEMBERS OF HIS FAMILY (THE "GLEASMANS") (SEE NOTE G(3)). THE COMPANY INTENDS TO DEVELOP AND DESIGN SPECIFIC APPLICATIONS FOR THIS TECHNOLOGY RELATING TO STEERING DRIVES FOR TRACKER VEHICLES, INFINITELY VARIABLE TRANSMISSIONS, HYDRAULIC PUMPS AND MOTORS AND CONSTANT VELOCITY JOINTS AND SPHERICAL GEARINGS. AS CONSIDERATION FOR THIS CONTRIBUTED TECHNOLOGY, THE COMPANY ISSUED 16,464,400 SHARES OF COMMON STOCK AND $365,000 TO THE GLEASMANS. IN SEPTEMBER 1996, THE COMPANY ISSUED 2,535,600 SHARES OF COMMON STOCK (VALUED AT $406,000) TO INDIVIDUALS AS CONSIDERATION FOR THE COST OF SERVICES AND FACILITIES PROVIDED IN ASSISTING WITH THE DEVELOPMENT OF THIS TECHNOLOGY.
For the period from inception through December 31, 1997, the Company has accumulated a deficit of $1,411,000, and has been dependent upon equity financing to meet its obligations and sustain operations. These factors raise substantial doubt about the Company's ability to continue as a going concern. In order to continue its operations, the Company is seeking additional financing by means of an offering of securities (see Note F(3)). However, there is no assurance that the Company will complete its proposed securities offering or that it can obtain adequate additional financing from other sources or that products will be developed which will be commercially successful, or that profitable operations can be attained. The financial statements do not include any adjustments relating to the recoverability or classification of recorded asset amounts or the amount and classification of liabilities that might be necessary as a result of the above uncertainty.

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

(1) Equipment:
Equipment is stated at cost less accumulated depreciation. Depreciation is provided using the straight-line method over the estimated useful lives of the assets which range from five to seven years.
(2) Research and development and patents:
Research and development costs and patent expenses are charged to operations as incurred.
(3) Use of estimates:

TORVEC, Inc.
(a development stage company)

Notes to Financial Statements
December 31, 1997

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

(1) Loss per share of common stock:
The Company adopted Statement of Financial Accounting Standards ("SFAS") No. 128, "Earnings Per Share," in the year ended December 31, 1997 and has retroactively applied the effects thereof for all periods presented. Accordingly, the presentation of per share information includes calculations of basic and dilutive loss per share. Additionally, pursuant to the Securities and Exchange Commission's Staff Accounting Bulletin No. 98, issuances of common shares and potential common shares issued for nominal consideration during the periods covered by statements of operations that are included in the registration statement and in subsequent filings with the SEC are reflected in the computation of loss per share in a manner similar to a stock split or stock dividend.
(2) Fair value of financial instruments:
The carrying value of cash and accrued expenses approximates their fair value due to the short maturity of those instruments.
(3) Stock-based compensation:
Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based Compensation" ("SFAS No. 123") encourages, but does not require, companies to record compensation cost for stock-based employee compensation plans at fair value. The Company has elected to account for its employee stock-based compensation plans using the intrinsic value method prescribed by Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to Employees" ("APB No. 25"). Under the provisions of APB No. 25, compensation cost for stock options is measured as the excess, if any, of the quoted market price of the Company's common stock at the date of the grant over the amount an employee must pay to acquire the stock. Stock options granted to nonemployees for goods or services are measured using the fair value of these options and such costs are included in operating results as an expense.
(4) Recently issued accounting pronouncements:

TORVEC, INC.
(a development stage company)

Notes to Financial Statements
December 31, 1997

In June 1997, the Financial Accounting Standards Board issued Statements of Financial Accounting Standards No. 129, "Disclosure of Information about Capital Structure"; No. 130, "Reporting Comprehensive Income" and No. 131, "Disclosures about Segments of an Enterprise and Related Information". The Company has not yet determined if the above pronouncements will have a significant effect on the information presented in the financial statements.

NOTE C - RELATED PARTY TRANSACTIONS

(1) In February 1997, the Company entered into a three year consulting agreement with LT Lawrence (the "Consultant") whereby the Consultant will provide financial consulting services and assistance in obtaining financing as well as other services. In consideration thereof, members of the Consultant received an aggregate of 1,000,000 shares of common stock for $50 and warrants to purchase an additional 500,000 shares of common stock (see Note F(1)). The Company valued the shares of common stock at $1.50 per share.

TORVEC, INC.
(a development stage company)

Notes to Financial Statements
December 31, 1997

NOTE C - RELATED PARTY TRANSACTIONS (CONTINUED)

(1) (continued) In the event the Consultant provides the Company with interested parties who effect debt or equity financing, the Agreement provides for compensation based on a percentage of the consideration received as defined in the Agreement.
(2) On December 1, 1997, the Company entered into three year consulting agreements with three members of the Gleasman family whereby each will provide technical services to the Company in exchange for compensation of $12,500 each per month. In addition, the Company granted them options to purchase a total of 75,000 shares of common stock at an exercise price of $5.00 per share (Note F(2)). For the year ended December 31, 1997, the Company incurred expenses amounting to approximately $45,000 in connection with these agreements. Prior to December 1997, one member of the Gleasman family provided consulting services to the Company. Amounts charged to operations for the year ended December 31, 1997 and for the period ended December 31, 1996 were approximately $55,000 and $18,000, respectively.
(3) For the period September 25, 1996 (inception) through December 31, 1996 and for the year ended December 31, 1997 approximately $4,000 and $116,000, respectively, were charged to operations for services provided by two law firms, each of which has a partner who is a stockholder of the Company. At December 31, 1997, the Company owed $14,000 to one of these firms which is included in accounts payable.

NOTE D - INCOME TAXES

The Company recognizes deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.
At December 31, 1997, the Company has available $223,000 of net operating loss carryforwards to offset future taxable income tax expiring through 2012.
At December 31, 1997, the Company has a deferred tax asset of approximately $88,000 representing the benefits of its net operating loss carryforward and a deferred tax asset of $466,000 from temporary differences, principally compensatory stock and stock options not currently deductible and certain operating expenses which have been capitalized as start-up costs for federal income tax purposes. The total of these deferred tax assets has been fully reserved by a valuation allowance since realization of their benefit is uncertain.

TORVEC, INC.
(a development stage company)

Notes to Financial Statements
December 31, 1997

A reconciliation between the actual income tax benefit and income taxes computed by applying the federal income tax rate of 34% to the net loss is as follows:

TORVEC, INC.
(a development stage company)
Notes to Financial Statements
December 31, 1997

                                                          Period
                                                          from
                                                       September 26,
                                                          1996
                                                       (Inception)
                                          Year Ended     Through
                                          December 31,  December 31,
                                              1997          1996

     Computed federal income tax           $(313,000)    $(166,000)
     (benefit) at 34% rate
     State tax (benefit), net of federal     (49,000)      (26,000)
     tax benefit
     Valuation allowance                     362,000       192,000


                                                  $0            $0



       TORVEC, INC.
       (a development stage company)
       Notes to Financial Statements
       December 31, 1997

TORVEC, INC.
(a development stage company)

Notes to Financial Statements
December 31, 1997

NOTE D - INCOME TAXES (CONTINUED)

THE INTERNAL REVENUE CODE CONTAINS PROVISIONS WHICH MAY LIMIT THE UTILIZATION OF THE NET OPERATING LOSS CARRYFORWARD AVAILABLE IN ANY GIVEN YEAR IF SIGNIFICANT CHANGES OCCUR IN STOCKHOLDER OWNERSHIP INTERESTS. IF THE PROPOSED OFFERING DISCUSSED IN NOTE F(3) TO THE FINANCIAL STATEMENTS IS CONSUMMATED, THE AMOUNT OF CARRYFORWARD AVAILABLE IN ANY GIVEN YEAR COULD BE LIMITED.
Note E - Accounts Payable and Accrued Expenses At December 31, 1997, accounts payable and accrued expenses consist of the following:

                Professional fees  (Note C(3))         $14,00
                                               0
Trade payables                            21,000
Consulting (Note C(2))                    38,000
                                         -------
                                         $73,000
                                         =======

NOTE F - STOCKHOLDERS' EQUITY

(1) Warrants:
In April 1997, the Company granted an aggregate of 500,000 warrants to five employees of the Consultant (see Note C(1)). The warrants are exercisable into common stock at the initial public offering (the "IPO") price and are exercisable for five years from the date the Company's IPO is declared effective ("warrant term"). However, if fifty percent or more of either the Company's assets or its common stock is acquired by another entity or group during the warrant term, the exercise price shall be $1.50. The Company will record a charge to operations representing the fair value of the warrants when the IPO is declared effective.
(2) Stock options:
In December 1997, the Board of Directors of the Company, subject to stockholder approval approved a Stock Option Plan (the "Plan") which provides for the granting of up to 2,000,000 shares of common stock, pursuant to which officers, directors, key employees and key consultants/advisors are eligible to receive incentive, nonstatutory or reload stock options. Options granted under the Plan are

TORVEC, INC.
(a development stage company)

Notes to Financial Statements
December 31, 1997

exercisable for a period of up to 10 years from date of grant at an exercise price which is not less than the fair value on date of grant, except that the exercise period of options granted to a stockholder owning more than 10% of the outstanding capital stock may not exceed five years and their exercise price may not be less than 110% of the fair value of the common stock at date of grant. Options generally vest over five years.
In connection with certain consulting agreements (see Note C(2)) the Company granted an aggregate of 75,000 nonqualified options to purchase common stock under the Plan at an exercise price of $5.00 per share. The options vest 20% per annum and are exercisable through November 30, 2007. The Company valued these options at $234,000 using the Black-Scholes Option pricing model with the following weighted average assumptions for the year ended December 31, 1997: risk-free interest rate of 5.91%, dividend yield 0%, volatility 40% and expected life for options granted for 10 years. The options are being amortized over the term of the consulting agreements. At December 31, 1997 these options had a remaining life of 121 months.
NOTE F - STOCKHOLDERS' EQUITY (CONTINUED)
(2) Stock options: (continued) In connection with employment agreements which commence upon the date the IPO is declared effective, (Note G(2)) the Company granted 380,000 options under the Plan at an exercise price of $5.00 per share. The options are exercisable for a period of ten years from January 1, 1998 and vest 20% per annum. At December 31, 1997, 1,545,000 options are available under the Plan.
(3) Proposed offering:
The Company anticipates offering its securities in a private placement. There is no assurance that such offering will be consummated. In connection therewith the Company anticipates incurring substantial expenses which, if the offering is not consummated, will be charged to expense.
(4) Subscriptions receivable:
At December 31, 1997, the Company had subscriptions receivable for 70,000 shares of common stock which was subsequently collected.
(5) Noncash transaction:
During 1997, the Company granted 12,000 and 2,000 shares of common stock for services provided. The Company valued the shares at their fair value of $1.50 and $3.00 per share, respectively.

TORVEC, INC.
(a development stage company)

Notes to Financial Statements
December 31, 1997

Note G - Commitments and Other Matter
(1) Lease:
In January 1998 the Company entered into an agreement with a stockholder/landlord, which is effective upon the date that the proceeds of an IPO are received to lease land and a building for one year at $52,500 per month. The agreement provides for four one year renewal periods at the Company's option. In addition, pursuant to this agreement the landlord will provide labor, utilities and equipment under the terms of the lease. The Agreement also provides for the purchase of land adjacent to the leased premises for one year after the effective date of the lease for $350,000.
The Company paid approximately $53,000 representing the first month's rent, which is reflected as a current asset at December 31, 1997, and approximately $111,000 representing the last month's rent and two- twelfths of the purchase price of the land which is reflected as noncurrent assets at December 31, 1997.

Note G - Commitments and Other Matter (continued)
(2) Employment agreements:
The Company has entered into three employment agreements for a period of three years, commencing on the first day of the month in which the Company receives the proceeds from an IPO.
Two agreements each provide for salaries of $150,000 per year. One agreement provides for a salary of $240,000 in the first year, $252,000 in the second year and $264,000 in the third year and provides for a minimum bonus of $15,000 per quarter for the duration of the agreement.
(3) Arbitration:
During 1997 certain members of the Gleasman family were named in a lawsuit seeking monetary damages relating to the development of certain technology and related matters. The court stayed all aspects of the litigation and directed that the parties arbitrate such matters in dispute. The Company has not been named as a defendant in this action. In the event the claimants prevail, it could adversely affect the Company's exclusive ownership of certain technology. The Gleasmans believe that the claims are without merit

PART III

ITEM 1. INDEX TO EXHIBITS.

The following exhibits are filed as a part of this Registration Statement:

EXHIBIT
 SEQUENTIAL
NUMBER                  EXHIBIT                                         PAGE

NUMBER


  2.1             Certificate of Incorporation of Torvec, Inc.
  2.2             Bylaws of Torvec, Inc.
  3               Specimen Stock Certificate
  6.1             Employment Agreement with Herbert H. Dobbs
  6.2             Employment Agreement with Lee E. Sawyer

  6.3             Employment Agreement with Morton A. Polster
  6.4             Consulting Agreement with Keith E. Gleasman
  6.5             Consulting Agreement with James  A. Gleasman
  6.6             Consulting Agreement with Vernon E. Gleasman
  6.7             Torvec, Inc. Stock Option Plan
  6.8             Specimen Stock Option Agreement
  6.9             Assignments of Patents, Patent Properties, Technology and
                  Know-How to Company
  6.10            Neri Service and Space Agreement
  6.11            Ford Motor Company Agreement and Extension of Term
 12.1             Power of Attorney
 12.2             October 24, 1997 Letter from Yogendra B. Jonchhe , Alfred
                  State University Depart. of Mechanical Engineering Technology
 12.3             March 12, 1998 Letter from J.U. Koo, Kia Motors Corp.

SIGNATURES

In accordance with Section of the Securities Exchange Act of 1934, the Registrant caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized.

TORVEC, INC.

Date: _______, 1998                   By: /S HERBERT H. DOBBS
                                         ------------------------------
                                         Herbert H. Dobbs, Chairman of the
                                         Board of Directors




Date:_________, 1998                  By: /S KEITH E. GLEASMAN
                                         -----------------------------
                                         Keith E. Gleasman, Director and
                                         President

Date:__________, 1998 By: /S LEE E. SAWYER

Lee E. Sawyer, Director

Date:__________, 1998                 By: /S MORTON A. POLSTER
                                         ----------------------------
                                         Morton A. Polster, Director; Secretary
                                         of Torvec, Inc.



Date:__________, 1998                 By: /S JAMES A. GLEASMAN
                                         ---------------------------
                                         James A. Gleasman, Director;
                                         Consultant to Torvec, Inc.



Date: _________, 1998                 By: /S SAMUEL M. BRONSKY
                                         --------------------------
                                         Samuel M. Bronsky,
                                         Chief Financial Officer


EXHIBIT NUMBER 2.2

BY-LAWS OF
TORVEC, INC.

ARTICLE I
OFFICES

The principal office of the corporation shall be in the County of Monroe, State of New York. The corporation may also have offices at such other places within or without the State of New York as the board may from time to time determine or the business of the corporation may require.

ARTICLE II
SHAREHOLDERS

1. PLACE OF MEETINGS

Meetings of shareholders shall be held at the principal office of the corporation or at such place within or without the State of New York as the board shall authorize.

2. ANNUAL MEETING

     The annual meeting of  the shareholders shall be
held at a time and place  determined by the directors
during  the  month of  May  in  each year,  when  the

shareholders shall elect a board and transact such other business as may properly come before the meeting. The date of the annual meeting may be changed by the Board or by the President by giving at least 10 days notice to each shareholder.

3. SPECIAL MEETINGS

     Special  meetings  of  the shareholders  may  be
called by the board or by  the president and shall be
called  by  the president  or  the  secretary at  the

request in writing of a majority of the board or at the request in writing by shareholders owning a majority in amount of the shares issued and outstanding. Such request shall state the purpose or

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 2 -

purposes of the proposed meeting. Business transacted at a special meeting shall be confined to the purposes stated in the notice.
4. FIXING RECORD DATE

For the purpose of determining the shareholders entitled to notice of, or to vote at, any meeting of shareholders or any adjournment thereof, or to express consent to, or dissent from, any proposal without a meeting, or for the purpose of determining shareholders entitled to receive payment of any dividend or the allotment of any rights, or for the purpose of any other action, the board shall fix, in advance, a date as the record date for any such determination of shareholders. Such date shall not be more than fifty nor less than ten days before the date of such meeting, nor more than fifty days prior to any other action. If no record date is fixed it shall be determined in accordance with the provisions of law.

5. NOTICE OF MEETINGS OF SHAREHOLDERS

Written notice of each meeting of shareholders shall state the purpose or purposes for which the meeting is called, the place, date and hour of the meeting and unless it is the annual meeting, shall indicate that it is being issued by or at the direction of the person or persons calling the meeting. Notice shall be given either personally or by mail to each shareholder entitled to vote at such meeting, not less than ten nor more than fifty days before the date of the meeting. If action is proposed to be taken that might entitle shareholders to payment for their shares, the notice shall include a statement of that purpose and to that effect. If mailed, the notice is given when deposited in the United States mail, with postage thereon prepaid, directed to the shareholder at his address as it appears on the record of shareholders, or, if he shall have filed with the secretary a written request that notices to him be mailed to some other address, then directed to him at such other address.

6. WAIVERS

Notice of meeting need not be given to any shareholder who signs a waiver of notice, in person

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 3 -

or by proxy, whether before or after the meeting. The attendance of any shareholder at a meeting, in person without protesting prior to the conclusion of the meeting the lack of notice of such meeting, shall constitute a waiver of notice by him.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 4 -

7. QUORUM OF SHAREHOLDERS

Unless the certificate of incorporation provides otherwise, the holders of one-third of the shares entitled to vote thereat shall constitute a quorum at a meeting of shareholders for the transaction of any business, provided that when a specified item of business is required to be voted on by a class or classes, the holders of a majority of the shares of such class or classes shall constitute a quorum for the transaction of such specified item of business.
When a quorum is once present to organize a meeting, it is not broken by the subsequent withdrawal of any shareholders.
The shareholders present may adjourn the meeting despite the absence of a quorum.

8. PROXIES

Every shareholder entitled to vote at a meeting of shareholders or to express consent or dissent without a meeting may authorize another person or persons to act for him by proxy.
Every proxy must be signed by the shareholder or his attorney-in-fact. No proxy shall be valid after expiration of eleven months from the date thereof unless otherwise provided in the proxy. Every proxy shall be revocable at the pleasure of the shareholder executing it, except as otherwise provided by law.

9. QUALIFICATION OF VOTERS

Every shareholder of record shall be entitled at every meeting of shareholders to one vote for every share standing in his name on the record of shareholders, unless otherwise provided in the certificate of incorporation.

10. VOTE OF SHAREHOLDERS

Except as otherwise required by statute or by the certificate of incorporation or by the by-laws:

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 5 -

(a) directors shall be elected by a plurality of the votes cast at a meeting of shareholders by the holders of shares entitled to vote in the election.
(b) all other corporate action shall be authorized by a majority of the votes cast.

11. WRITTEN CONSENT OF SHAREHOLDERS

Any action that may be taken by vote may be taken without a meeting on written consent, setting forth the action so taken, signed by the holders of all the outstanding shares entitled to vote thereon or signed by such lesser number of holders as may be provided for in the certificate of incorporation, and such consent may be executed on one or more copies which shall collectively constitute a single document.

ARTICLE III
DIRECTORS

1. BOARD OF DIRECTORS

Subject to any provision in the certificate of incorporation the business of the corporation shall be managed by its board of directors, each of whom shall be at least 18 years of age.

2. NUMBER OF DIRECTORS

The number of directors shall be one if there is only one shareholder, and two if there are two shareholders. If there are three or more shareholders there shall be at least three and a maximum of fifteen directors, with the number to be determined by the Board of Directors.

3. ELECTION AND TERM OF DIRECTORS

At each annual meeting of shareholders, the shareholders shall elect directors to hold office until the next annual meeting. Each director shall

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 6 -

hold office until the expiration of the term for which he is elected and until his successor has been elected and qualified, or until his prior resignation or removal.

4. NEWLY CREATED DIRECTORSHIPS AND VACANCIES

Newly created directorships resulting from an increase in the number of directors and vacancies occurring in the board for any reason except the removal of directors without cause may be filled by a vote of a majority of the directors then in office, although less than a quorum exists, unless otherwise provided in the certificate of incorporation. Vacancies occurring by reason of the removal of directors without cause shall be filled by vote of the shareholders unless otherwise provided in the certificate of incorporation. A director elected to fill a vacancy caused by resignation, death or removal shall be elected to hold office for the unexpired term of his predecessor.

5. REMOVAL OF DIRECTORS

Any or all of the directors may be removed for cause by vote of the shareholders or by action of the board. Directors may be removed without cause only by vote of the shareholders.

6. RESIGNATION

A director may resign at any time by giving written notice to the board, the president or the secretary of the corporation. Unless otherwise specified in the notice, the resignation shall take effect upon receipt thereof by the board or such officer, and the acceptance of the resignation shall not be necessary to make it effective.

7. QUORUM OF DIRECTORS

Unless otherwise provided in the certificate of incorporation, a majority of the entire board shall constitute a quorum for the transaction of business or of any specified item of business.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 7 -

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 8 -

8. ACTION OF THE BOARD

Unless otherwise required by law, the vote of a majority of the directors present at the time of the vote, if a quorum is present at such time, shall be the act of the board. Each director present shall have one vote regardless of the number of shares, if any, which he may hold. Any action that may be taken by vote may be taken without a meeting on written consent, setting forth the actions so taken, signed by all directors entitled to vote thereon, and such consent may be executed on one or more copies which shall collectively constitute a single document.

9. TELEPHONE CONFERENCES

Unless otherwise restricted by the certificate of incorporation or these by-laws, members of the board of directors, or any committee designated by the board of directors, may participate in a meeting of the board of directors, or any committee, by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting.

10. PLACE AND TIME OF BOARD MEETINGS

The board may hold its meetings at the office of the corporation or at such other places, either within or without the State of New York, as it may from time to time determine.

11. REGULAR ANNUAL MEETING

A regular annual meeting of the board shall be held immediately following the annual meeting of shareholders at the place of such annual meeting of shareholders.

12. NOTICE OF MEETINGS OF THE BOARD; ADJOURNMENT

(a)Regular meetings of the board may be held without notice at such time and place as it shall

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 9 -

from time to time determine. Special meetings of the board shall be held upon notice to the directors and may be called by the president upon three days notice to each director either personally or by mail or by wire; special meetings shall be called by the president or by the secretary in a like manner on written request of two directors. Notice of a meeting need not be given to any director who submits a waiver of notice whether before or after the meeting or who attends the meeting without protesting prior thereto or at its commencement, the lack of notice to him.
(b)A majority of the directors present, whether or not a quorum is present, may adjourn any meeting to another time and place. Notice of the adjournment shall be given all directors who were absent at the time of the adjournment and, unless such time and place are announced at the meeting, to the other directors.

13. CHAIRMAN

At all meetings of the board the president, or in his absence, a chairman chosen by the board shall preside.

14. EXECUTIVE AND OTHER COMMITTEES

The board, by resolution adopted by a majority of the entire board, may designate from among its members an executive committee and other committees, each consisting of three or more directors. Each such committee shall serve at the pleasure of the board.

15. COMPENSATION

No compensations shall be paid to directors, as such, for their services, but by resolution of the board a fixed sum established on an annual and/or per meeting basis plus expenses for actual attendance, at each regular or special meeting of the board may be authorized. Nothing herein contained shall be construed to preclude any director from serving the corporation in any other capacity and receiving compensation therefor.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 10 -

ARTICLE IV
OFFICERS

1. OFFICERS, ELECTION, TERM

(a)Unless otherwise provided for in the certificate of incorporation, the board may elect or appoint a president, one or more vice-presidents, a secretary and a treasurer, and such other officers as it may determine, who shall have such duties, powers and functions as hereinafter provided.
(b)All officers shall be elected or appointed to hold office until the meeting of the board following the annual meeting of shareholders.
(c)Each officer shall hold office for the term for which he is elected or appointed and until his successor has been elected or appointed and qualified.

2. REMOVAL, RESIGNATION, SALARY, ETC.

(a)Any officer elected or appointed by the board may be removed by the board with or without cause.
(b)In the event of the death, resignation or removal of an officer, the board in its discretion may elect or appoint a successor to fill the unexpired term.
(c)When all of the issued and outstanding stock of the Corporation is owned by one person, such person may hold all or any combination of offices, otherwise, any two or more offices may be held by the same person, except the offices of president and secretary.
(d)The salaries of all officers shall be fixed by the board.
(e)The directors may require any officer to give security for the faithful performance of his duties.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 11 -

3. PRESIDENT

The president shall be the chief executive officer of the corporation; he shall preside at all meetings of the shareholders and of the board; he shall have the management of the business of the corporation and shall see that all orders and resolutions of the board are carried into effect.
4. VICE PRESIDENTS

During the absence or disability of the president, the vice president, or if there are more than one, the executive vice president, shall have all of the powers and functions of the president. Each vice president shall perform such other duties as the board shall prescribe.

5. SECRETARY

The secretary shall:
(a)attend all meetings of the board and of the shareholders;
(b)record all votes and minutes of all proceedings in a book to be kept for that purpose;
(c)give or cause to be given notice of all meetings of shareholders and of special meetings of the board;
(d)keep in safe custody the seal of the corporation and affix it to any instrument when authorized by the board;
(e)when required, prepare or cause to be prepared and available at each meeting of shareholders a certified list in alphabetical order of the names of shareholders entitled to vote thereat, indicating the number of shares of each respective class held by each;
(f)keep all the documents and records of the corporation as required by law or otherwise in a proper and safe manner;
(g)perform such other duties as may be prescribed by the board.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 12 -

6. ASSISTANT SECRETARIES

During the absence or disability of the secretary, the assistant secretary, or if there are more than one, the one so designated by the secretary or by the board, shall have all the powers and functions of the secretary.

7. TREASURER

The treasurer shall:
(a)have the custody of the corporate funds and securities;
(b)keep full and accurate accounts of receipts and disbursements in the corporate books;
(c)deposit all money and other valuables in the name and to the credit of the corporation in such depositories as may be designated by the board;
(d)disburse the funds of the corporation as may be ordered or authorized by the board and preserve proper vouchers for such disbursements;
(e)render to the president and board at the regular meetings of the board, or whenever they require it, an account of all his transactions as treasurer and of the financial condition of the corporation;
(f)render a full financial report at the annual meeting of the shareholders if so requested;
(g)be furnished by all corporate officers and agents at his request, with such reports and statements as he may require as to all financial transactions of the corporation;
(h)perform such other duties as are given to him by these by-laws or as from time to time are assigned to him by the board or the president.

8. ASSISTANT TREASURER

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 13 -

During the absence or disability of the treasurer, the assistant treasurer, or if there are more than one, the one so designated by the secretary or by the board, shall have all the powers and functions of the treasurer.

9. SURETIES AND BONDS

In case the corporation shall so require, any officer or agent of the corporation shall execute to the corporation a bond in such sum and with such surety or sureties as the corporation may direct, conditioned upon the faithful performance of his duties to the corporation and including responsibility for negligence and for the accounting for all property, funds or securities of the corporation which may come into his hands.

ARTICLE V
CERTIFICATES FOR SHARES

1. CERTIFICATES

The shares of the corporation shall be represented by certificates. They shall by numbered and entered in the books of the corporation as they are issued. They shall exhibit the holder's name and the number of shares and shall be signed by the president or a vice-president and the treasurer or the secretary and shall bear the corporate seal.

2. LOST OR DESTROYED CERTIFICATES

The board may direct a new certificate or certificates to be issued in place of any certificate or certificates theretofore issued by the corporation, alleged to have been lost or destroyed, upon the making of an affidavit of that fact by the person claiming the certificate to be lost or destroyed. When authorizing such issue of a new certificate or certificates, the board may, in its discretion and as a condition precedent to the issuance thereof, require the owner of such lost or destroyed certificate or certificates, or his legal representative, to advertise the same in such manner as it shall require and/or give the corporation a

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 14 -

bond in such sum and with such surety or sureties as it may direct as indemnity against any claim that may be made against the corporation with respect to the certificate alleged to have been lost or destroyed.

3. TRANSFERS OF SHARES

(a)Upon surrender to the corporation or the transfer agent of the corporation of a certificate for shares duly endorsed or accompanied by proper evidence of succession, assignment or authority to transfer, it shall be the duty of the corporation to issue a new certificate to the person entitled thereto, and cancel the old certificate; every such transfer shall be entered on the transfer book of the corporation which shall be kept at its principal office. No transfer shall be made within ten days next preceding the annual meeting of shareholders.
(b)The corporation shall be entitled to treat the holder of record of any share as the holder in fact thereof and, accordingly, shall not be bound to recognize any equitable or other claim to or interest in such share on the part of any other person whether or not it shall have express or other notice thereof, except as expressly provided by the laws of New York.

4. CLOSING TRANSFER BOOKS

The board shall have the power to close the share transfer books of the corporation for a period of not more than ten days during the thirty day period immediately preceding (1) any shareholders' meeting, or (2) any date upon which shareholders shall be called upon to or have a right to take action without a meeting, or (3) any date fixed for the payment of a dividend or any other form of distribution, and only those shareholders of record at the time the transfer books are closed, shall be recognized as such for the purpose of (1) receiving notice of or voting at such meeting, or (2) allowing them to take appropriate action, or (3) entitling them to receive any dividend or other form of distribution.

ARTICLE VI
DIVIDENDS

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 15 -

Subject to the provisions of the certificate of incorporation and to applicable law, dividends on the outstanding shares of the corporation may be declared in such amounts and at such time or times as the board may determine. Before payment of any dividend, there may be set aside out of the net profits of the corporation available for dividends such sum or sums as the board from time to time in its absolute discretion deems proper as a reserve fund to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose as the board shall think conducive to the interest of the corporation, and the board may modify or abolish any such reserve.

ARTICLE VII
CORPORATE SEAL

The seal of the corporation shall be circular in form and bear the name of the corporation, the year of its organization and the words "Corporate Seal, New York." The seal may be used by causing it to be impressed directly on the instrument or writing to be sealed, or upon adhesive substance affixed thereto. The seal on the certificate for shares or on any corporate obligation for the payment of money may be a facsimile, engraved or printed.

ARTICLE VIII
EXECUTION OF INSTRUMENTS

All corporate instruments and documents shall be signed or countersigned, executed, verified or acknowledged by such officer or officers or other person or persons as the board may from time to time designate.

ARTICLE IX
FISCAL YEAR

The fiscal year shall begin the first day of January in each year.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 16 -

ARTICLE X

REFERENCES TO CERTIFICATE OF INCORPORATION

Reference to the certificate of incorporation in these by-laws shall include all amendments thereto or changes thereof unless specifically excepted.

ARTICLE XI
INDEMNIFICATION OF DIRECTORS AND OFFICERS

1. GENERALLY

Each person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a "proceeding"), by reason of the fact that he or his testator or intestate (a) is or was a director or officer of the Corporation or (b) is or was a director or officer of the Corporation who serves or served, in any capacity, any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise at the request of the Corporation (hereinafter an "Indemnitee"), shall be indemnified and held harmless by the Corporation against all expense, liability and loss including ERISA excise taxes or penalties, judgments, fines, penalties, amounts paid in settlement (provided the Corporation shall have given its prior consent to such settlement, which consent shall not be unreasonably withheld by it) and reasonable expenses, including attorneys' fees suffered or incurred by such Indemnitee in connection therewith and such indemnification shall continue as to an Indemnitee who has ceased to be a director or officer and shall inure to the benefit of the Indemnitee's heirs and fiduciaries; provided, however, that no indemnification may be made to or on behalf of any director or officer if his acts were committed in bad faith or were the result of active and deliberate dishonesty and were material to the cause of action so adjudicated or otherwise disposed of, or he personally gained in fact a financial profit or other advantage to which he was not legally entitled. Notwithstanding the foregoing, except as contemplated by Section 3 hereof, the Corporation shall indemnify any such Indemnitee in connection with a proceeding (or part thereof) initiated by such Indemnitee only if such proceeding (or part thereof) was authorized by the Board of Directors of the Corporation.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 17 -

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 18 -

2. ADVANCEMENT OF EXPENSES

All expenses reasonably incurred by an Indemnitee in connection with a threatened or actual proceeding with respect to which any such Indemnitee is or may be entitled to indemnification under this Article shall be advanced to him or promptly reimbursed by the Corporation in advance of the final disposition of such proceeding, upon receipt of an undertaking by him or on his behalf to repay the amount of such advances, if any, as to which he is ultimately found not to be entitled to indemnification or, where indemnification is granted, to the extent such advances exceed the indemnification to which he is entitled. Such person shall cooperate in good faith with any request by the Corporation that common counsel be used by the parties to an action or proceeding who are similarly situated unless to do so would be inappropriate due to an actual or potential conflict of interest.

3. PROCEDURE FOR INDEMNIFICATION

(a)Not later than thirty (30) days following final disposition of a proceeding with respect to which the Corporation has received written request by an Indemnitee for indemnification pursuant to this Article or with respect to which there has been an advancement of expenses pursuant to Section 2 of this Article, if such indemnification has not been ordered by a court, the Board of Directors shall meet and find whether the Indemnitee met the standard of conduct set forth in Section 1 of this Article, and, if it finds that he did, or to the extent it so finds, shall authorize such indemnification.
(b)Such standard shall be found to have been met unless (i) a judgment or other final adjudication adverse to the Indemnitee established that the standard of conduct set forth in Section 1 of this Article was not met, or (ii) if the proceeding was disposed of other than by judgment or other final adjudication, the Board finds in good faith that, if it had been disposed of by judgment or other final adjudication, such judgment or other final adjudication would have been adverse to the Indemnitee and would have established that the standard of conduct set forth in Section 1 of this Article was not met.

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 19 -

(c)If the Board fails or is unable to make the determination called for by paragraph (a) of this
Section 3, or if indemnification is denied, in whole or in part, because of an adverse finding by the Board, or because the Board believes the expenses for which indemnification is requested to be unreasonable, such action, inaction or inability of the Board shall in no way affect the right of the Indemnitee to make application therefor in any court having jurisdiction thereof. In such action or proceeding, or in a suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the issue shall be whether the Indemnitee met the standard of conduct set forth in Section 1 of this Article, or whether the expenses were reasonable, as the case may be (not whether the finding of the Board with respect thereto was correct.) If the judgment or other final adjudication in such action or proceeding establishes that the Indemnitee met the standard set forth in
Section 1 of this Article, or that the disallowed expenses were reasonable, or to the extent that it does, the Board shall then find such standard to have been met or the expenses to be reasonable, and shall grant such indemnification, and shall also grant to the Indemnitee indemnification of the expenses incurred by him in connection with the action or proceeding resulting in the judgment or other final adjudication that such standard of conduct was met, or if pursuant to such court determination such person is entitled to less than the full amount of indemnification denied by the Corporation, the portion of such expenses proportionate to the amount of such indemnification so awarded. Neither the failure of the Board to have made timely a determination prior to the commencement of such suit that indemnification of the Indemnitee is proper in the circumstances because the Indemnitee has met the applicable standard of conduct set forth in Section 1, nor an actual determination by the Board that the Indemnitee has not met such applicable standard of conduct, shall create a presumption that the Indemnitee has not met the applicable standard of conduct. In any suit brought by the Indemnitee to enforce a right to indemnification, or by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the Indemnitee is not entitled to indemnification, under this Article or otherwise, shall be on the Corporation.
(d)A finding by the Board pursuant to this
Section 3 that the standard of conduct set forth in
Section 1 of this Article has been met shall mean a

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 20 -

finding of the Board or shareholders as provided by law.

4. CONTRACTUAL ARTICLE

The rights conferred by this Article are contract rights which shall not be abrogated by any amendment or repeal of this Article with respect to events occurring prior to such amendment or repeal and shall, to the fullest extent permitted by law, be retroactive to events occurring prior to the adoption of this Article. No amendment of the Business Corporation Law, insofar as it reduces the permissible extent of the right of indemnification of an indemnitee under this Article, shall be effective as to such person with respect to any event, act or omission occurring or allegedly occurring prior to the effective date of such amendment irrespective of the date of any claim or legal action in respect thereto. This Article shall be binding on any successor to the Corporation, including any corporation or other entity which acquires all or substantially all of the Corporation's assets.

5. NON-EXCLUSIVITY

The indemnification provided by this Article shall not be deemed exclusive of any other rights to which any person covered hereby may be entitled other than pursuant to this Article. The Corporation is authorized to enter into agreements with any such person providing rights to indemnification or advancement of expenses in addition to the provisions therefor in this Article, and the Corporation's shareholders and its Board of Directors are authorized to adopt, in their discretion, resolutions providing any such person with any such rights.

6. INSURANCE

The Corporation may maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have the power to indemnify such person against such expense,

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc

- 21 -

liability or loss under this Article or applicable law.

7.INDEMNIFICATION OF EMPLOYEES AND AGENTS OF THE CORPORATION

The Corporation may, to the extent authorized from time to time by the Board of Directors, grant rights to indemnification and the advancement of expenses to any employee or agent of the Corporation with the same scope and effect as provided in this Article to directors and officers of the Corporation.

ARTICLE XII
BY-LAW CHANGES

All bylaws of the company shall be subject to alteration or repeal, and new bylaws may be made, either by the affirmative vote of the holders of record of a majority of the outstanding stock of the company entitled to vote in respect thereof, given at any annual meeting or at any special meeting, provided notice of the proposed alteration or repeal or of the proposed new bylaws be included in the notice of such meeting, or by the affirmative vote of a majority of the whole board of directors given at a special meeting of the board of directors called for the purpose, provided notice of the proposed alteration or repeal or of the proposed new bylaws be included in the notice of such meeting.

DATED: September 26, 1997

\\cdog1\sys\depts\adm\wpfiles\sec\ex2-2.x2adoc.doc


EXHIBIT NUMBER 3

NO. SHARES
TORVEC, INC.
INCORPORATED UNDER THE LAWS OF THE STATE OF NEW YORK
THE CORPORATION IS AUTHORIZED TO ISSUE 40,000,000 COMMON
SHARES WITH A PAR VALUE OF $.01 EACH
SEE LEGEND ON REVERSE
This Certifies that

_________________________________is the registered holder of

______________________ fully paid and non-assessable Shares

of the above Corporation transferable only on the books of the Corporation by the holder hereof in person or by duly authorized Attorney upon surrender of this Certificate properly endorsed.

In Witness Whereof, the said Corporation has caused this Certificate to be signed by its duly authorized officers and to be sealed with the Seal of the Corporation.
This ______________ day of ______________A.D. 19__


SECRETARY PRESIDENT

\\cdog1\sys\depts\adm\wpfiles\sec\ex3.doc

NO SALE, OFFER TO SELL, OR TRANSFER OF THE UNITS REPRESENTED BY THIS CERTIFICATE SHALL BE MADE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND IN COMPLIANCE WITH ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT THE PROPOSED TRANSFER IS EXEMPT FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND IS IN COMPLIANCE WITH APPLICABLE STATE SECURITIES LAWS.
CERTIFICATE FOR SHARES of the Common Stock


ISSUED TO

DATE

For Value Received, ______ hereby sell, assign and transfer unto

\\cdog1\sys\depts\adm\wpfiles\sec\ex3.doc



_____________________________________ Shares of the Common Stock represented by the within Certificate, and do hereby irrevocably constitute and appoint
_____________ Attorney
to transfer the said Stock on the books of the within named Corporation with full power of substitution in the premises.


Dated______________, 19__

In presence of

____.

\\cdog1\sys\depts\adm\wpfiles\sec\ex3.doc


EXHIBIT NO. 6.1

EMPLOYMENT AGREEMENT

1. AGREEMENT

This writing represents an agreement ("Agreement") between Herbert H. Dobbs, 448 West Maryknoll Rd., Rochester Hills, MI 48309 (the "Employee") and TORVEC Inc., 11 Pond View Drive, Pittsford, NY, 14534 (the "Employer") and defines the employment relationship between the Employee and the Employer.

2. THE EMPLOYEE'S POSITION The Employee shall hold the positions of Chairman and Chief Executive Officer and so long as elected by the stockholders a member of the Board of Directors of Employer.. The Employee's duties shall be those usual to the Employee's position in the Employer's industry; provided, however, the Employer, at the Employer's sole discretion, may increase, decrease or otherwise modify the Employee's duties. The Employee shall at all times exercise his best efforts for Employer and shall diligently and proficiently perform his duties for the Employer.

3. EMPLOYEE COMPENSATION
A. Annual Salary:

The Employer shall pay the Employee, in equal monthly installments, at the rate of $150,000.00 per year.
B. Stock Options:

Subject to the approval by its shareholders of the Company's 1998 Stock Option Plan, there is hereby granted to the Employee a non-qualified stock option to purchase up to 100,000 shares of the Company's $.01 par value Common Stock at an exercise price of $5.00 per share. The option granted

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 2 -

hereby shall be subject to the terms and conditions set forth in the Stock Option Agreement attached hereto and made a part hereof. The term of the option shall be for a period of 10 years, shall vest on a cumulative basis at a rate of 20% per year, shall provide for immediate and full vesting in the event the Company is acquired and shall provide that the right to exercise the option in accordance with its terms shall survive the Employee's termination of employment.
4. EMPLOYEE BENEFITS
A. Vacation:

The Employee is entitled to three (3) weeks paid vacation for each twelve (12) months of this Agreement.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 3 -

B. Additional Benefits:

1. The Employee will be included in such fringe benefit programs as the Employer hereafter adopts for the benefit of all employees.
2. Employer will provide suitable housing for Employee during such periods as Employee physically conducts his business from the Rochester, New York metropolitan area.
3. For a period of eighteen months after the commencement of this Agreement, Employer will pay to Employee as additional compensation an amount equal to the amount actually expended by Employee to continue COBRA insurance coverages with his present employer.
4. 12 paid holidays per year.
5. Sick pay days accrue at the same rate as vacation days.
5. TERM OF AGREEMENT This Agreement shall be for a period of three (3) years commencing on the first day of the month in which Employer receives the proceeds from its initial public offering of securities and shall automatically renew for three (3) years, unless the Employer informs the Employee of its intention to allow such Agreement to expire by giving written notice to the Employee at least six (6) months prior to the termination date.
6. CHANGE OF OWNERSHIP If TORVEC Inc. is bought out by another company, this Agreement may also be bought out at the prorated lump sum of base pay and bonus for lesser of twelve months or the remaining months on this Agreement.
7. TERMINATION OF THE CONTRACT
A. Cause of Termination:

1. Termination by the Employee The Employee may terminate this Agreement, for any reason, upon written notice to the Employer not fewer than twelve (12) months before the date of the intended termination.
2. Termination by Employer

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 4 -

The Employer may at any time terminate this Agreement without cause, by a notice to that effect to the Employee. As severance compensation, the Employer shall continue to pay the Employee his base pay and bonus for a period of twelve (12) months, subject to the limitations in Paragraph 7B2(b) below.
The Employer may terminate this Agreement without notice for just cause, including but not limited to, habitual neglect of or failure to perform duties after written warning from Employer to correct such failure, theft or misappropriation, or the Employee's continued incapacity due to mental or physical illness to perform the Employee's duties.
In the event of termination because of incapacity to perform due to mental or physical illness only, the Employer shall pay the Employee's monthly salary and minimum bonus for twelve (12) months.
B. Effect of Termination of Agreement:

Except as otherwise provided herein, upon expiration of the term of this Agreement, or by termination pursuant to any provision of this Agreement, all obligations of the Employee and the Employer shall terminate.
If the Employer gives notice to the Employee as provided in Paragraph 7A2 herein:
1. The Employee agrees:

(a) To continue to devote his best efforts and time to performance of his duties for the Employer and to cooperate with the Employer in effecting an orderly transfer of responsibilities and duties to a successor over a period of time to be determined by the Employer in its sole discretion, but not to exceed three (3) months.
(b) To consult with the Employer as may reasonably be required.
2. The Employer agrees:

(a) To cooperate in the Employee's effort to obtain new employment;
(b) To continue to pay the Employee, at the rate required hereunder, including both salary and minimum bonus until the Employee obtains new employment or until the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 5 -

conclusion of twelve (12) months; and, to the extent the Employee's total compensation in his new employment is less than his total compensation (salary and bonus) from the Employer would have been, the Employer shall pay the difference between the total compensation in the new employment and the total compensation that the Employee would have earned with the Employer until the conclusion of the term of the twelve (12) months following termination;
(c) To provide the benefits provided by this Agreement to the Employee until the Employee obtains new employment or until expiration of twelve (12) months whichever occurs first.
8. CONFIDENTIALITY AND TRANSFER OF INVENTIONS
A. Except as may be required by his employment hereunder, Employee will not at any time or in any manner, directly or indirectly, divulge, disclose or communicate to any person, firm, corporation, organization or entity any Trade Secrets of Employer. Trade Secrets include information concerning matters affecting or relating to the products, pricing, marketing and sales strategies, servicing of products, processes, formulas, inventions, discoveries, devices, finances or business of Employer or of its customers. Employee will at all times hold inviolate and keep secret all knowledge or information and Trade Secrets acquired by him concerning the names of the Employer's customers, their addresses, the prices Employer obtains or has obtained from them for its goods or services, all knowledge or information acquired by him concerning the products, formulas, processes, marketing and sales methodology and training and all other trade secrets of Employer's customers. In addition, Employee shall make no disclosure, directly or indirectly, of any financial information, contractual relationships, policies, past or contemplated future actions of policies of Employer, personnel matters, marketing or sales strategies or data, pricing information, technical data or specifications and written or oral communications of any sort of Employer or any of its customers which have not previously been disclosed to the general public with Employer's consent or without first obtaining the consent of Employer for such disclosure. Upon any termination of this Agreement or Employee's employment, Employee or his representatives shall immediately deliver to Employer all notes, notebooks, letters, papers, drawings, memos, communications, blueprints or other writings or data relating to the business of Employer or its customers.
B. Employee shall promptly disclose to Employer all ideas, discoveries, designs, improvements, innovations and inventions (collectively referred to herein as "inventions"), whether patentable or not, either relating to

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 6 -

the existing business, products, plans, processes, or procedures of Employer, or any parent or subsidiary of Employer, or suggested by or resulting from Employee's work at Employer, or resulting wholly or in part from the use of Employer's time, material, facilities or ideas, which Employee makes or conceives, in whole or in part, whether or not during working hours, alone or with others, at any time during the term of his employment pursuant to this Agreement or during the first six-month period immediately following termination of his employment for any reason, and Employee agrees that all such inventions shall be the exclusive property of Employer.
C. Employee hereby assigns to Employer all his rights and interests in and to all such inventions and all patents which may be obtained on them, in this or any foreign country. At Employer's expense, but without charge to it, Employee agrees to execute, acknowledge and deliver to Employer any specific assignments to any such inventions or other relevant documents and take any such further action as may be considered necessary by Employer at any time to obtain or defend letters patent in any and all countries or to obtain documents relating to registration, ownership or transfer of copyrights, or to vest title in such inventions in Employer or its assigns or to obtain for Employer any other legal protection for such inventions.
D. Because Employee shall acquire by reason of his employment and association with Employer an extensive knowledge of Employer's Trade Secrets, customers, procedures, and other confidential information, the parties hereto recognize that in the event of a breach or threat of breach by Employee of the terms and provisions contained in this Paragraph 8, compensation alone to Employer would not be an adequate remedy for a breach of those terms and provisions. Therefore, it is agreed that in the event of a breach or threat of a breach of the provisions of this Paragraph 8 by Employee, Employer shall be entitled to an immediate injunction from any court of competent jurisdiction restraining Employee from committing or continuing to commit a breach of such provisions without the showing or proving of actual damages. Any preliminary injunction or restraining order shall continue in full force and effect until any and all disputes between the parties regarding this Agreement have been finally resolved on the merits by settlement or by a court of law. Employee hereby waives any right he may have to require Employer to post a bond or other security with respect to obtaining or continuing any such injunction or temporary restraining order and, further, hereby releases Employer, its officers, directors, employees and agents from and waives any claim for damages against them which he might have with respect to Employer's obtaining in good faith any injunction or restraining order pursuant to this Agreement.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 7 -

Employee agrees that any action for injunction brought pursuant to this Paragraph 8 may be brought in the New York State Supreme Court in the County of Monroe and hereby submits to the jurisdiction of that court and waives any objection as to venue.
9. CONSTRUCTION OF THIS AGREEMENT
A. Choice of Law:

This Agreement is to be construed pursuant to the laws of the State of New York, including New York law regarding choice of law.
B. Invalid Agreement Provisions:

Should any provision of this Agreement become legally unenforceable, no other provision of this Agreement shall be affected, and the Agreement shall continue as if the Agreement had been executed absent the unenforceable provision.
C. No Other Agreements:

This Agreement represents the entire Agreement between the Employee and the Employer, and supersedes any and all negotiations and other agreements, oral, implied or written, in any way related to the employment relationship between the Employee and the Employer. No agreements, representations, or understandings (oral, written, or implied) other than those expressly set forth herein have been made or entered into by either party with respect to any aspect of the Employee's employment or any of the matters dealt with herein. In executing this Agreement, neither the Employer nor the Employee relies upon any promise, representation, or other inducement that is not expressed in this Agreement. This Agreement may be modified only by a written Agreement signed by both the Employee and the Employer and may not be modified in any oral agreement or representation.
D. Practices Inconsistent With This Agreement:

No provision of this Agreement shall be modified or construed by any practice or policy that is inconsistent with such provision, and failure by either the Employee or the Employer to comply with any provision, shall not affect the rights of either to thereafter comply or require the other to comply.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 8 -

10. ARBITRATION Any dispute between Employer and the Employee in any way arising out of this Agreement, other than an action for an injunction brought pursuant to Paragraph 8 of this Agreement, including the termination of employees employment and/or this Agreement, shall be submitted to arbitration by an arbitrator selected by the American Arbitration Association. The arbitrator's decision with respect to any such dispute shall be final and binding. Any such disputes must be submitted to arbitration within six (6) months of termination, cancellation, or expiration of this Agreement. Any party who, in violation of this paragraph, initiates a lawsuit against the other party, shall pay the other party's reasonable attorney's fees and costs incurred in such lawsuit. Except as otherwise provided herein, such arbitration shall take place in accordance with the Rules of Commercial Arbitration of the American Arbitration Association, and shall be held in Monroe County, New York.

                  TORVEC Inc.

Date:   ______________      By: ____________________________
                                  President
                                  Employer


Date:   ______________      ________________________________
                               Herbert H. Dobbs
                               Employee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 9 -

STOCK OPTION AGREEMENT

THIS STOCK OPTION AGREEMENT MADE as of this 1st day of January, 1998 between TORVEC, INC., a New York business corporation (herein referred to as the "Company"), and HERBERT H. DOBBS (herein referred to as the "Optionee");

WITNESSETH:

1. The Company hereby grants to the Optionee an Option (hereinafter referred to as "Option") to purchase an aggregate of 100,000 shares of the $.01 par value Common Stock of the Company (herein referred to as the "Shares") at an exercise price of $5.00 per Share to be paid by the Optionee with cash, a certified check or a bank cashier's check made payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, the Optionee may pay for the Shares, either in whole or in part, by the delivery of Common Stock of the Company already owned by him which will be accepted as payment for the Shares, based upon such Common Stock's fair market value on the date of exercise. In addition, provided the Board of Directors shall approve the specific transfer, payment for the Shares, either in whole or in part, may be made by delivery of Common Stock acquired by the Optionee under any of the Company's stock option plans, provided, however, that if this Option is exercised in part, Shares acquired by such partial exercise may not be used as payment for additional Shares to be acquired under this Agreement. In order for the Optionee to so use shares of Common Stock previously acquired under any of the Company's stock option plans as payment for the Shares either in whole or in part, the transfer of such previously acquired Common Stock as payment for all or a portion of the exercise price under this Agreement must occur more than two years from the date of the grant and one year from the date of exercise of the prior option pursuant to which the Optionee acquired such Common Stock.
2. The term during which the Option shall be exercisable shall commence on January 1, 1998 and expire on the close of business December 31, 2007, subject to earlier termination as provided in the Torvec, Inc. 1998 Stock Option Plan (herein referred to as the "Plan"). The Option to purchase the number of Shares granted under this Agreement shall vest on the 1st day of each of the first five years of the Option Term on a cumulative basis, in accordance with the following schedule:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 10 -

                         VESTED         NON-VESTED

1/1/98 - 12/31/98           20%             80%
1/1/99 - 12/31/99           40%             60%
1/1/2000 - 12/31/2000       60%             40%
1/1/01 - 12/31/2001         80%             20%
1/1/02 - 12/31/2002        100%              0%

provided however, that to the extent the Optionee shall fail to exercise or, due to the above limitation, be prohibited from exercising his Option in any year during the Option period, such annual right to exercise this Option shall not expire, but shall be cumulative, and carry over into and be exercisable in any subsequent year during which the Option is outstanding.
This Option may be exercised by the Optionee in accordance with its terms during the Option Term even though, at the time of such exercise, whether in whole or in part, the Optionee is no longer an employee of the Company.
3. Notwithstanding the vesting schedule set forth in
Section 2 hereof, the Optionee's right to exercise this Option in full shall immediately vest upon the occurrence of a change in control of the Company. For this purpose, the term "change in control of the Company" shall generally include a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company. Specifically, the term shall include (i) the purchase or other acquisition by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, or any comparable successor provisions, of the beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of more than 50% of either the outstanding shares of common stock or the combined voting power of the Company's then outstanding voting securities entitled to vote generally, or (ii) the approval by the shareholders of the Company of a reorganization, merger, or consolidation with respect to which, in such case, persons who were shareholders of the Company immediately prior to such reorganization, merger, or consolidation do not immediately thereafter, own more than 50% of either the outstanding shares of common stock or the combined voting power of the reorganized, merged or consolidated Company's then outstanding voting securities entitled to vote generally or
(iii) the liquidation and/or dissolution of the Company.
4. The Option is not transferable by the Optionee other than by Will or the laws of descent and distribution and is exercisable, during his lifetime, only by the Optionee. In the event that the right to exercise the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 11 -

Option passes to the Optionee's estate, or to a person to whom such right devolves by reason of the Optionee's death, then the Option shall be non transferable in the hands of the Optionee's Executor or Administrator or of such person, except that the Option may be distributed by the Optionee's Executor or Administrator to the distributees of the Optionee's estate as a part thereof.
5. In order for the Option to be exercised, in whole or in part, the notice by the Optionee to the Company in the form attached hereto must be accompanied by payment in full of the option price for the Shares being purchased. In addition, the Optionee agrees to tender to the Company an additional amount, in cash, certified check, cashier's check or bank draft, equal to the amount of any taxes required to be collected or withheld by the company in connection with the exercise of his Option.
6. The Company agrees that it will use its best efforts to register the sale of the Shares to be issued upon the exercise of the Option with the Securities and Exchange Commission under the Securities Act of 1933. Upon the effectiveness of the Registration Statement covering the Shares, the Optionee shall be able to sell the Shares in "open market transactions" free of Federal Securities Law restrictions, provided that at the time of sale, or within the three month period immediately prior to such sale, he is not nor has he been an "affiliate" of the Company. The Optionee further understands that, in accordance with applicable Commission rules governing controlling persons of public companies, members of the board of directors of a public company, such as the Company, are deemed to be "affiliates" during their term of office. The Optionee, therefore, agrees that he will consult with the Company's counsel as to any Securities Law restrictions, including a limitation on the number of Shares which may be sold at any one time, on his ability to sell the Shares prior to any sale thereof.
7. The Company agrees to provide the Optionee with a copy of the Prospectus prepared by the Company in connection with the Registration Statement filed to register the Shares, together with its exhibits, and the Company hereby acknowledges its obligation to provide the Optionee with all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year of the Company and all updates thereof. The Optionee agrees that prior to exercise, either in whole or in part of the Option granted to him hereunder, he shall have read such materials, including the most recent annual and quarterly reports to shareholders, and shall have received, if requested, and read all the documents incorporated by reference in the Prospectus and Registration Statement filed with the Securities and Exchange Commission.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 12 -

8. The Optionee understands that except as provided in Paragraph 6 above, the Company has not agreed to register either the issuance or the resale of the Shares in accordance with the provisions of the Securities Act of 1933 or to register either the issuance or the resale of the Shares under any applicable State Securities Laws. Hence, the Optionee agrees that by virtue of the provision of certain rules respecting "restricted securities" promulgated under such Federal and/or State Laws, unless the resale of the Shares is registered as provided in Paragraph 6 above, and until the registration of such Shares in accordance with Paragraph 6 above shall have been declared effective by order of the Commission, the Shares which the Optionee shall purchase upon the exercise of this Option must be held indefinitely and may not be sold, transferred, pledged, hypothecated, or otherwise encumbered for value, unless and until a secondary distribution and/or resale of such Shares is subsequently registered under such Federal and/or State Securities Laws, or unless an exemption from registration is available, in which case the Optionee still may be limited as to the amount of the Shares that may be sold, transferred, pledged and/or encumbered for value. The Optionee therefore agrees that, until the registration of such Shares shall have been declared effective by order of the Commission, the Company may affix upon any certificate representing the Shares, a legend that such Shares may not be transferred in violation of Section 5 of the Securities Act of 1933.
9. The Optionee understands and agrees that the Shares to be acquired upon the exercise of the Option may not be sold, transferred, exchanged, hypothecated, encumbered, pledged or otherwise disposed of for value for a period of six (6) months from the date of the grant of this Option.
10. The Optionee understands that the Company has established certain policies and procedures governing trading in the Company's securities, including the Shares to be acquired upon the exercise of this Option, while in possession of material, inside information regarding the Company and/or any of its subsidiaries, receipt of which is hereby acknowledged. The Optionee agrees that upon exercise of this Option, either in whole or in part, he will comply with all of the terms and conditions of such policy, including the procedures and guidelines established for its implementation. In particular, the Optionee agrees that where required under such guidelines and procedures, he will obtain permission of the Company's Clearinghouse Committee composed of senior management prior to effectuating any sale or other transfer for value of the Shares to be acquired by virtue of the exercise of this Option.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 13 -

11. All the terms and provisions of the Plan, duly adopted at a meeting of the Company's Board of Directors on _______________ and approved by a majority vote of the Company's shareholders either in person or by proxy at a duly called meeting of such shareholders held on _______________ and as amended to date, are hereby expressly incorporated into this Stock Option Agreement and made a part hereof as if printed herein and the Optionee, by the Optionee's signature hereon, acknowledges receipt of a certified copy of said Plan. If there shall be any conflict between this Agreement and the Plan, the provisions of the Plan shall control.
12. In accordance with certain terms and conditions of the Plan, the aggregate number and kind of shares that may be purchased pursuant to the grant of the Option under this Agreement shall be proportionately adjusted for any increase, decrease or change in the total number of the outstanding shares of the Company resulting from a stock dividend, stock-split or other corporate reorganization which would result in or have the effect of the Optionee being treated differently (but for the adjustment) than he would be treated had he been the beneficial owner of the Shares subject to the Option on the record date for such dividend, split or reorganization, as the case may be.
13. The Optionee understands that the Option granted hereunder constitutes a "nonqualified stock option" for federal, and if applicable, state income tax purposes. Consequently, the Optionee understands that under current provisions of federal tax law, for regular as well as for purposes to the federal alternative minimum income tax, no gain or loss generally is recognized to the Optionee upon the grant of the Option. In addition, the Company will receive no business expense deduction as a result of the grant of the Option. For federal income tax purposes, upon the exercise of the Option, the difference between the exercise price and the fair market value of the Shares on the date of exercise constitutes ordinary income to the Optionee and is taxed to the Optionee at normal, ordinary tax rates, except to the extent the Shares are not transferable and are subject to a substantial risk of forfeiture. To the extent such difference is required to be included as income by the Optionee, the Company is entitled to a business expense deduction. Upon the later sale of the Shares, long or short term capital gain or loss will be recognized by the Optionee, depending upon the holding period (eighteen months for long term capital gain or loss) and the extent to which the selling price exceeds or is less than the Optionee's basis in the stock. The amount of gain will be taxed at normal, ordinary tax rates, with a maximum rate of 20% if the Shares are held for a period of at least eighteen months. If the Shares are held for a period of at least twelve months, the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 14 -

maximum rate on any gain from their sale will be taxed at 28%.
The Optionee also understands that the provisions of federal tax law described herein are subject to change and, consequently, the Optionee agrees to consult with his or her own tax advisor with respect to the tax treatment to be accorded the grant of the Option herein, the exercise of such Option, and the disposition of the Shares.
13. Consistent with the provisions of the Plan, this Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and to any executor, administrator, legal representative, legatee, or distributee entitled by law to the Optionee's right hereunder.
14. Except insofar as an interpretation of federal securities law otherwise is required, or is controlling, this Agreement shall be governed by and construed in accordance with the laws of the State of New York. IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Optionee has hereunto set his hand, as of the day and year first above written.
TORVEC, INC.
By:____________________________


Herbert H. Dobbs, Optionee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 15 -

NOTICE OF EXERCISE OF STOCK OPTION
AND
RECORD OF STOCK TRANSFER

Torvec, Inc.
3740 Route 104
Williamson, New York 14587
Gentlemen:
I hereby exercise my Stock Option granted to me by Torvec, Inc. under a Stock Option Agreement dated _______________, subject to all the terms and provisions thereof and of the Torvec, Inc. 1998 Stock Option Plan referred to therein and notify you of my desire to purchase Shares of the $.01 par value Common Stock of the Company which were offered to me pursuant to the Stock Option Agreement. Enclosed is my payment in the sum of in full payment of such Shares.
I understand that a Registration Statement covering the Shares to be issued to me pursuant to this exercise of the Option granted to me was filed with the Securities and Exchange Commission on _______________. The Registration Statement became effective on _______________. Consequently, I understand that unless I am an "affiliate" of the Company, the Shares I am acquiring are freely tradeable and may be sold by me in "open market" transactions. If I am an "affiliate" of the Company, however, or have been one during the three month period prior to sale, I recognize that I may not sell freely on the open market and therefore agree that I will consult the Company's counsel as to the securities law restrictions on my ability to sell the Shares.
I also understand that under the Plan, and in accordance with the terms of the Stock Option Agreement, I may not sell, assign, alienate, pledge, encumber or otherwise transfer for value the Shares unless a period of six (6) months has elapsed from the date of the grant of the Option to me.
I acknowledge that I am aware that the Company has established a policy with respect to trading in its securities while in possession of material inside information regarding the Company and/or its subsidiaries, and that, in accordance with certain guidelines and procedures designed to implement such policy, I may be required to obtain permission from a Clearinghouse Committee, composed of Senior Management, prior

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 16 -

to any sale or other transfer for value of the Shares hereby acquired.
I also acknowledge that I have received and have read the Prospectus dated _______________ prepared by the Company in connection with the grant of the Option contained herein, together with its exhibits, and all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year and all quarterly and current updates thereof. I acknowledge that I have received all documents incorporated by reference in the Prospectus and the Registration Statement filed with the Securities and Exchange Commission that I requested and have read the same. I acknowledge that I have had the opportunity to ask questions of and receive answers from the Company's management concerning the information set forth in such Prospectus, reports and updates and have been satisfied with the answers provided regarding the same.
Finally, I acknowledge that there are significant federal income tax consequences resulting from my exercise of this Option, that I have consulted with and received advice from qualified tax counsel both as to the nature of such tax consequences and their impact upon my own personal income tax situation as the result of such exercise, and that I fully understand such impact and have planned accordingly.

DATED: ________________ __________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a

- 17 -

Receipt is hereby acknowledged of the delivery to me by Torvec, Inc. on , 19 of stock certificates for shares of $.01 par value common stock purchased by me pursuant to the terms and conditions of the Torvec, Inc. 1998 Stock Option Plan referred to above.

DATED: ______________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-1.x2a


EXHIBIT NO. 6.2

EMPLOYMENT AGREEMENT

1.AGREEMENT This writing represents an agreement ("Agreement") between Lee E. Sawyer, 16 Williamsburg Lane, Rolling Hills, California, 90274 (the "Employee") and TORVEC Inc.. 11 Pond View Drive, Pittsford, NY, 14534 (the "Employer") and defines the employment relationship between the Employee and the Employer.
2.THE EMPLOYEE'S POSITION The Employee shall hold the positions of President and Chief Operating Officer and so long as elected by the stockholders a member of the Board of Directors of Employer.. The Employee's duties shall be those usual to the Employee's position in the Employer's industry; provided, however, the Employer, at the Employer's sole discretion, may increase, decrease or otherwise modify the Employee's duties. The Employee shall at all times exercise his best efforts for Employer and shall diligently and proficiently perform his duties for the Employer.
3.EMPLOYEE COMPENSATION
A.Annual Salary:

The Employer shall pay the Employee, in equal monthly installments, at the rate equivalent to the amounts listed below:

                         $240,000         CY     1998


          $252,000         CY     1999 (5%
                                  increase)


\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a



          $264,600         CY     2000 (5%
                                  increase)

Salary to be paid in equal monthly installments reduced by withholding the usual payroll deductions.
B.Bonus:
At the end of each quarter for each quarter worked or prorated portion of a quarter worked, the Employer shall pay the Employee the minimum bonus listed below:


$15,000 per quarter for 1998
$15,000 per quarter for 1999
$15,000 per quarter for 2000

Bonus to be paid withholding the usual payroll deductions. Any increase in bonus beyond the minimum will be determined by the Board of Directors taking into account Employee performance and the profitability and financial conditions of Employer.
C.Stock Options:

Subject to the approval by its shareholders of the Company's 1998 Stock Option Plan, there is hereby granted to the Employee a non-qualified stock option to purchase up to 180,000 shares of the Company's $.01 par value Common Stock at an exercise price of $5.00 per share. The option granted hereby shall be subject to the terms and conditions set forth in the Stock Option Agreement attached hereto and made a part hereof. The term of the option shall be for a period of 10 years, shall vest on a cumulative basis at a rate of 20% per year, shall provide for immediate and full vesting in the event the Company is acquired and shall provide that the right to exercise the option in accordance with its terms shall survive the Employee's termination of employment.
4.EMPLOYEE BENEFITS
A.Automobile(s):

The Employer shall provide a $700 per month lease car allowance for securing automobile(s) for the Employee's use. The Employee shall provide insurance (100/300), gasoline, usual expenses and maintenance for the automobile(s). The Employee shall be able to add to this lease car amount in order to obtain a higher level of vehicle(s) if he desires.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

B.Vacation:

The Employee is entitled to three (3) weeks paid vacation for each twelve (12) months of this Agreement.


C.Additional Benefits:

1. The Employee will be included in such fringe benefit programs as the Employer hereafter adopts for the benefit of all employees.
2. Employer will provide suitable housing for Employee during such periods as Employee physically conducts his business from the Rochester, New York metropolitan area.
3. For a period of eighteen months after the commencement of this Agreement, Employer will pay to Employee as additional compensation an amount equal to the amount actually expended by Employee to continue COBRA insurance coverages with his present employer.
4. 12 paid holidays per year.
5. Sick pay days accrue at the same rate as vacation days.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

5.TERM OF AGREEMENT This Agreement shall be for a period of three (3) years commencing on the first day of the month in which Employer receives the proceeds from its initial public offering of securities and shall automatically renew for three (3) years, unless the Employer informs the Employee of its intention to allow such Agreement to expire by giving written notice to the Employee at least six (6) months prior to the termination date.
6.CHANGE OF OWNERSHIP If TORVEC Inc. is bought out by another company, this Agreement may also be bought out at the prorated lump sum of base pay and bonus for lesser of twelve months or the remaining months on this Agreement.
7.TERMINATION OF THE CONTRACT
A.Cause of Termination:

1.Termination by the Employee The Employee may terminate this Agreement, for any reason, upon written notice to the Employer not fewer than twelve (12) months before the date of the intended termination.
2.Termination by Employer The Employer may at any time terminate this Agreement without cause, by a notice to that effect to the Employee. As severance compensation, the Employer shall continue to pay the Employee his base pay and bonus for a period of twelve (12) months, subject to the limitations in Paragraph 7B2(b) below. The Employer may terminate this Agreement without notice for just cause, including but not limited to, habitual neglect of or failure to perform duties after written warning from Employer to correct such failure, theft or misappropriation, or the Employee's continued incapacity due to mental or physical illness to perform the Employee's duties. In the event of termination because of incapacity to perform due to mental or physical illness only, the Employer shall pay the Employee's monthly salary and minimum bonus for twelve (12) months.
B.Effect of Termination of Agreement:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

Except as otherwise provided herein, upon expiration of the term of this Agreement, or by termination pursuant to any provision of this Agreement, all obligations of the Employee and the Employer shall terminate.
If the Employer gives notice to the Employee as provided in Paragraph 7A2 herein:
1.The Employee agrees:

(a)To continue to devote his best efforts and time to performance of his duties for the Employer and to cooperate with the Employer in effecting an orderly transfer of responsibilities and duties to a successor over a period of time to be determined by the Employer in its sole discretion, but not to exceed three (3) months.
(b)To consult with the Employer as may reasonably be required.
2.The Employer agrees:

(a)To cooperate in the Employee's effort to obtain new employment;
(b)To continue to pay the Employee, at the rate required hereunder, including both salary and minimum bonus until the Employee obtains new employment or until the conclusion of twelve (12) months; and, to the extent the Employee's total compensation in his new employment is less than his total compensation (salary and bonus) from the Employer would have been, the Employer shall pay the difference between the total compensation in the new employment and the total compensation that the Employee would have earned with the Employer until the conclusion of the term of the twelve (12) months following termination;
(c)To provide the benefits provided by this Agreement to the Employee until the Employee obtains new employment or until expiration of twelve (12) months whichever occurs first.
8. CONFIDENTIALITY AND TRANSFER OF INVENTIONS
A. Except as may be required by his employment hereunder, Employee will not at any time or in any manner, directly or indirectly, divulge, disclose or communicate to any person, firm, corporation, organization or entity any Trade Secrets of Employer. Trade Secrets include information concerning matters affecting or relating to the products, pricing, marketing and sales strategies, servicing

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

of products, processes, formulas, inventions, discoveries, devices, finances or business of Employer or of its customers. Employee will at all times hold inviolate and keep secret all knowledge or information and Trade Secrets acquired by him concerning the names of the Employer's customers, their addresses, the prices Employer obtains or has obtained from them for its goods or services, all knowledge or information acquired by him concerning the products, formulas, processes, marketing and sales methodology and training and all other trade secrets of Employer's customers. In addition, Employee shall make no disclosure, directly or indirectly, of any financial information, contractual relationships, policies, past or contemplated future actions of policies of Employer, personnel matters, marketing or sales strategies or data, pricing information, technical data or specifications and written or oral communications of any sort of Employer or any of its customers which have not previously been disclosed to the general public with Employer's consent or without first obtaining the consent of Employer for such disclosure. Upon any termination of this Agreement or Employee's employment, Employee or his representatives shall immediately deliver to Employer all notes, notebooks, letters, papers, drawings, memos, communications, blueprints or other writings or data relating to the business of Employer or its customers.
B. Employee shall promptly disclose to Employer all ideas, discoveries, designs, improvements, innovations and inventions (collectively referred to herein as "inventions"), whether patentable or not, either relating to the existing business, products, plans, processes, or procedures of Employer, or any parent or subsidiary of Employer, or suggested by or resulting from Employee's work at Employer, or resulting wholly or in part from the use of Employer's time, material, facilities or ideas, which Employee makes or conceives, in whole or in part, whether or not during working hours, alone or with others, at any time during the term of his employment pursuant to this Agreement or during the first six-month period immediately following termination of his employment for any reason, and Employee agrees that all such inventions shall be the exclusive property of Employer.
C. Employee hereby assigns to Employer all his rights and interests in and to all such inventions and all patents which may be obtained on them, in this or any foreign country. At Employer's expense, but without charge to it, Employee agrees to execute, acknowledge and deliver to Employer any specific assignments to any such inventions or other relevant documents and take any such further action as may be considered necessary by Employer at any time to obtain or defend letters patent in any and all countries or to obtain documents relating to registration, ownership or

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

transfer of copyrights, or to vest title in such inventions in Employer or its assigns or to obtain for Employer any other legal protection for such inventions.
D. Because Employee shall acquire by reason of his employment and association with Employer an extensive knowledge of Employer's Trade Secrets, customers, procedures, and other confidential information, the parties hereto recognize that in the event of a breach or threat of breach by Employee of the terms and provisions contained in this Paragraph 8, compensation alone to Employer would not be an adequate remedy for a breach of those terms and provisions. Therefore, it is agreed that in the event of a breach or threat of a breach of the provisions of this Paragraphs 8 by Employee, Employer shall be entitled to an immediate injunction from any court of competent jurisdiction restraining Employee from committing or continuing to commit a breach of such provisions without the showing or proving of actual damages. Any preliminary injunction or restraining order shall continue in full force and effect until any and all disputes between the parties regarding this Agreement have been finally resolved on the merits by settlement or by a court of law. Employee hereby waives any right he may have to require Employer to post a bond or other security with respect to obtaining or continuing any such injunction or temporary restraining order and, further, hereby releases Employer, its officers, directors, employees and agents from and waives any claim for damages against them which he might have with respect to Employer's obtaining in good faith any injunction or restraining order pursuant to this Agreement. Employee agrees that any action for injunction brought pursuant to this Paragraph 8 may be brought in the New York State Supreme Court in the County of Monroe and hereby submits to the jurisdiction of that court and waives any objection as to venue.
9.CONSTRUCTION OF THIS AGREEMENT
A.Choice of Law:

This Agreement is to be construed pursuant to the laws of the State of New York, including New York law regarding choice of law.
B.Invalid Agreement Provisions:

Should any provision of this Agreement become legally unenforceable, no other provision of this Agreement shall be affected, and the Agreement shall continue as if the Agreement had been executed absent the unenforceable provision.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

C.No Other Agreements:

This Agreement represents the entire Agreement between the Employee and the Employer, and supersedes any and all negotiations and other agreements, oral, implied or written, in any way related to the employment relationship between the Employee and the Employer. No agreements, representations, or understandings (oral, written, or implied) other than those expressly set forth herein have been made or entered into by either party with respect to any aspect of the Employee's employment or any of the matters dealt with herein. In executing this Agreement, neither the Employer nor the Employee relies upon any promise, representation, or other inducement that is not expressed in this Agreement. This Agreement may be modified only by a written Agreement signed by both the Employee and the Employer and may not be modified in any oral agreement or representation.
D.Practices Inconsistent With This Agreement:

No provision of this Agreement shall be modified or construed by any practice or policy that is inconsistent with such provision, and failure by either the Employee or the Employer to comply with any provision, shall not affect the rights of either to thereafter comply or require the other to comply.
10.ARBITRATION
Any dispute between Employer and the Employee in any way arising out of this Agreement, other than an action for an injunction brought pursuant to Paragraph 8 of this Agreement, including the termination of employees employment and/or this Agreement, shall be submitted to arbitration by an arbitrator selected by the American Arbitration Association. The arbitrator's decision with respect to any such dispute shall be final and binding. Any such disputes must be submitted to arbitration within six (6) months of termination, cancellation, or expiration of this Agreement. Any party who, in violation of this paragraph, initiates a lawsuit against the other party, shall pay the other party's reasonable attorney's fees and costs incurred in such lawsuit. Except as otherwise provided herein, such arbitration shall take place in accordance with the Rules of Commercial Arbitration of the American Arbitration Association, and shall be held in Monroe County, New York.

TORVEC Inc.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

Date:______________       By:______________________________
                             President
                             Employer


Date:______________       _________________________________
                             Lee E. Sawyer
                             Employee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

STOCK OPTION AGREEMENT

THIS STOCK OPTION AGREEMENT MADE as of this 1st day of January, 1998 between TORVEC, INC., a New York business corporation (herein referred to as the "Company"), and LEE E. SAWYER (herein referred to as the "Optionee");

WITNESSETH:

1. The Company hereby grants to the Optionee an Option (hereinafter referred to as "Option") to purchase an aggregate of 180,000 shares of the $.01 par value Common Stock of the Company (herein referred to as the "Shares") at an exercise price of $5.00 per Share to be paid by the Optionee with cash, a certified check or a bank cashier's check made payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, the Optionee may pay for the Shares, either in whole or in part, by the delivery of Common Stock of the Company already owned by him which will be accepted as payment for the Shares, based upon such Common Stock's fair market value on the date of exercise. In addition, provided the Board of Directors shall approve the specific transfer, payment for the Shares, either in whole or in part, may be made by delivery of Common Stock acquired by the Optionee under any of the Company's stock option plans, provided, however, that if this Option is exercised in part, Shares acquired by such partial exercise may not be used as payment for additional Shares to be acquired under this Agreement. In order for the Optionee to so use shares of Common Stock previously acquired under any of the Company's stock option plans as payment for the Shares either in whole or in part, the transfer of such previously acquired Common Stock as payment for all or a portion of the exercise price under this Agreement must occur more than two years from the date of the grant and one year from the date of exercise of the prior option pursuant to which the Optionee acquired such Common Stock.
2. The term during which the Option shall be exercisable shall commence on January 1, 1998 and expire on the close of business December 31, 2007, subject to earlier termination as provided in the Torvec, Inc. 1998 Stock Option Plan (herein referred to as the "Plan"). The Option to purchase the number of Shares granted under this Agreement shall vest on the 1st day of each of the first five years of the Option Term on a cumulative basis, in accordance with the following schedule:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

                                      VESTED       NON-
VESTED

          1/1/98 - 12/31/98           20%           80%
          1/1/99 - 12/31/99           40%           60%
          1/1/2000 - 12/31/2000       60%           40%
          1/1/01 - 12/31/200         180%           20%
          1/1/02 - 12/31/2002        100%            0%

provided however, that to the extent the Optionee shall fail to exercise or, due to the above limitation, be prohibited from exercising his Option in any year during the Option period, such annual right to exercise this Option shall not expire, but shall be cumulative, and carry over into and be exercisable in any subsequent year during which the Option is outstanding.
This Option may be exercised by the Optionee in accordance with its terms during the Option Term even though, at the time of such exercise, whether in whole or in part, the Optionee is no longer an employee of the Company.
3. Notwithstanding the vesting schedule set forth in
Section 2 hereof, the Optionee's right to exercise this Option in full shall immediately vest upon the occurrence of a change in control of the Company. For this purpose, the term "change in control of the Company" shall generally include a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company. Specifically, the term shall include (i) the purchase or other acquisition by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, or any comparable successor provisions, of the beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of more than 50% of either the outstanding shares of common stock or the combined voting power of the Company's then outstanding voting securities entitled to vote generally, or (ii) the approval by the shareholders of the Company of a reorganization, merger, or consolidation with respect to which, in such case, persons who were shareholders of the Company immediately prior to such reorganization, merger, or consolidation do not immediately thereafter, own more than 50% of either the outstanding shares of common stock or the combined voting power of the reorganized, merged or consolidated Company's then outstanding voting securities entitled to vote generally or
(iii) the liquidation and/or dissolution of the Company.
4. The Option is not transferable by the Optionee other than by Will or the laws of descent and distribution

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

and is exercisable, during his lifetime, only by the Optionee. In the event that the right to exercise the Option passes to the Optionee's estate, or to a person to whom such right devolves by reason of the Optionee's death, then the Option shall be non transferable in the hands of the Optionee's Executor or Administrator or of such person, except that the Option may be distributed by the Optionee's Executor or Administrator to the distributees of the Optionee's estate as a part thereof.
5. In order for the Option to be exercised, in whole or in part, the notice by the Optionee to the Company in the form attached hereto must be accompanied by payment in full of the option price for the Shares being purchased. In addition, the Optionee agrees to tender to the Company an additional amount, in cash, certified check, cashier's check or bank draft, equal to the amount of any taxes required to be collected or withheld by the company in connection with the exercise of his Option.
6. The Company agrees that it will use its best efforts to register the sale of the Shares to be issued upon the exercise of the Option with the Securities and Exchange Commission under the Securities Act of 1933. Upon the effectiveness of the Registration Statement covering the Shares, the Optionee shall be able to sell the Shares in "open market transactions" free of Federal Securities Law restrictions, provided that at the time of sale, or within the three month period immediately prior to such sale, he is not nor has he been an "affiliate" of the Company. The Optionee further understands that, in accordance with applicable Commission rules governing controlling persons of public companies, members of the board of directors of a public company, such as the Company, are deemed to be "affiliates" during their term of office. The Optionee, therefore, agrees that he will consult with the Company's counsel as to any Securities Law restrictions, including a limitation on the number of Shares which may be sold at any one time, on his ability to sell the Shares prior to any sale thereof.
7. The Company agrees to provide the Optionee with a copy of the Prospectus prepared by the Company in connection with the Registration Statement filed to register the Shares, together with its exhibits, and the Company hereby acknowledges its obligation to provide the Optionee with all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year of the Company and all updates thereof. The Optionee agrees that prior to exercise, either in whole or in part of the Option granted to him hereunder, he shall have read such materials, including the most recent annual and quarterly reports to shareholders, and shall have received, if requested, and read all the documents

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

incorporated by reference in the Prospectus and Registration Statement filed with the Securities and Exchange Commission.
8. The Optionee understands that except as provided in Paragraph 6 above, the Company has not agreed to register either the issuance or the resale of the Shares in accordance with the provisions of the Securities Act of 1933 or to register either the issuance or the resale of the Shares under any applicable State Securities Laws. Hence, the Optionee agrees that by virtue of the provision of certain rules respecting "restricted securities" promulgated under such Federal and/or State Laws, unless the resale of the Shares is registered as provided in Paragraph 6 above, and until the registration of such Shares in accordance with Paragraph 6 above shall have been declared effective by order of the Commission, the Shares which the Optionee shall purchase upon the exercise of this Option must be held indefinitely and may not be sold, transferred, pledged, hypothecated, or otherwise encumbered for value, unless and until a secondary distribution and/or resale of such Shares is subsequently registered under such Federal and/or State Securities Laws, or unless an exemption from registration is available, in which case the Optionee still may be limited as to the amount of the Shares that may be sold, transferred, pledged and/or encumbered for value. The Optionee therefore agrees that, until the registration of such Shares shall have been declared effective by order of the Commission, the Company may affix upon any certificate representing the Shares, a legend that such Shares may not be transferred in violation of Section 5 of the Securities Act of 1933.
9. The Optionee understands and agrees that the Shares to be acquired upon the exercise of the Option may not be sold, transferred, exchanged, hypothecated, encumbered, pledged or otherwise disposed of for value for a period of six (6) months from the date of the grant of this Option.
10. The Optionee understands that the Company has established certain policies and procedures governing trading in the Company's securities, including the Shares to be acquired upon the exercise of this Option, while in possession of material, inside information regarding the Company and/or any of its subsidiaries, receipt of which is hereby acknowledged. The Optionee agrees that upon exercise of this Option, either in whole or in part, he will comply with all of the terms and conditions of such policy, including the procedures and guidelines established for its implementation. In particular, the Optionee agrees that where required under such guidelines and procedures, he will obtain permission of the Company's Clearinghouse Committee composed of senior management prior to effectuating any sale or other transfer for value of the Shares to be acquired by virtue of the exercise of this Option.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

11. All the terms and provisions of the Plan, duly adopted at a meeting of the Company's Board of Directors on _______________ and approved by a majority vote of the Company's shareholders either in person or by proxy at a duly called meeting of such shareholders held on _______________ and as amended to date, are hereby expressly incorporated into this Stock Option Agreement and made a part hereof as if printed herein and the Optionee, by the Optionee's signature hereon, acknowledges receipt of a certified copy of said Plan. If there shall be any conflict between this Agreement and the Plan, the provisions of the Plan shall control.
12. In accordance with certain terms and conditions of the Plan, the aggregate number and kind of shares that may be purchased pursuant to the grant of the Option under this Agreement shall be proportionately adjusted for any increase, decrease or change in the total number of the outstanding shares of the Company resulting from a stock dividend, stock-split or other corporate reorganization which would result in or have the effect of the Optionee being treated differently (but for the adjustment) than he would be treated had he been the beneficial owner of the Shares subject to the Option on the record date for such dividend, split or reorganization, as the case may be.
13. The Optionee understands that the Option granted hereunder constitutes a "nonqualified stock option" for federal, and if applicable, state income tax purposes. Consequently, the Optionee understands that under current provisions of federal tax law, for regular as well as for purposes to the federal alternative minimum income tax, no gain or loss generally is recognized to the Optionee upon the grant of the Option. In addition, the Company will receive no business expense deduction as a result of the grant of the Option. For federal income tax purposes, upon the exercise of the Option, the difference between the exercise price and the fair market value of the Shares on the date of exercise constitutes ordinary income to the Optionee and is taxed to the Optionee at normal, ordinary tax rates, except to the extent the Shares are not transferable and are subject to a substantial risk of forfeiture. To the extent such difference is required to be included as income by the Optionee, the Company is entitled to a business expense deduction. Upon the later sale of the Shares, long or short term capital gain or loss will be recognized by the Optionee, depending upon the holding period (eighteen months for long term capital gain or loss) and the extent to which the selling price exceeds or is less than the Optionee's basis in the stock. The amount of gain will be taxed at normal, ordinary tax rates, with a maximum rate of 20% if the Shares are held for a period of at least eighteen months. If the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

Shares are held for a period of at least twelve months, the maximum rate on any gain from their sale will be taxed at 28%.
The Optionee also understands that the provisions of federal tax law described herein are subject to change and, consequently, the Optionee agrees to consult with his or her own tax advisor with respect to the tax treatment to be accorded the grant of the Option herein, the exercise of such Option, and the disposition of the Shares.
13. Consistent with the provisions of the Plan, this Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and to any executor, administrator, legal representative, legatee, or distributee entitled by law to the Optionee's right hereunder.
14. Except insofar as an interpretation of federal securities law otherwise is required, or is controlling, this Agreement shall be governed by and construed in accordance with the laws of the State of New York. IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Optionee has hereunto set his hand, as of the day and year first above written.
TORVEC, INC.

By:______________________

Lee E. Sawyer, Optionee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

NOTICE OF EXERCISE OF STOCK OPTION
AND
RECORD OF STOCK TRANSFER

Torvec, Inc.
3740 Route 104
Williamson, New York 14587
Gentlemen:
I hereby exercise my Stock Option granted to me by Torvec, Inc. under a Stock Option Agreement dated _______________, subject to all the terms and provisions thereof and of the Torvec, Inc. 1998 Stock Option Plan referred to therein and notify you of my desire to purchase Shares of the $.01 par value Common Stock of the Company which were offered to me pursuant to the Stock Option Agreement. Enclosed is my payment in the sum of in full payment of such Shares.
I understand that a Registration Statement covering the Shares to be issued to me pursuant to this exercise of the Option granted to me was filed with the Securities and Exchange Commission on _______________. The Registration Statement became effective on _______________. Consequently, I understand that unless I am an "affiliate" of the Company, the Shares I am acquiring are freely tradeable and may be sold by me in "open market" transactions. If I am an "affiliate" of the Company, however, or have been one during the three month period prior to sale, I recognize that I may not sell freely on the open market and therefore agree that I will consult the Company's counsel as to the securities law restrictions on my ability to sell the Shares.
I also understand that under the Plan, and in accordance with the terms of the Stock Option Agreement, I may not sell, assign, alienate, pledge, encumber or otherwise transfer for value the Shares unless a period of six (6) months has elapsed from the date of the grant of the Option to me.
I acknowledge that I am aware that the Company has established a policy with respect to trading in its securities while in possession of material inside information regarding the Company and/or its subsidiaries, and that, in accordance with certain guidelines and procedures designed to implement such policy, I may be required to obtain permission from a Clearinghouse Committee, composed of Senior Management, prior

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

to any sale or other transfer for value of the Shares hereby acquired.
I also acknowledge that I have received and have read the Prospectus dated _______________ prepared by the Company in connection with the grant of the Option contained herein, together with its exhibits, and all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year and all quarterly and current updates thereof. I acknowledge that I have received all documents incorporated by reference in the Prospectus and the Registration Statement filed with the Securities and Exchange Commission that I requested and have read the same. I acknowledge that I have had the opportunity to ask questions of and receive answers from the Company's management concerning the information set forth in such Prospectus, reports and updates and have been satisfied with the answers provided regarding the same. Finally, I acknowledge that there are significant federal income tax consequences resulting from my exercise of this Option, that I have consulted with and received advice from qualified tax counsel both as to the nature of such tax consequences and their impact upon my own personal income tax situation as the result of such exercise, and that I fully understand such impact and have planned accordingly.

DATED: ______________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a

Receipt is hereby acknowledged of the delivery to me by Torvec, Inc. on , 19 of stock certificates for shares of $.01 par value common stock purchased by me pursuant to the terms and conditions of the Torvec, Inc. 1998 Stock Option Plan referred to above.

DATED:______________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-2.x2a


EXHIBIT NUMBER 6.3

EMPLOYMENT AGREEMENT

1. AGREEMENT

This writing represents an agreement ("Agreement") between Morton A. Polster, 64 Brunswick Street, Rochester, NY 14607-2307 (the "Employee") and TORVEC Inc., 11 Pond View Drive, Pittsford, NY, 14534 (the "Employer") and defines the employment relationship between the Employee and the Employer.

2. THE EMPLOYEE'S POSITION The Employee shall hold the positions of Secretary and Legal and Patent Counsel and so long as elected by the stockholders a member of the Board of Directors of Employer.. The Employee's duties shall be those usual to the Employee's position in the Employer's industry; provided, however, the Employer, at the Employer's sole discretion, may increase, decrease or otherwise modify the Employee's duties. The Employee shall at all times exercise his best efforts for Employer and shall diligently and proficiently perform his duties for the Employer.

3. EMPLOYEE COMPENSATION
A. Annual Salary:

The Employer shall pay the Employee, in equal monthly installments, at the rate of $150,000.00 per year.
B. Stock Options:

Subject to the approval by its shareholders of the Company's 1998 Stock Option Plan, there is hereby granted to the Employee a non-qualified stock option to purchase up to 100,000 shares of the Company's $.01 par value Common Stock at an exercise price of $5.00 per share. The option granted

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

hereby shall be subject to the terms and conditions set forth in the Stock Option Agreement attached hereto and made a part hereof. The term of the option shall be for a period of 10 years, shall vest on a cumulative basis at a rate of 20% per year, shall provide for immediate and full vesting in the event the Company is acquired and shall provide that the right to exercise the option in accordance with its terms shall survive the Employee's termination of employment.
4. EMPLOYEE BENEFITS
A. Vacation:

The Employee is entitled to three (3) weeks paid vacation for each twelve (12) months of this Agreement.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

B. Additional Benefits:

1. The Employee will be included in such fringe benefit programs as the Employer hereafter adopts for the benefit of all employees.
2. Employer will provide suitable housing for Employee during such periods as Employee physically conducts his business from the Rochester, New York metropolitan area.
3. For a period of eighteen months after the commencement of this Agreement, Employer will pay to Employee as additional compensation an amount equal to the amount actually expended by Employee to continue COBRA insurance coverages with his present employer.
4. 12 paid holidays per year.
5. Sick pay days accrue at the same rate as vacation days.
5. TERM OF AGREEMENT This Agreement shall be for a period of three (3) years commencing on the first day of the month in which Employer receives the proceeds from its initial public offering of securities and shall automatically renew for three (3) years, unless the Employer informs the Employee of its intention to allow such Agreement to expire by giving written notice to the Employee at least six (6) months prior to the termination date.
6. CHANGE OF OWNERSHIP If TORVEC Inc. is bought out by another company, this Agreement may also be bought out at the prorated lump sum of base pay and bonus for lesser of twelve months or the remaining months on this Agreement.
7. TERMINATION OF THE CONTRACT
A. Cause of Termination:

1. Termination by the Employee The Employee may terminate this Agreement, for any reason, upon written notice to the Employer not fewer than twelve (12) months before the date of the intended termination.
2. Termination by Employer

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

The Employer may at any time terminate this Agreement without cause, by a notice to that effect to the Employee. As severance compensation, the Employer shall continue to pay the Employee his base pay and bonus for a period of twelve (12) months, subject to the limitations in Paragraph 7B2(b) below.
The Employer may terminate this Agreement without notice for just cause, including but not limited to, habitual neglect of or failure to perform duties after written warning from Employer to correct such failure, theft or misappropriation, or the Employee's continued incapacity due to mental or physical illness to perform the Employee's duties.
In the event of termination because of incapacity to perform due to mental or physical illness only, the Employer shall pay the Employee's monthly salary and minimum bonus for twelve (12) months.
B. Effect of Termination of Agreement:

Except as otherwise provided herein, upon expiration of the term of this Agreement, or by termination pursuant to any provision of this Agreement, all obligations of the Employee and the Employer shall terminate.


If the Employer gives notice to the Employee as

provided in Paragraph 7A2 herein:
1. The Employee agrees:

(a) To continue to devote his best efforts and time to performance of his duties for the Employer and to cooperate with the Employer in effecting an orderly transfer of responsibilities and duties to a successor over a period of time to be determined by the Employer in its sole discretion, but not to exceed three (3) months.
(b) To consult with the Employer as may reasonably be required.
2. The Employer agrees:

(a) To cooperate in the Employee's effort to obtain new employment;
(b) To continue to pay the Employee, at the rate required hereunder, including both salary and minimum bonus until the Employee obtains new employment or until the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

conclusion of twelve (12) months; and, to the extent the Employee's total compensation in his new employment is less than his total compensation (salary and bonus) from the Employer would have been, the Employer shall pay the difference between the total compensation in the new employment and the total compensation that the Employee would have earned with the Employer until the conclusion of the term of the twelve (12) months following termination;
(c) To provide the benefits provided by this Agreement to the Employee until the Employee obtains new employment or until expiration of twelve (12) months whichever occurs first.
8. CONFIDENTIALITY AND TRANSFER OF INVENTIONS
A. Except as may be required by his employment hereunder, Employee will not at any time or in any manner, directly or indirectly, divulge, disclose or communicate to any person, firm, corporation, organization or entity any Trade Secrets of Employer. Trade Secrets include information concerning matters affecting or relating to the products, pricing, marketing and sales strategies, servicing of products, processes, formulas, inventions, discoveries, devices, finances or business of Employer or of its customers. Employee will at all times hold inviolate and keep secret all knowledge or information and Trade Secrets acquired by him concerning the names of the Employer's customers, their addresses, the prices Employer obtains or has obtained from them for its goods or services, all knowledge or information acquired by him concerning the products, formulas, processes, marketing and sales methodology and training and all other trade secrets of Employer's customers. In addition, Employee shall make no disclosure, directly or indirectly, of any financial information, contractual relationships, policies, past or contemplated future actions of policies of Employer, personnel matters, marketing or sales strategies or data, pricing information, technical data or specifications and written or oral communications of any sort of Employer or any of its customers which have not previously been disclosed to the general public with Employer's consent or without first obtaining the consent of Employer for such disclosure. Upon any termination of this Agreement or Employee's employment, Employee or his representatives shall immediately deliver to Employer all notes, notebooks, letters, papers, drawings, memos, communications, blueprints or other writings or data relating to the business of Employer or its customers.
B. Employee shall promptly disclose to Employer all ideas, discoveries, designs, improvements, innovations and inventions (collectively referred to herein as "inventions"), whether patentable or not, either relating to

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

the existing business, products, plans, processes, or procedures of Employer, or any parent or subsidiary of Employer, or suggested by or resulting from Employee's work at Employer, or resulting wholly or in part from the use of Employer's time, material, facilities or ideas, which Employee makes or conceives, in whole or in part, whether or not during working hours, alone or with others, at any time during the term of his employment pursuant to this Agreement or during the first six-month period immediately following termination of his employment for any reason, and Employee agrees that all such inventions shall be the exclusive property of Employer.
C. Employee hereby assigns to Employer all his rights and interests in and to all such inventions and all patents which may be obtained on them, in this or any foreign country. At Employer's expense, but without charge to it, Employee agrees to execute, acknowledge and deliver to Employer any specific assignments to any such inventions or other relevant documents and take any such further action as may be considered necessary by Employer at any time to obtain or defend letters patent in any and all countries or to obtain documents relating to registration, ownership or transfer of copyrights, or to vest title in such inventions in Employer or its assigns or to obtain for Employer any other legal protection for such inventions.
D. Because Employee shall acquire by reason of his employment and association with Employer an extensive knowledge of Employer's Trade Secrets, customers, procedures, and other confidential information, the parties hereto recognize that in the event of a breach or threat of breach by Employee of the terms and provisions contained in this Paragraph 8, compensation alone to Employer would not be an adequate remedy for a breach of those terms and provisions. Therefore, it is agreed that in the event of a breach or threat of a breach of the provisions of this Paragraph 8 by Employee, Employer shall be entitled to an immediate injunction from any court of competent jurisdiction restraining Employee from committing or continuing to commit a breach of such provisions without the showing or proving of actual damages. Any preliminary injunction or restraining order shall continue in full force and effect until any and all disputes between the parties regarding this Agreement have been finally resolved on the merits by settlement or by a court of law. Employee hereby waives any right he may have to require Employer to post a bond or other security with respect to obtaining or continuing any such injunction or temporary restraining order and, further, hereby releases Employer, its officers, directors, employees and agents from and waives any claim for damages against them which he might have with respect to Employer's obtaining in good faith any injunction or restraining order pursuant to this Agreement.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

Employee agrees that any action for injunction brought pursuant to this Paragraph 8 may be brought in the New York State Supreme Court in the County of Monroe and hereby submits to the jurisdiction of that court and waives any objection as to venue.
9. CONSTRUCTION OF THIS AGREEMENT
A. Choice of Law:

This Agreement is to be construed pursuant to the laws of the State of New York, including New York law regarding choice of law.
B. Invalid Agreement Provisions:

Should any provision of this Agreement become legally unenforceable, no other provision of this Agreement shall be affected, and the Agreement shall continue as if the Agreement had been executed absent the unenforceable provision.
C. No Other Agreements:

This Agreement represents the entire Agreement between the Employee and the Employer, and supersedes any and all negotiations and other agreements, oral, implied or written, in any way related to the employment relationship between the Employee and the Employer. No agreements, representations, or understandings (oral, written, or implied) other than those expressly set forth herein have been made or entered into by either party with respect to any aspect of the Employee's employment or any of the matters dealt with herein. In executing this Agreement, neither the Employer nor the Employee relies upon any promise, representation, or other inducement that is not expressed in this Agreement. This Agreement may be modified only by a written Agreement signed by both the Employee and the Employer and may not be modified in any oral agreement or representation.
D. Practices Inconsistent With This Agreement:

No provision of this Agreement shall be modified or construed by any practice or policy that is inconsistent with such provision, and failure by either the Employee or the Employer to comply with any provision, shall not affect the rights of either to thereafter comply or require the other to comply.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

10. ARBITRATION Any dispute between Employer and the Employee in any way arising out of this Agreement, other than an action for an injunction brought pursuant to Paragraph 8 of this Agreement, including the termination of employees employment and/or this Agreement, shall be submitted to arbitration by an arbitrator selected by the American Arbitration Association. The arbitrator's decision with respect to any such dispute shall be final and binding. Any such disputes must be submitted to arbitration within six (6) months of termination, cancellation, or expiration of this Agreement. Any party who, in violation of this paragraph, initiates a lawsuit against the other party, shall pay the other party's reasonable attorney's fees and costs incurred in such lawsuit. Except as otherwise provided herein, such arbitration shall take place in accordance with the Rules of Commercial Arbitration of the American Arbitration Association, and shall be held in Monroe County, New York.

                              TORVEC Inc.

Date: ______________      By:_____________________________
                              President
                              Employer


Date:______________          ____________________________________
                              Morton A. Polster
                              Employee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

STOCK OPTION AGREEMENT

THIS STOCK OPTION AGREEMENT MADE as of this 1st day of January, 1998 between TORVEC, INC., a New York business corporation (herein referred to as the "Company"), and MORTON A. POLSTER (herein referred to as the "Optionee");

WITNESSETH:

1. The Company hereby grants to the Optionee an Option (hereinafter referred to as "Option") to purchase an aggregate of 100,000 shares of the $.01 par value Common Stock of the Company (herein referred to as the "Shares") at an exercise price of $5.00 per Share to be paid by the Optionee with cash, a certified check or a bank cashier's check made payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, the Optionee may pay for the Shares, either in whole or in part, by the delivery of Common Stock of the Company already owned by him which will be accepted as payment for the Shares, based upon such Common Stock's fair market value on the date of exercise. In addition, provided the Board of Directors shall approve the specific transfer, payment for the Shares, either in whole or in part, may be made by delivery of Common Stock acquired by the Optionee under any of the Company's stock option plans, provided, however, that if this Option is exercised in part, Shares acquired by such partial exercise may not be used as payment for additional Shares to be acquired under this Agreement. In order for the Optionee to so use shares of Common Stock previously acquired under any of the Company's stock option plans as payment for the Shares either in whole or in part, the transfer of such previously acquired Common Stock as payment for all or a portion of the exercise price under this Agreement must occur more than two years from the date of the grant and one year from the date of exercise of the prior option pursuant to which the Optionee acquired such Common Stock.
2. The term during which the Option shall be exercisable shall commence on January 1, 1998 and expire on the close of business December 31, 2007, subject to earlier termination as provided in the Torvec, Inc. 1998 Stock Option Plan (herein referred to as the "Plan"). The Option to purchase the number of Shares granted under this Agreement shall vest on the 1st day of each of the first five years of the Option Term on a cumulative basis, in accordance with the following schedule:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

                        VESTED          NON-
                                      VESTED

1/1/98 - 12/31/98        20%            80%
1/1/99 - 12/31/99        40%            60%
1/1/2000 - 12/31/2000    60%            40%
1/1/01 - 12/31/2001      80%            20%
1/1/02 - 12/31/2002     100%             0%

provided however, that to the extent the Optionee shall fail to exercise or, due to the above limitation, be prohibited from exercising his Option in any year during the Option period, such annual right to exercise this Option shall not expire, but shall be cumulative, and carry over into and be exercisable in any subsequent year during which the Option is outstanding.
This Option may be exercised by the Optionee in accordance with its terms during the Option Term even though, at the time of such exercise, whether in whole or in part, the Optionee is no longer an employee of the Company.
3. Notwithstanding the vesting schedule set forth in
Section 2 hereof, the Optionee's right to exercise this Option in full shall immediately vest upon the occurrence of a change in control of the Company. For this purpose, the term "change in control of the Company" shall generally include a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company. Specifically, the term shall include (i) the purchase or other acquisition by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, or any comparable successor provisions, of the beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of more than 50% of either the outstanding shares of common stock or the combined voting power of the Company's then outstanding voting securities entitled to vote generally, or (ii) the approval by the shareholders of the Company of a reorganization, merger, or consolidation with respect to which, in such case, persons who were shareholders of the Company immediately prior to such reorganization, merger, or consolidation do not immediately thereafter, own more than 50% of either the outstanding shares of common stock or the combined voting power of the reorganized, merged or consolidated Company's then outstanding voting securities entitled to vote generally or
(iii) the liquidation and/or dissolution of the Company.
4. The Option is not transferable by the Optionee other than by Will or the laws of descent and distribution

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

and is exercisable, during his lifetime, only by the Optionee. In the event that the right to exercise the Option passes to the Optionee's estate, or to a person to whom such right devolves by reason of the Optionee's death, then the Option shall be non transferable in the hands of the Optionee's Executor or Administrator or of such person, except that the Option may be distributed by the Optionee's Executor or Administrator to the distributees of the Optionee's estate as a part thereof.
5. In order for the Option to be exercised, in whole or in part, the notice by the Optionee to the Company in the form attached hereto must be accompanied by payment in full of the option price for the Shares being purchased. In addition, the Optionee agrees to tender to the Company an additional amount, in cash, certified check, cashier's check or bank draft, equal to the amount of any taxes required to be collected or withheld by the company in connection with the exercise of his Option.
6. The Company agrees that it will use its best efforts to register the sale of the Shares to be issued upon the exercise of the Option with the Securities and Exchange Commission under the Securities Act of 1933. Upon the effectiveness of the Registration Statement covering the Shares, the Optionee shall be able to sell the Shares in "open market transactions" free of Federal Securities Law restrictions, provided that at the time of sale, or within the three month period immediately prior to such sale, he is not nor has he been an "affiliate" of the Company. The Optionee further understands that, in accordance with applicable Commission rules governing controlling persons of public companies, members of the board of directors of a public company, such as the Company, are deemed to be "affiliates" during their term of office. The Optionee, therefore, agrees that he will consult with the Company's counsel as to any Securities Law restrictions, including a limitation on the number of Shares which may be sold at any one time, on his ability to sell the Shares prior to any sale thereof.
7. The Company agrees to provide the Optionee with a copy of the Prospectus prepared by the Company in connection with the Registration Statement filed to register the Shares, together with its exhibits, and the Company hereby acknowledges its obligation to provide the Optionee with all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year of the Company and all updates thereof. The Optionee agrees that prior to exercise, either in whole or in part of the Option granted to him hereunder, he shall have read such materials, including the most recent annual and quarterly reports to shareholders, and shall have received, if requested, and read all the documents

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

incorporated by reference in the Prospectus and Registration Statement filed with the Securities and Exchange Commission.
8. The Optionee understands that except as provided in Paragraph 6 above, the Company has not agreed to register either the issuance or the resale of the Shares in accordance with the provisions of the Securities Act of 1933 or to register either the issuance or the resale of the Shares under any applicable State Securities Laws. Hence, the Optionee agrees that by virtue of the provision of certain rules respecting "restricted securities" promulgated under such Federal and/or State Laws, unless the resale of the Shares is registered as provided in Paragraph 6 above, and until the registration of such Shares in accordance with Paragraph 6 above shall have been declared effective by order of the Commission, the Shares which the Optionee shall purchase upon the exercise of this Option must be held indefinitely and may not be sold, transferred, pledged, hypothecated, or otherwise encumbered for value, unless and until a secondary distribution and/or resale of such Shares is subsequently registered under such Federal and/or State Securities Laws, or unless an exemption from registration is available, in which case the Optionee still may be limited as to the amount of the Shares that may be sold, transferred, pledged and/or encumbered for value. The Optionee therefore agrees that, until the registration of such Shares shall have been declared effective by order of the Commission, the Company may affix upon any certificate representing the Shares, a legend that such Shares may not be transferred in violation of Section 5 of the Securities Act of 1933.
9. The Optionee understands and agrees that the Shares to be acquired upon the exercise of the Option may not be sold, transferred, exchanged, hypothecated, encumbered, pledged or otherwise disposed of for value for a period of six (6) months from the date of the grant of this Option.
10. The Optionee understands that the Company has established certain policies and procedures governing trading in the Company's securities, including the Shares to be acquired upon the exercise of this Option, while in possession of material, inside information regarding the Company and/or any of its subsidiaries, receipt of which is hereby acknowledged. The Optionee agrees that upon exercise of this Option, either in whole or in part, he will comply with all of the terms and conditions of such policy, including the procedures and guidelines established for its implementation. In particular, the Optionee agrees that where required under such guidelines and procedures, he will obtain permission of the Company's Clearinghouse Committee composed of senior management prior to effectuating any sale

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

or other transfer for value of the Shares to be acquired by virtue of the exercise of this Option.
11. All the terms and provisions of the Plan, duly adopted at a meeting of the Company's Board of Directors on _______________ and approved by a majority vote of the Company's shareholders either in person or by proxy at a duly called meeting of such shareholders held on _______________ and as amended to date, are hereby expressly incorporated into this Stock Option Agreement and made a part hereof as if printed herein and the Optionee, by the Optionee's signature hereon, acknowledges receipt of a certified copy of said Plan. If there shall be any conflict between this Agreement and the Plan, the provisions of the Plan shall control.
12. In accordance with certain terms and conditions of the Plan, the aggregate number and kind of shares that may be purchased pursuant to the grant of the Option under this Agreement shall be proportionately adjusted for any increase, decrease or change in the total number of the outstanding shares of the Company resulting from a stock dividend, stock-split or other corporate reorganization which would result in or have the effect of the Optionee being treated differently (but for the adjustment) than he would be treated had he been the beneficial owner of the Shares subject to the Option on the record date for such dividend, split or reorganization, as the case may be.
13. The Optionee understands that the Option granted hereunder constitutes a "nonqualified stock option" for federal, and if applicable, state income tax purposes. Consequently, the Optionee understands that under current provisions of federal tax law, for regular as well as for purposes to the federal alternative minimum income tax, no gain or loss generally is recognized to the Optionee upon the grant of the Option. In addition, the Company will receive no business expense deduction as a result of the grant of the Option. For federal income tax purposes, upon the exercise of the Option, the difference between the exercise price and the fair market value of the Shares on the date of exercise constitutes ordinary income to the Optionee and is taxed to the Optionee at normal, ordinary tax rates, except to the extent the Shares are not transferable and are subject to a substantial risk of forfeiture. To the extent such difference is required to be included as income by the Optionee, the Company is entitled to a business expense deduction. Upon the later sale of the Shares, long or short term capital gain or loss will be recognized by the Optionee, depending upon the holding period (eighteen months for long term capital gain or loss) and the extent to which the selling price exceeds or is less than the Optionee's basis in the stock. The amount of gain will be taxed at normal, ordinary tax rates, with a maximum rate of 20% if the Shares

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

are held for a period of at least eighteen months. If the Shares are held for a period of at least twelve months, the maximum rate on any gain from their sale will be taxed at 28%.
The Optionee also understands that the provisions of federal tax law described herein are subject to change and, consequently, the Optionee agrees to consult with his or her own tax advisor with respect to the tax treatment to be accorded the grant of the Option herein, the exercise of such Option, and the disposition of the Shares.
13. Consistent with the provisions of the Plan, this Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and to any executor, administrator, legal representative, legatee, or distributee entitled by law to the Optionee's right hereunder.
14. Except insofar as an interpretation of federal securities law otherwise is required, or is controlling, this Agreement shall be governed by and construed in accordance with the laws of the State of New York. IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Optionee has hereunto set his hand, as of the day and year first above written.
TORVEC, INC. By: ____________________________

Morton A. Polster, Optionee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

NOTICE OF EXERCISE OF STOCK OPTION
AND
RECORD OF STOCK TRANSFER

Torvec, Inc.
3740 Route 104
Williamson, New York 14587
Gentlemen:
I hereby exercise my Stock Option granted to me by Torvec, Inc. under a Stock Option Agreement dated _______________, subject to all the terms and provisions thereof and of the Torvec, Inc. 1998 Stock Option Plan referred to therein and notify you of my desire to purchase Shares of the $.01 par value Common Stock of the Company which were offered to me pursuant to the Stock Option Agreement. Enclosed is my payment in the sum of in full payment of such Shares.
I understand that a Registration Statement covering the Shares to be issued to me pursuant to this exercise of the Option granted to me was filed with the Securities and Exchange Commission on _______________. The Registration Statement became effective on _______________. Consequently, I understand that unless I am an "affiliate" of the Company, the Shares I am acquiring are freely tradeable and may be sold by me in "open market" transactions. If I am an "affiliate" of the Company, however, or have been one during the three month period prior to sale, I recognize that I may not sell freely on the open market and therefore agree that I will consult the Company's counsel as to the securities law restrictions on my ability to sell the Shares.
I also understand that under the Plan, and in accordance with the terms of the Stock Option Agreement, I may not sell, assign, alienate, pledge, encumber or otherwise transfer for value the Shares unless a period of six (6) months has elapsed from the date of the grant of the Option to me.
I acknowledge that I am aware that the Company has established a policy with respect to trading in its securities while in possession of material inside information regarding the Company and/or its subsidiaries, and that, in accordance with certain guidelines and procedures designed to implement such policy, I may be required to obtain permission from a Clearinghouse Committee, composed of Senior Management, prior

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

to any sale or other transfer for value of the Shares hereby acquired.
I also acknowledge that I have received and have read the Prospectus dated _______________ prepared by the Company in connection with the grant of the Option contained herein, together with its exhibits, and all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year and all quarterly and current updates thereof. I acknowledge that I have received all documents incorporated by reference in the Prospectus and the Registration Statement filed with the Securities and Exchange Commission that I requested and have read the same. I acknowledge that I have had the opportunity to ask questions of and receive answers from the Company's management concerning the information set forth in such Prospectus, reports and updates and have been satisfied with the answers provided regarding the same.
Finally, I acknowledge that there are significant federal income tax consequences resulting from my exercise of this Option, that I have consulted with and received advice from qualified tax counsel both as to the nature of such tax consequences and their impact upon my own personal income tax situation as the result of such exercise, and that I fully understand such impact and have planned accordingly.

DATED:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a

Receipt is hereby acknowledged of the delivery to me by Torvec, Inc. on , 19 of stock certificates for shares of $.01 par value common stock purchased by me pursuant to the terms and conditions of the Torvec, Inc. 1998 Stock Option Plan referred to above.

DATED:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-3.x2a


EXHIBIT NUMBER 6.4

CONSULTING AGREEMENT

THIS AGREEMENT made and entered into the 6th day of February, 1998, effective as of December 1, 1997, by and between Torvec, Inc., a New York corporation having a principal place of business at 11 Pondview Drive, Pittsford, New York, 14534 (hereinafter "TORVEC") and Keith E. Gleasman, an individual having a principal place of business at 11 McCoord Woods Drive, Fairport, New York, 14450 (hereinafter "Consultant").
WITNESSETH WHEREAS, Consultant has experience in the design, development, and manufacture of gears, clutches, couplings, and other mechanical elements , for all purposes including, but not limited to use in automotive components and motor vehicles and is willing to design, develop, and manufacture such products for TORVEC; and WHEREAS, TORVEC desires to have Consultant design, develop, and assist in the manufacturing of such products for TORVEC under the terms and conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the mutual covenants and promises set forth herein, the parties hereto agree as follows.
1. Definitions. The following definitions shall apply for all purposes of this Agreement:
(a) "Work Product" shall mean all data, designs, documentation, inventions, soft- ware and information, in whatever form, first produced created or emanating from, by or for Consultant in the performance of work or the rendition of services under this Agreement.
(b) "Background Rights" shall mean all data, designs, documentation, inventions, software and information, in whatever form, not first produced created or emanating from, by or for Consultant as a result of or related to the performance of work or the rendition of services under this Agreement, but included in or necessary for use in or with the Work Product or any other product or any portion thereof which is produced or contemplated by Torvec.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

(c) "TORVEC Representative" shall mean the Chief Operating Officer of Torvec or his alternate as designated in writing by him.
2. Work to be performed and services to be rendered.
(a) Consultant agrees, during the term of this Agreement, the Consultant shall devote his full time and effort to the design, development, and manufacture of inventions and products for Torvec, and the training of others performing such work.
(b) The work to be performed and the services to be rendered hereunder shall be performed by the Consultant, and such work or services may not be subcontracted or otherwise performed by third parties on behalf of Consultant without the prior written permission of TORVEC, which permission shall not be unreasonably withheld; provided, however, that Consultant shall be responsible therefor pursuant to this Agreement.
3. Rights in the Work Product and Background Rights.
(a) Consultant hereby grants to TORVEC, and TORVEC hereby accepts, the entire, right title and interest of Consultant in and to the Work Product and in and to all patents, copyrights, trade secrets, trademarks, and other proprietary rights in or based on the Work Product.
(b) Consultant hereby grants to TORVEC, and TORVEC hereby accepts, an unlimited, unrestricted, royalty-free, fully paid-up, worldwide exclusive right and license, with the right to grant licenses and sublicenses to others without accounting to Consultant, under the Background Rights and the entire right, title, and interest of Consultant to the Background Rights and all proprietary rights therein or based thereon.
(c) Consultant and TORVEC agree that if the Work Product or any portion thereof is copyrightable, it shall be deemed to be a "work made for hire," as such term is defined in the Copyright Laws of the United States.
(d) Consultant shall cooperate with TORVEC or its designees and execute all documents of assignment, oaths, declaration and other documents, as may be prepared by TORVEC, to effect the foregoing or to perfect or enforce any proprietary rights resulting from or related to this Agreement. Such cooperation and execution shall be at no additional compensation to Consultant; provided, however, that TORVEC shall reimburse Consultant for reasonable out-of pocket expenses incurred.
4. Compensation..

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

(a) As compensation in full for the successful performance of all work and services to be performed hereunder, including the grant of rights and licenses in and to Work Product and Background Rights, TORVEC shall pay Consultant a fixed fee of $12,500.00 per month.
(b) TORVEC shall reimburse Consultant for expenses incurred by Consultant in the performance of work and the rendition of services under this Agreement, provided that reimbursement of travel and related expenses shall be in accordance with TORVEC's then current policies applicable to TORVEC employees for the reimbursement of such expenses. Consultant shall obtain receipts for all expenses in excess of $25 and shall submit them to TORVEC.
(c) Subject to the approval by its shareholders of the Company's 1998 Stock Option Plan, there is hereby granted to the Consultant a non-qualified stock option to purchase up to 25,000 shares of the Company's $.01 par value Common Stock at an exercise price of $5.00 per share. The option granted hereby shall be subject to the terms and conditions set forth in the Stock Option Agreement attached hereto and made a part hereof. The term of the option shall be for a period of 10 years, shall vest on a cumulative basis at a rate of 20% per year, shall provide for immediate and full vesting in the event the Company is acquired and shall provide that the right to exercise the option in accordance with its terms shall survive the Consultant's termination of services.
5. Confidentiality.
(a) Consultant agrees that the Work Product and Background Rights are the sole and exclusive property of TORVEC, and Consultant shall treat the Work Product and Background Rights on a confidential basis and not disclose it to any third party or use it for the benefit of other than TORVEC; provided, however, that Consultant shall be relieved of such obligation if and when TORVEC discloses the Work Product and Background Rights without any restriction on use or further disclosure.
(b) Consultant shall keep confidential and not disclose or use for the benefit of other than TORVEC any and all written or tangible information stamped "confidential," "proprietary" or with a similar legend which is made available or disclosed to Consultant as a result of or in any way related to this Agreement; provided, however, that Consultant shall have no obligation hereunder for that portion of such information which is disclosed by TORVEC to others without any restriction on use and disclosure.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

(c) Consultant acknowledges that his promised services hereunder are of special, unique, unusual and extraordinary character which gives them peculiar value, the loss of which cannot adequately be compensated in damages in an action at law, and Consultant further acknowledges that in his consultative capacity hereunder he will be making use of, acquiring and adding to confidential information of special and unique value relating to the affairs of the TORVEC, its subsidiaries and affiliates, including but not limited to its financial affairs, new products, marketing plans, and costs of providing the products. In addition to and not in limitation of any other restrictive covenants which may be binding upon Consultant, Consultant agrees that he will not (except for the benefit of or with the written consent of the TORVEC, its successors or assigns);
(1) During or after the Term of Consultation, disclose any of said information to any person, firm or corporation for any purpose whatsoever; and
(2) During the Term of Consultation or within two (2) years thereafter, in any area in which duties have at any time been assigned to him hereunder during the Term of Consultation, engage (as an individual or as a stockholder, partner, member, agent, employee or representative of any person, firm, corporation limited liability company or partnership, or association), or have any interest, direct or indirect, in any entity developing or producing products or related business in competition with the business of the TORVEC; provided that this paragraph shall not prevent the Consultant from acquiring and holding shares of stock of TORVEC and not to exceed two (2%) percent of the outstanding shares of stock of any other corporation which engages in a related business if such shares are available to the general public on a national securities exchange or NASDAQ..
6. Term of agreement.
(a) This Agreement shall be for a period of three years commencing on December 1, 1997 unless terminated or canceled as provided herein.
(b) The term of any right or licenses under proprietary rights granted to TORVEC as a result of or related to this Agreement shall be for the full term of such proprietary rights.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

7. Warranties and representations. Consultant warrants and represents that:
(a) The Work Product is original work developed pursuant to this Agreement;
(b) The Work Product was created by the Consultant;
(c) The Work Product, in whole or in part, does not, upon information and belief, infringe any patents, copyrights, trade secrets or other proprietary rights of third parties and Consultant has received no claims or charges of such infringement by the Work Product or any portion thereof, and Consultant has no reason to believe that the Work Product, in whole or in part, may infringe the patents, copyrights, trade secrets or other proprietary rights of third parties;
(d) Consultant has the authority to enter into this Agreement and to perform all obligations, hereunder, including, but not limited to, the grant of rights and licenses to the Work Product and Background Rights and all proprietary rights therein or based thereon; and
(e) Consultant has not granted any rights or licenses to third parties under Work Product or any portion thereof.
8. Indemnities. Consultant shall indemnify and hold TORVEC harmless against any loss or liability to person or property arising out of the performance of Consultant under this Agreement
9. Disability waiver. TORVEC recognizes that Consultant's past association with TORVEC has created unique goodwill to TORVEC. TORVEC desires to retain Consultant's services and prevent them from being used by its competitors, even though Consultant may become disabled or incapacitated. Accordingly, it is expressly understood that Consultant's inability to render Services to TORVEC because of absences, or temporary or permanent illness, disability, or incapacity, or for any other reasonable cause, shall not constitute a failure to perform his obligations hereunder and shall not be deemed a breach or default by him.
10. Death benefit. Should Consultant die during the term of this Agreement, the Agreement shall terminate as of the last day of the month of his death. TORVEC shall, for a period of twelve (12) months after Consultant's death, pay to his legal representatives, or to his surviving widow (provided that Consultant has so instructed TORVEC in writing prior to his death) the sum of $12,500.00, monthly to be paid on the last day of each month during the twelve

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

(12) month period. If Consultant dies during the last year of this Agreement, however, the $12,500.00 monthly payments to his legal representatives or widow, as the case may be, shall not in any case be made after the termination date set forth in this Agreement.
11. Termination/Cancellation.
(a) This Agreement may be terminated or canceled by either party upon the occurrence of any of the following events, and neither party shall have any liability to the other party for the exercise of such right.
(1) By either party, if the other party has breached a covenant, obligation or warranty under this Agreement and such breach remains uncured for a period of 30 days after notice thereof is sent to such other party;
(2) By either party, if the other party ceases to conduct business.
(b) In the event either party terminates or cancels this Agreement pursuant to this Paragraph 11, TORVEC shall have no further liability to Consultant, except to pay Consultant a pro-rata share of the compensation of Paragraph 4 for that portion of the Work Product performed through the date of termination/cancellation.
12. Arbitration. Any controversy or claim arising out of or relating to this Agreement shall be settled by arbitration in accordance with the Rules of Commercial Arbitration of the American Arbitration Association. Any judgment upon the award rendered in such arbitration may be entered in any court of competent jurisdiction. Notwithstanding the provisions of this paragraph, TORVEC shall have the right to seek enforcement of the provisions of paragraph 5 above by a court proceeding for an injunction.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

13. General.
(a) This Agreement is the sole and entire agreement between the parties relating to the subject matter hereof and the Work Product and the Background Rights, and supersedes all prior understandings, agreements, and documentation relating to the subject matter hereof other than prior assignments and transfers of ownership by Consultant to Torvec which assignments and transfers remain in full force and effect. This Agreement may be amended only by an instrument executed by the authorized representatives of both parties.
(b) Any termination, cancellation or expiration of this Agreement notwithstanding, provisions which are intended to survive and continue shall so survive and continue, including, but not limited to, the provisions of Paragraphs 3, 5, 7, 8, 9,10 11 and 12.
(c) This Agreement shall be interpreted in accordance with the substantive law of the State of New York. IN WITNESS WHEREOF the parties hereto have caused this Agreement to be executed by their duly authorized representatives and to be effective as of the date first above written.

TORVEC, INC.

By:______________________         _______________________
Title:                             Keith E. Gleasman
Date: ___________________          Date:_________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

STOCK OPTION AGREEMENT

THIS STOCK OPTION AGREEMENT MADE as of this 1st day of December, 1997 between TORVEC, INC., a New York business corporation (herein referred to as the "Company"), and KEITH E. GLEASMAN (herein referred to as the "Optionee");

WITNESSETH:

1. The Company hereby grants to the Optionee an Option (hereinafter referred to as "Option") to purchase an aggregate of 25,000 shares of the $.01 par value Common Stock of the Company (herein referred to as the "Shares") at an exercise price of $5.00 per Share to be paid by the Optionee with cash, a certified check or a bank cashier's check made payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, the Optionee may pay for the Shares, either in whole or in part, by the delivery of Common Stock of the Company already owned by him which will be accepted as payment for the Shares, based upon such Common Stock's fair market value on the date of exercise. In addition, provided the Board of Directors shall approve the specific transfer, payment for the Shares, either in whole or in part, may be made by delivery of Common Stock acquired by the Optionee under any of the Company's stock option plans, provided, however, that if this Option is exercised in part, Shares acquired by such partial exercise may not be used as payment for additional Shares to be acquired under this Agreement. In order for the Optionee to so use shares of Common Stock previously acquired under any of the Company's stock option plans as payment for the Shares either in whole or in part, the transfer of such previously acquired Common Stock as payment for all or a portion of the exercise price under this Agreement must occur more than two years from the date of the grant and one year from the date of exercise of the prior option pursuant to which the Optionee acquired such Common Stock.
2. The term during which the Option shall be exercisable shall commence on December 1, 1997 and expire on the close of business November 30, 2007, subject to earlier termination as provided in the Torvec, Inc. 1998 Stock Option Plan (herein referred to as the "Plan"). The Option to purchase the number of Shares granted under this Agreement vest on the 1st day of each of the five years of the Option Term on a cumulative basis, in accordance with the following schedule:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

                          VESTED      NON-VESTED

12/1/97 - 11/30/98         20%           80%
12/1/98 - 11/30/99         40%           60%
12/1/99 - 11/30/2000       60%           40%
12/1/2000 - 11/30/2001     80%           20%
12/1/2001 - 11/30/2002    100%            0%

provided however, that to the extent the Optionee shall fail to exercise or, due to the above limitation, be prohibited from exercising his Option in any year during the Option period, such annual right to exercise this Option shall not expire, but shall be cumulative and carry over into and be exercisable in any subsequent year during which the Option is outstanding.
This Option may be exercised by the Optionee in accordance with its terms during the Option Term even though, at the time of such exercise, whether in whole or in part, the Optionee is no longer an consultant of the Company.
3. Notwithstanding the limitation upon immediate exercise set forth in Section 2 hereof, this Option shall be exercisable in full immediately upon the occurrence of a change in control of the Company. For this purpose, the term "change in control of the Company" shall generally include a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company. Specifically, the term shall include (i) the purchase or other acquisition by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, or any comparable successor provisions, of the beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of more than 50% of either the outstanding shares of common stock or the combined voting power of the Company's then outstanding voting securities entitled to vote generally, or (ii) the approval by the shareholders of the Company of a reorganization, merger, or consolidation with respect to which, in such case, persons who were shareholders of the Company immediately prior to such reorganization, merger, or consolidation do not immediately thereafter, own more than 50% of either the outstanding shares of common stock or the combined voting power of the reorganized, merged or consolidated Company's then outstanding voting securities entitled to vote generally or
(iii) the liquidation and/or dissolution of the Company.
4. The Option is not transferable by the Optionee other than by Will or the laws of descent and distribution and is exercisable, during his lifetime, only by the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

Optionee. In the event that the right to exercise the Option passes to the Optionee's estate, or to a person to whom such right devolves by reason of the Optionee's death, then the Option shall be non transferable in the hands of the Optionee's Executor or Administrator or of such person, except that the Option may be distributed by the Optionee's Executor or Administrator to the distributees of the Optionee's estate as a part thereof.
5. In order for the Option to be exercised, in whole or in part, the notice by the Optionee to the Company in the form attached hereto must be accompanied by payment in full of the option price for the Shares being purchased. In addition, the Optionee agrees to tender to the Company an additional amount, in cash, certified check, cashier's check or bank draft, equal to the amount of any taxes required to be collected or withheld by the company in connection with the exercise of his Option.
6. The Company agrees that it will use its best efforts to register the sale of the Shares to be issued upon the exercise of the Option with the Securities and Exchange Commission under the Securities Act of 1933. Upon the effectiveness of the Registration Statement covering the Shares, the Optionee shall be able to sell the Shares in "open market transactions" free of Federal Securities Law restrictions, provided that at the time of sale, or within the three month period immediately prior to such sale, he is not nor has he been an "affiliate" of the Company. The Optionee further understands that, in accordance with applicable Commission rules governing controlling persons of public companies, members of the board of directors of a public company, and/or persons who hold significant policy-making positions with a public company, such as the Company, are deemed to be "affiliates" during their term of office. The Optionee, therefore, agrees that he will consult with the Company's counsel as to any Securities Law restrictions, including a limitation on the number of Shares which may be sold at any one time, on his ability to sell the Shares prior to any sale thereof.
7. The Company agrees to provide the Optionee with a copy of the Prospectus prepared by the Company in connection with the Registration Statement filed to register the Shares, together with its exhibits, and the Company hereby acknowledges its obligation to provide the Optionee with all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year of the Company and all updates thereof. The Optionee agrees that prior to exercise, either in whole or in part of the Option granted to him hereunder, he shall have read such materials, including the most recent annual and quarterly reports to shareholders, and shall have received, if requested, and read all the documents

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

incorporated by reference in the Prospectus and Registration Statement filed with the Securities and Exchange Commission.
8. The Optionee understands that except as provided in Paragraph 6 above, the Company has not agreed to register either the issuance or the resale of the Shares in accordance with the provisions of the Securities Act of 1933 or to register either the issuance or the resale of the Shares under any applicable State Securities Laws. Hence, the Optionee agrees that by virtue of the provision of certain rules respecting "restricted securities" promulgated under such Federal and/or State Laws, unless the resale of the Shares is registered as provided in Paragraph 6 above, and until the registration of such Shares in accordance with Paragraph 6 above shall have been declared effective by order of the Commission, the Shares which the Optionee shall purchase upon the exercise of this Option must be held indefinitely and may not be sold, transferred, pledged, hypothecated, or otherwise encumbered for value, unless and until a secondary distribution and/or resale of such Shares is subsequently registered under such Federal and/or State Securities Laws, or unless an exemption from registration is available, in which case the Optionee still may be limited as to the amount of the Shares that may be sold, transferred, pledged and/or encumbered for value. The Optionee therefore agrees that, until the registration of such Shares shall have been declared effective by order of the Commission, the Company may affix upon any certificate representing the Shares, a legend that such Shares may not be transferred in violation of Section 5 of the Securities Act of 1933.
9. The Optionee understands and agrees that the Shares to be acquired upon the exercise of the Option may not be sold, transferred, exchanged, hypothecated, encumbered, pledged or otherwise disposed of for value for a period of six (6) months from the date of the grant of this Option.
10. The Optionee understands that the Company has established certain policies and procedures governing trading in the Company's securities, including the Shares to be acquired upon the exercise of this Option, while in possession of material, inside information regarding the Company and/or any of its subsidiaries, receipt of which is hereby acknowledged. The Optionee agrees that upon exercise of this Option, either in whole or in part, he will comply with all of the terms and conditions of such policy, including the procedures and guidelines established for its implementation. In particular, the Optionee agrees that where required under such guidelines and procedures, he will obtain permission of the Company's Clearinghouse Committee composed of senior management prior to effectuating any sale or other transfer for value of the Shares to be acquired by virtue of the exercise of this Option.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

11. All the terms and provisions of the Plan, duly adopted at a meeting of the Company's Board of Directors on _______________ and approved by a majority vote of the Company's shareholders either in person or by proxy at a duly called meeting of such shareholders held on _______________ and as amended to date, are hereby expressly incorporated into this Stock Option Agreement and made a part hereof as if printed herein and the Optionee, by the Optionee's signature hereon, acknowledges receipt of a certified copy of said Plan. If there shall be any conflict between this Agreement and the Plan, the provisions of the Plan shall control.
12. In accordance with certain terms and conditions of the Plan, the aggregate number and kind of shares that may be purchased pursuant to the grant of the Option under this Agreement shall be proportionately adjusted for any increase, decrease or change in the total number of the outstanding shares of the Company resulting from a stock dividend, stock-split or other corporate reorganization which would result in or have the effect of the Optionee being treated differently (but for the adjustment) than he would be treated had he been the beneficial owner of the Shares subject to the Option on the record date for such dividend, split or reorganization, as the case may be.
13. The Optionee understands that the Option granted hereunder constitutes a "nonqualified stock option" for federal, and if applicable, state income tax purposes. Consequently, the Optionee understands that under current provisions of federal tax law, for

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

regular as well as for purposes to the federal alternative minimum income tax, no gain or loss generally is recognized to the Optionee upon the grant of the Option. In addition, the Company will receive no business expense deduction as a result of the grant of the Option.
For federal income tax purposes, upon the exercise of the Option, the difference between the exercise price and the fair market value of the Shares on the date of exercise constitutes ordinary income to the Optionee and is taxed to the Optionee at normal, ordinary tax rates, except to the extent the Shares are not transferable and are subject to a substantial risk of forfeiture. To the extent such difference is required to be included as income by the Optionee, the Company is entitled to a business expense deduction. Upon the later sale of the Shares, long or short term capital gain or loss will be recognized by the Optionee, depending upon the holding period (eighteen months for long term capital gain or loss) and the extent to which the selling price exceeds or is less than the Optionee's basis in the stock. The amount of gain will be taxed at normal, ordinary tax rates, with a maximum rate of 20% if the Shares are held for a period of at least eighteen months. If the Shares are held for a period of at least twelve months, the maximum rate on any gain from their sale will be taxed at 28%.
The Optionee also understands that the provisions of federal tax law described herein are subject to change and, consequently, the Optionee agrees to consult with his or her own tax advisor with respect to the tax treatment to be accorded the grant of the Option herein, the exercise of such Option, and the disposition of the Shares.
14. Consistent with the provisions of the Plan, this Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and to any executor, administrator, legal representative, legatee, or distributee entitled by law to the Optionee's right hereunder.
15. Except insofar as an interpretation of federal securities law otherwise is required, or is controlling, this Agreement shall be governed by and construed in accordance with the laws of the State of New York. IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Optionee has hereunto set his hand, as of the day and year first above written.
TORVEC, INC. By: ____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a


Keith E. Gleasman, Optionee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

NOTICE OF EXERCISE OF STOCK OPTION
AND
RECORD OF STOCK TRANSFER

Torvec, Inc.
3740 Route 104
Williamson, New York 14587
Gentlemen:
I hereby exercise my Stock Option granted to me by Torvec, Inc. under a Stock Option Agreement dated _______________, subject to all the terms and provisions thereof and of the Torvec, Inc. 1998 Stock Option Plan referred to therein and notify you of my desire to purchase Shares of the $.01 par value Common Stock of the Company which were offered to me pursuant to the Stock Option Agreement. Enclosed is my payment in the sum of in full payment of such Shares.
I understand that a Registration Statement covering the Shares to be issued to me pursuant to this exercise of the Option granted to me was filed with the Securities and Exchange Commission on _______________. The Registration Statement became effective on _______________. Consequently, I understand that unless I am an "affiliate" of the Company, the Shares I am acquiring are freely tradeable and may be sold by me in "open market" transactions. If I am an "affiliate" of the Company, however, or have been one during the three month period prior to sale, I recognize that I may not sell freely on the open market and therefore agree that I will consult the Company's counsel as to the securities law restrictions on my ability to sell the Shares.
I also understand that under the Plan, and in accordance with the terms of the Stock Option Agreement, I may not sell, assign, alienate, pledge, encumber or otherwise transfer for value the Shares unless a period of six (6) months has elapsed from the date of the grant of the Option to me.
I acknowledge that I am aware that the Company has established a policy with respect to trading in its securities while in possession of material inside information regarding the Company and/or its subsidiaries, and that, in accordance with certain guidelines and procedures designed to implement such policy, I may be required to obtain permission from a Clearinghouse Committee, composed of Senior Management, prior to any sale or other transfer for value of the Shares hereby acquired.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

I also acknowledge that I have received and have read the Prospectus dated _______________ prepared by the Company in connection with the grant of the Option contained herein, together with its exhibits, and all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year and all quarterly and current updates thereof. I acknowledge that I have received all documents incorporated by reference in the Prospectus and the Registration Statement filed with the Securities and Exchange Commission that I requested and have read the same. I acknowledge that I have had the opportunity to ask questions of and receive answers from the Company's management concerning the information set forth in such Prospectus, reports and updates and have been satisfied with the answers provided regarding the same.
Finally, I acknowledge that there are significant federal income tax consequences resulting from my exercise of this Option, that I have consulted with and received advice from qualified tax counsel both as to the nature of such tax consequences and their impact upon my own personal income tax situation as the result of such exercise, and that I fully understand such impact and have planned accordingly.

DATED: __________ _____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a

Receipt is hereby acknowledged of the delivery to me by Torvec, Inc. on , 19 of stock certificates for shares of $.01 par value common stock purchased by me pursuant to the terms and conditions of the Torvec, Inc. 1998 Stock Option Plan referred to above.

DATED: __________ _____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-4doc.x2a


EXHIBIT NUMBER 6.5

CONSULTING AGREEMENT

THIS AGREEMENT made and entered into the 6th day of February, 1998, effective December 1, 1997, by and between Torvec, Inc., a New York corporation having a principal place of business at 11 Pondview Drive, Pittsford, New York, 14534 (hereinafter "TORVEC") and James Gleasman, an individual having a principal place of business at 166 Brittany Lane, Pittsford, New York, (hereinafter "Consultant").
WITNESSETH WHEREAS, Consultant has experience in the design, development, and manufacture of gears, clutches, couplings, and other mechanical elements , for all purposes including, but not limited to use in automotive components and motor vehicles and is willing to design, develop, and manufacture such products for TORVEC; and WHEREAS, TORVEC desires to have Consultant design, develop, and assist in the manufacturing of such products for TORVEC under the terms and conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the mutual covenants and promises set forth herein, the parties hereto agree as follows.
1. Definitions. The following definitions shall apply for all purposes of this Agreement:
(a) "Work Product" shall mean all data, designs, documentation, inventions, soft- ware and information, in whatever form, first produced created or emanating from, by or for Consultant in the performance of work or the rendition of services under this Agreement.
(b) "Background Rights" shall mean all data, designs, documentation, inventions, software, marketing, joint venture, business plans and information, in whatever form, not first produced created or emanating from, by or for Consultant as a result of or related to the performance of work or the rendition of services under this Agreement, but included in or necessary for use in or with the Work Product or any other product or any portion thereof which is produced or contemplated by Torvec.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

(c) "TORVEC Representative" shall mean the Chief Operating Officer of Torvec or his alternate as designated in writing by him.
2. Work to be performed and services to be rendered.
(a) Consultant agrees, during the term of this Agreement, the Consultant shall devote his full time and effort to the design, development, and manufacture of inventions and products for Torvec, the training of others performing such work, and the development of marketing strategies and joint venture opportunities for TORVEC.
(b) The work to be performed and the services to be rendered hereunder shall be performed by the Consultant, and such work or services may not be subcontracted or otherwise performed by third parties on behalf of Consultant without the prior written permission of TORVEC, which permission shall not be unreasonably withheld; provided, however, that Consultant shall be responsible therefor pursuant to this Agreement.
3. Rights in the Work Product and Background Rights.
(a) Consultant hereby grants to TORVEC, and TORVEC hereby accepts, the entire, right title and interest of Consultant in and to the Work Product and in and to all patents, copyrights, trade secrets, trademarks, business plans, marketing and joint venture concepts, and other proprietary rights in or based on the Work Product.
(b) Consultant hereby grants to TORVEC, and TORVEC hereby accepts, an unlimited, unrestricted, royalty-free, fully paid-up, worldwide exclusive right and license, with the right to grant licenses and sublicenses to others without accounting to Consultant, under the Background Rights and the entire right, title, and interest of Consultant to the Background Rights and all proprietary rights therein or based thereon.
(c) Consultant and TORVEC agree that if the Work Product or any portion thereof is copyrightable, it shall be deemed to be a "work made for hire," as such term is defined in the Copyright Laws of the United States.
(d) Consultant shall cooperate with TORVEC or its designees and execute all documents of assignment, oaths, declaration and other documents, as may be prepared by TORVEC, to effect the foregoing or to perfect or enforce any proprietary rights resulting from or related to this Agreement. Such cooperation and execution shall be at no additional compensation to Consultant; provided, however, that TORVEC shall reimburse Consultant for reasonable out-of pocket expenses incurred.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

4. Compensation.
(a) As compensation in full for the successful performance of all work and services to be performed hereunder, including the grant of rights and licenses in and to Work Product and Background Rights, TORVEC shall pay Consultant a fixed fee of $12,500.00 per month.
(b) TORVEC shall reimburse Consultant for expenses incurred by Consultant in the performance of work and the rendition of services under this Agreement, provided that reimbursement of travel and related expenses shall be in accordance with TORVEC's then current policies applicable to TORVEC employees for the reimbursement of such expenses. Consultant shall obtain receipts for all expenses in excess of $25 and shall submit them to TORVEC.
(c) Subject to the approval by its shareholders of the Company's 1998 Stock Option Plan, there is hereby granted to the Consultant a non-qualified stock option to purchase up to 25,000 shares of the Company's $.01 par value Common Stock at an exercise price of $5.00 per share. The option granted hereby shall be subject to the terms and conditions set forth in the Stock Option Agreement attached hereto and made a part hereof. The term of the option shall be for a period of 10 years, shall vest on a cumulative basis at a rate of 20% per year, shall provide for immediate and full vesting in the event the Company is acquired and shall provide that the right to exercise the option in accordance with its terms shall survive the Consultant's termination of services.
5. Confidentiality.
(a) Consultant agrees that the Work Product and Background Rights are the sole and exclusive property of TORVEC, and Consultant shall treat the Work Product and Background Rights on a confidential basis and not disclose it to any third party or use it for the benefit of other than TORVEC; provided, however, that Consultant shall be relieved of such obligation if and when TORVEC discloses the Work Product and Background Rights without any restriction on use or further disclosure.
(b) Consultant shall keep confidential and not disclose or use for the benefit of other than TORVEC any and all written or tangible information stamped "confidential," "proprietary" or with a similar legend which is made available or disclosed to Consultant as a result of or in any way related to this Agreement; provided, however, that Consultant shall have no obligation hereunder for that portion of such information which is disclosed by TORVEC to others without any restriction on use and disclosure.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

(c) Consultant acknowledges that his promised services hereunder are of special, unique, unusual and extraordinary character which gives them peculiar value, the loss of which cannot adequately be compensated in damages in an action at law, and Consultant further acknowledges that in his consultative capacity hereunder he will be making use of, acquiring and adding to confidential information of special and unique value relating to the affairs of the TORVEC, its subsidiaries and affiliates, including but not limited to its financial affairs, new products, marketing plans, and costs of providing the products. In addition to and not in limitation of any other restrictive covenants which may be binding upon Consultant, Consultant agrees that he will not (except for the benefit of or with the written consent of the TORVEC, its successors or assigns);
(1) During or after the Term of Consultation, disclose any of said information to any person, firm or corporation for any purpose whatsoever; and
(2) During the Term of Consultation or within two (2) years thereafter, in any area in which duties have at any time been assigned to him hereunder during the Term of Consultation, engage (as an individual or as a stockholder, partner, member, agent, employee or representative of any person, firm, corporation limited liability company or partnership, or association), or have any interest, direct or indirect, in any entity developing or producing products or related business in competition with the business of the TORVEC; provided that this paragraph shall not prevent the Consultant from acquiring and holding shares of stock of TORVEC and not to exceed two (2%) percent of the outstanding shares of stock of any other corporation which engages in a related business if such shares are available to the general public on a national securities exchange or NASDAQ..
6. Term of agreement.
(a) This Agreement shall be for a period of three years commencing on December 1, 1997 unless terminated or canceled as provided herein.
(b) The term of any right or licenses under proprietary rights granted to TORVEC as a result of or

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

related to this Agreement shall be for the full term of such proprietary rights.
7. Warranties and representations. Consultant warrants and represents that:
(a) The Work Product is original work developed pursuant to this Agreement;
(b) The Work Product was created by the Consultant;
(c) The Work Product, in whole or in part, does not, upon information and belief, infringe any patents, copyrights, trade secrets or other proprietary rights of third parties and Consultant has received no claims or charges of such infringement by the Work Product or any portion thereof, and Consultant has no reason to believe that the Work Product, in whole or in part, may infringe the patents, copyrights, trade secrets or other proprietary rights of third parties;
(d) Consultant has the authority to enter into this Agreement and to perform all obligations, hereunder, including, but not limited to, the grant of rights and licenses to the Work Product and Background Rights and all proprietary rights therein or based thereon; and
(e) Consultant has not granted any rights or licenses to third parties under Work Product or any portion thereof.
8. Indemnities. Consultant shall indemnify and hold TORVEC harmless against any loss or liability to person or property arising out of the performance of Consultant under this Agreement
9. Disability waiver. TORVEC recognizes that Consultant's past association with TORVEC has created unique goodwill to TORVEC. TORVEC desires to retain Consultant's services and prevent them from being used by its competitors, even though Consultant may become disabled or incapacitated. Accordingly, it is expressly understood that Consultant's inability to render Services to TORVEC because of absences, or temporary or permanent illness, disability, or incapacity, or for any other reasonable cause, shall not constitute a failure to perform his obligations hereunder and shall not be deemed a breach or default by him.
10. Death benefit. Should Consultant die during the term of this Agreement, the Agreement shall terminate as of the last day of the month of his death. TORVEC shall, for a period of twelve (12) months after Consultant's death, pay to his legal representatives, or to his surviving widow (provided that Consultant has so instructed TORVEC in

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

writing prior to his death) the sum of $12,500.00, monthly to be paid on the last day of each month during the twelve
(12) month period. If Consultant dies during the last year of this Agreement, however, the $12,500.00 monthly payments to his legal representatives or widow, as the case may be, shall not in any case be made after the termination date set forth in this Agreement.
11. Termination/Cancellation.
(a) This Agreement may be terminated or canceled by either party upon the occurrence of any of the following events, and neither party shall have any liability to the other party for the exercise of such right.
(1) By either party, if the other party has breached a covenant, obligation or warranty under this Agreement and such breach remains uncured for a period of 30 days after notice thereof is sent to such other party;
(2) By either party, if the other party ceases to conduct business.
(b) In the event either party terminates or cancels this Agreement pursuant to this Paragraph 11, TORVEC shall have no further liability to Consultant, except to pay Consultant a pro-rata share of the compensation of Paragraph 4 for that portion of the Work Product performed through the date of termination/cancellation.
12. Arbitration. Any controversy or claim arising out of or relating to this Agreement shall be settled by arbitration in accordance with the Rules of Commercial Arbitration of the American Arbitration Association. Any judgment upon the award rendered in such arbitration may be entered in any court of competent jurisdiction. Notwithstanding the provisions of this paragraph, TORVEC shall have the right to seek enforcement of the provisions of paragraph 5 above by a court proceeding for an injunction.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

13. General.
(a) This Agreement is the sole and entire agreement between the parties relating to the subject matter hereof and the Work Product and the Background Rights, and supersedes all prior understandings, agreements, and documentation relating to the subject matter hereof other than prior assignments and transfers of ownership by Consultant to Torvec which assignments and transfers remain in full force and effect. This Agreement may be amended only by an instrument executed by the authorized representatives of both parties.
(b) Any termination, cancellation or expiration of this Agreement notwithstanding, provisions which are intended to survive and continue shall so survive and continue, including, but not limited to, the provisions of Paragraphs 3, 5, 7, 8, 9,10 11 and 12.
(c) This Agreement shall be interpreted in accordance with the substantive law of the State of New York. IN WITNESS WHEREOF the parties hereto have caused this Agreement to be executed by their duly authorized representatives and to be effective as of the date first above written.

TORVEC, INC.

By:_____________________   ___________________________
Title:                     James Gleasman
Date: __________________   Date:______________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

STOCK OPTION AGREEMENT

THIS STOCK OPTION AGREEMENT MADE as of this 1st day of December, 1997 between TORVEC, INC., a New York business corporation (herein referred to as the "Company"), and JAMES
A.GLEASMAN (herein referred to as the "Optionee");

WITNESSETH:

1. The Company hereby grants to the Optionee an Option (hereinafter referred to as "Option") to purchase an aggregate of 25,000 shares of the $.01 par value Common Stock of the Company (herein referred to as the "Shares") at an exercise price of $5.00 per Share to be paid by the Optionee with cash, a certified check or a bank cashier's check made payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, the Optionee may pay for the Shares, either in whole or in part, by the delivery of Common Stock of the Company already owned by him which will be accepted as payment for the Shares, based upon such Common Stock's fair market value on the date of exercise. In addition, provided the Board of Directors shall approve the specific transfer, payment for the Shares, either in whole or in part, may be made by delivery of Common Stock acquired by the Optionee under any of the Company's stock option plans, provided, however, that if this Option is exercised in part, Shares acquired by such partial exercise may not be used as payment for additional Shares to be acquired under this Agreement. In order for the Optionee to so use shares of Common Stock previously acquired under any of the Company's stock option plans as payment for the Shares either in whole or in part, the transfer of such previously acquired Common Stock as payment for all or a portion of the exercise price under this Agreement must occur more than two years from the date of the grant and one year from the date of exercise of the prior option pursuant to which the Optionee acquired such Common Stock.
2. The term during which the Option shall be exercisable shall commence on December 1, 1997 and expire on the close of business November 30, 2007, subject to earlier termination as provided in the Torvec, Inc. 1998 Stock Option Plan (herein referred to as the "Plan"). The Option to purchase the number of Shares granted under this Agreement vest on the 1st day of each of the five years of the Option Term on a cumulative basis, in accordance with the following schedule:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

                           VESTED      NON-VESTED

12/1/97 - 11/30/98           20%           80%
12/1/98 - 11/30/99           40%           60%
12/1/99 - 11/30/2000         60%           40%
12/1/2000 - 11/30/2001       80%           20%
12/1/2001 - 11/30/2002      100%            0%

provided however, that to the extent the Optionee shall fail to exercise or, due to the above limitation, be prohibited from exercising his Option in any year during the Option period, such annual right to exercise this Option shall not expire, but shall be cumulative and carry over into and be exercisable in any subsequent year during which the Option is outstanding.
This Option may be exercised by the Optionee in accordance with its terms during the Option Term even though, at the time of such exercise, whether in whole or in part, the Optionee is no longer an consultant of the Company.
3. Notwithstanding the limitation upon immediate exercise set forth in Section 2 hereof, this Option shall be exercisable in full immediately upon the occurrence of a change in control of the Company. For this purpose, the term "change in control of the Company" shall generally include a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company. Specifically, the term shall include (i) the purchase or other acquisition by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, or any comparable successor provisions, of the beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of more than 50% of either the outstanding shares of common stock or the combined voting power of the Company's then outstanding voting securities entitled to vote generally, or (ii) the approval by the shareholders of the Company of a reorganization, merger, or consolidation with respect to which, in such case, persons who were shareholders of the Company immediately prior to such reorganization, merger, or consolidation do not immediately thereafter, own more than 50% of either the outstanding shares of common stock or the combined voting power of the reorganized, merged or consolidated Company's then outstanding voting securities entitled to vote generally or
(iii) the liquidation and/or dissolution of the Company.
4. The Option is not transferable by the Optionee other than by Will or the laws of descent and distribution and is exercisable, during his lifetime, only by the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

Optionee. In the event that the right to exercise the Option passes to the Optionee's estate, or to a person to whom such right devolves by reason of the Optionee's death, then the Option shall be non transferable in the hands of the Optionee's Executor or Administrator or of such person, except that the Option may be distributed by the Optionee's Executor or Administrator to the distributees of the Optionee's estate as a part thereof.
5. In order for the Option to be exercised, in whole or in part, the notice by the Optionee to the Company in the form attached hereto must be accompanied by payment in full of the option price for the Shares being purchased. In addition, the Optionee agrees to tender to the Company an additional amount, in cash, certified check, cashier's check or bank draft, equal to the amount of any taxes required to be collected or withheld by the company in connection with the exercise of his Option.
6. The Company agrees that it will use its best efforts to register the sale of the Shares to be issued upon the exercise of the Option with the Securities and Exchange Commission under the Securities Act of 1933. Upon the effectiveness of the Registration Statement covering the Shares, the Optionee shall be able to sell the Shares in "open market transactions" free of Federal Securities Law restrictions, provided that at the time of sale, or within the three month period immediately prior to such sale, he is not nor has he been an "affiliate" of the Company. The Optionee further understands that, in accordance with applicable Commission rules governing controlling persons of public companies, members of the board of directors of a public company, and/or persons who hold significant policy-making positions with a public company, such as the Company, are deemed to be "affiliates" during their term of office. The Optionee, therefore, agrees that he will consult with the Company's counsel as to any Securities Law restrictions, including a limitation on the number of Shares which may be sold at any one time, on his ability to sell the Shares prior to any sale thereof.
7. The Company agrees to provide the Optionee with a copy of the Prospectus prepared by the Company in connection with the Registration Statement filed to register the Shares, together with its exhibits, and the Company hereby acknowledges its obligation to provide the Optionee with all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year of the Company and all updates thereof. The Optionee agrees that prior to exercise, either in whole or in part of the Option granted to him hereunder, he shall have read such materials, including the most recent annual and quarterly reports to shareholders, and shall have received, if requested, and read all the documents

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

incorporated by reference in the Prospectus and Registration Statement filed with the Securities and Exchange Commission.
8. The Optionee understands that except as provided in Paragraph 6 above, the Company has not agreed to register either the issuance or the resale of the Shares in accordance with the provisions of the Securities Act of 1933 or to register either the issuance or the resale of the Shares under any applicable State Securities Laws. Hence, the Optionee agrees that by virtue of the provision of certain rules respecting "restricted securities" promulgated under such Federal and/or State Laws, unless the resale of the Shares is registered as provided in Paragraph 6 above, and until the registration of such Shares in accordance with Paragraph 6 above shall have been declared effective by order of the Commission, the Shares which the Optionee shall purchase upon the exercise of this Option must be held indefinitely and may not be sold, transferred, pledged, hypothecated, or otherwise encumbered for value, unless and until a secondary distribution and/or resale of such Shares is subsequently registered under such Federal and/or State Securities Laws, or unless an exemption from registration is available, in which case the Optionee still may be limited as to the amount of the Shares that may be sold, transferred, pledged and/or encumbered for value. The Optionee therefore agrees that, until the registration of such Shares shall have been declared effective by order of the Commission, the Company may affix upon any certificate representing the Shares, a legend that such Shares may not be transferred in violation of Section 5 of the Securities Act of 1933.
9. The Optionee understands and agrees that the Shares to be acquired upon the exercise of the Option may not be sold, transferred, exchanged, hypothecated, encumbered, pledged or otherwise disposed of for value for a period of six (6) months from the date of the grant of this Option.
10. The Optionee understands that the Company has established certain policies and procedures governing trading in the Company's securities, including the Shares to be acquired upon the exercise of this Option, while in possession of material, inside information regarding the Company and/or any of its subsidiaries, receipt of which is hereby acknowledged. The Optionee agrees that upon exercise of this Option, either in whole or in part, he will comply with all of the terms and conditions of such policy, including the procedures and guidelines established for its implementation. In particular, the Optionee agrees that where required under such guidelines and procedures, he will obtain permission of the Company's Clearinghouse Committee composed of senior management prior to effectuating any sale or other transfer for value of the Shares to be acquired by virtue of the exercise of this Option.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

11. All the terms and provisions of the Plan, duly adopted at a meeting of the Company's Board of Directors on _______________ and approved by a majority vote of the Company's shareholders either in person or by proxy at a duly called meeting of such shareholders held on _______________ and as amended to date, are hereby expressly incorporated into this Stock Option Agreement and made a part hereof as if printed herein and the Optionee, by the Optionee's signature hereon, acknowledges receipt of a certified copy of said Plan. If there shall be any conflict between this Agreement and the Plan, the provisions of the Plan shall control.
12. In accordance with certain terms and conditions of the Plan, the aggregate number and kind of shares that may be purchased pursuant to the grant of the Option under this Agreement shall be proportionately adjusted for any increase, decrease or change in the total number of the outstanding shares of the Company resulting from a stock dividend, stock-split or other corporate reorganization which would result in or have the effect of the Optionee being treated differently (but for the adjustment) than he would be treated had he been the beneficial owner of the Shares subject to the Option on the record date for such dividend, split or reorganization, as the case may be.
13. The Optionee understands that the Option granted hereunder constitutes a "nonqualified stock option" for federal, and if applicable, state income tax purposes. Consequently, the Optionee understands that under current provisions of federal tax law, for

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

regular as well as for purposes to the federal alternative minimum income tax, no gain or loss generally is recognized to the Optionee upon the grant of the Option. In addition, the Company will receive no business expense deduction as a result of the grant of the Option.
For federal income tax purposes, upon the exercise of the Option, the difference between the exercise price and the fair market value of the Shares on the date of exercise constitutes ordinary income to the Optionee and is taxed to the Optionee at normal, ordinary tax rates, except to the extent the Shares are not transferable and are subject to a substantial risk of forfeiture. To the extent such difference is required to be included as income by the Optionee, the Company is entitled to a business expense deduction. Upon the later sale of the Shares, long or short term capital gain or loss will be recognized by the Optionee, depending upon the holding period (eighteen months for long term capital gain or loss) and the extent to which the selling price exceeds or is less than the Optionee's basis in the stock. The amount of gain will be taxed at normal, ordinary tax rates, with a maximum rate of 20% if the Shares are held for a period of at least eighteen months. If the Shares are held for a period of at least twelve months, the maximum rate on any gain from their sale will be taxed at 28%.
The Optionee also understands that the provisions of federal tax law described herein are subject to change and, consequently, the Optionee agrees to consult with his or her own tax advisor with respect to the tax treatment to be accorded the grant of the Option herein, the exercise of such Option, and the disposition of the Shares.
14. Consistent with the provisions of the Plan, this Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and to any executor, administrator, legal representative, legatee, or distributee entitled by law to the Optionee's right hereunder.
15. Except insofar as an interpretation of federal securities law otherwise is required, or is controlling, this Agreement shall be governed by and construed in accordance with the laws of the State of New York. IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Optionee has hereunto set his hand, as of the day and year first above written.
TORVEC, INC. By: ____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a


James A. Gleasman, Optionee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

NOTICE OF EXERCISE OF STOCK OPTION
AND
RECORD OF STOCK TRANSFER

Torvec, Inc.
3740 Route 104
Williamson, New York 14587
Gentlemen:
I hereby exercise my Stock Option granted to me by Torvec, Inc. under a Stock Option Agreement dated _______________, subject to all the terms and provisions thereof and of the Torvec, Inc. 1998 Stock Option Plan referred to therein and notify you of my desire to purchase Shares of the $.01 par value Common Stock of the Company which were offered to me pursuant to the Stock Option Agreement. Enclosed is my payment in the sum of in full payment of such Shares.
I understand that a Registration Statement covering the Shares to be issued to me pursuant to this exercise of the Option granted to me was filed with the Securities and Exchange Commission on _______________. The Registration Statement became effective on _______________. Consequently, I understand that unless I am an "affiliate" of the Company, the Shares I am acquiring are freely tradeable and may be sold by me in "open market" transactions. If I am an "affiliate" of the Company, however, or have been one during the three month period prior to sale, I recognize that I may not sell freely on the open market and therefore agree that I will consult the Company's counsel as to the securities law restrictions on my ability to sell the Shares.
I also understand that under the Plan, and in accordance with the terms of the Stock Option Agreement, I may not sell, assign, alienate, pledge, encumber or otherwise transfer for value the Shares unless a period of six (6) months has elapsed from the date of the grant of the Option to me.
I acknowledge that I am aware that the Company has established a policy with respect to trading in its securities while in possession of material inside information regarding the Company and/or its subsidiaries, and that, in accordance with certain guidelines and procedures designed to implement such policy, I may be required to obtain permission from a Clearinghouse Committee, composed of Senior Management, prior to any sale or other transfer for value of the Shares hereby acquired.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

I also acknowledge that I have received and have read the Prospectus dated _______________ prepared by the Company in connection with the grant of the Option contained herein, together with its exhibits, and all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year and all quarterly and current updates thereof. I acknowledge that I have received all documents incorporated by reference in the Prospectus and the Registration Statement filed with the Securities and Exchange Commission that I requested and have read the same. I acknowledge that I have had the opportunity to ask questions of and receive answers from the Company's management concerning the information set forth in such Prospectus, reports and updates and have been satisfied with the answers provided regarding the same.
Finally, I acknowledge that there are significant federal income tax consequences resulting from my exercise of this Option, that I have consulted with and received advice from qualified tax counsel both as to the nature of such tax consequences and their impact upon my own personal income tax situation as the result of such exercise, and that I fully understand such impact and have planned accordingly.

DATED: ____________ ____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a

Receipt is hereby acknowledged of the delivery to me by Torvec, Inc. on , 19 of stock certificates for shares of $.01 par value common stock purchased by me pursuant to the terms and conditions of the Torvec, Inc. 1998 Stock Option Plan referred to above.

DATED: ____________ ____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-5.x2a


EXHIBIT NUMBER 6.6

CONSULTING AGREEMENT

THIS AGREEMENT made and entered into the 6th day of February, 1998, effective December 1, 1997, by and between Torvec, Inc., a New York corporation having a principal place of business at 11 Pondview Drive, Pittsford, New York, 14534 (hereinafter "TORVEC") and Vernon Gleasman, an individual having a principal place of business at 11 Pondview Drive, Pittsford, New York, 14534 (hereinafter "Consultant").

WITNESSETH

WHEREAS, Consultant has experience in the design, development, and manufacture of gears, clutches, couplings, and other mechanical elements , for all purposes including, but not limited to use in automotive components and motor vehicles and is willing to design, develop, and manufacture such products for TORVEC; and WHEREAS, TORVEC desires to have Consultant design, develop, and assist in the manufacturing of such products for TORVEC under the terms and conditions set forth in this Agreement.
NOW, THEREFORE, in consideration of the mutual covenants and promises set forth herein, the parties hereto agree as follows.
1. Definitions. The following definitions shall apply for all purposes of this Agreement:
(a) "Work Product" shall mean all data, designs, documentation, inventions, soft- ware and information, in whatever form, first produced created or emanating from, by or for Consultant in the performance of work or the rendition of services under this Agreement.
(b) "Background Rights" shall mean all data, designs, documentation, inventions, software and information, in whatever form, not first produced created or emanating from, by or for Consultant as a result of or related to the performance of work or the rendition of services under this Agreement, but included in or necessary for use in or with the Work Product or any other product or any portion thereof which is produced or contemplated by Torvec.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

(c) "TORVEC Representative" shall mean the Chief Operating Officer of Torvec or his alternate as designated in writing by him.
2. Work to be performed and services to be rendered.
(a) Consultant agrees, during the term of this Agreement, the Consultant shall devote his full time and effort to the design, development, and manufacture of inventions and products for Torvec, and the training of others performing such work.
(b) The work to be performed and the services to be rendered hereunder shall be performed by the Consultant, and such work or services may not be subcontracted or otherwise performed by third parties on behalf of Consultant without the prior written permission of TORVEC, which permission shall not be unreasonably withheld; provided, however, that Consultant shall be responsible therefor pursuant to this Agreement.
3. Rights in the Work Product and Background Rights.
(a) Consultant hereby grants to TORVEC, and TORVEC hereby accepts, the entire, right title and interest of Consultant in and to the Work Product and in and to all patents, copyrights, trade secrets, trademarks, and other proprietary rights in or based on the Work Product.
(b) Consultant hereby grants to TORVEC, and TORVEC hereby accepts, an unlimited, unrestricted, royalty-free, fully paid-up, worldwide exclusive right and license, with the right to grant licenses and sublicenses to others without accounting to Consultant, under the Background Rights and the entire right, title, and interest of Consultant to the Background Rights and all proprietary rights therein or based thereon.
(c) Consultant and TORVEC agree that if the Work Product or any portion thereof is copyrightable, it shall be deemed to be a "work made for hire," as such term is defined in the Copyright Laws of the United States.
(d) Consultant shall cooperate with TORVEC or its designees and execute all documents of assignment, oaths, declaration and other documents, as may be prepared by TORVEC, to effect the foregoing or to perfect or enforce any proprietary rights resulting from or related to this Agreement. Such cooperation and execution shall be at no additional compensation to Consultant; provided, however, that TORVEC shall reimburse Consultant for reasonable out-of pocket expenses incurred.
4. Compensation..

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

(a) As compensation in full for the successful performance of all work and services to be performed hereunder, including the grant of rights and licenses in and to Work Product and Background Rights, TORVEC shall pay Consultant a fixed fee of $12,500.00 per month.
(b) TORVEC shall reimburse Consultant for expenses incurred by Consultant in the performance of work and the rendition of services under this Agreement, provided that reimbursement of travel and related expenses shall be in accordance with TORVEC's then current policies applicable to TORVEC employees for the reimbursement of such expenses. Consultant shall obtain receipts for all expenses in excess of $25 and shall submit them to TORVEC.
(c) Subject to the approval by its shareholders of the Company's 1998 Stock Option Plan, there is hereby granted to the Consultant a non-qualified stock option to purchase up to 25,000 shares of the Company's $.01 par value Common Stock at an exercise price of $5.00 per share. The option granted hereby shall be subject to the terms and conditions set forth in the Stock Option Agreement attached hereto and made a part hereof. The term of the option shall be for a period of 10 years, shall vest on a cumulative basis at a rate of 20% per year, shall provide for immediate and full vesting in the event the Company is acquired and shall provide that the right to exercise the option in accordance with its terms shall survive the Consultant's termination of services.
5. Confidentiality.
(a) Consultant agrees that the Work Product and Background Rights are the sole and exclusive property of TORVEC, and Consultant shall treat the Work Product and Background Rights on a confidential basis and not disclose it to any third party or use it for the benefit of other than TORVEC; provided, however, that Consultant shall be relieved of such obligation if and when TORVEC discloses the Work Product and Background Rights without any restriction on use or further disclosure.
(b) Consultant shall keep confidential and not disclose or use for the benefit of other than TORVEC any and all written or tangible information stamped "confidential," "proprietary" or with a similar legend which is made available or disclosed to Consultant as a result of or in any way related to this Agreement; provided, however, that Consultant shall have no obligation hereunder for that portion of such information which is disclosed by TORVEC to others without any restriction on use and disclosure.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

(c) Consultant acknowledges that his promised services hereunder are of special, unique, unusual and extraordinary character which gives them peculiar value, the loss of which cannot adequately be compensated in damages in an action at law, and Consultant further acknowledges that in his consultative capacity hereunder he will be making use of, acquiring and adding to confidential information of special and unique value relating to the affairs of the TORVEC, its subsidiaries and affiliates, including but not limited to its financial affairs, new products, marketing plans, and costs of providing the products. In addition to and not in limitation of any other restrictive covenants which may be binding upon Consultant, Consultant agrees that he will not (except for the benefit of or with the written consent of the TORVEC, its successors or assigns);
(1) During or after the Term of Consultation, disclose any of said information to any person, firm or corporation for any purpose whatsoever; and
(2) During the Term of Consultation or within two (2) years thereafter, in any area in which duties have at any time been assigned to him hereunder during the Term of Consultation, engage (as an individual or as a stockholder, partner, member, agent, employee or representative of any person, firm, corporation limited liability company or partnership, or association), or have any interest, direct or indirect, in any entity developing or producing products or related business in competition with the business of the TORVEC; provided that this paragraph shall not prevent the Consultant from acquiring and holding shares of stock of TORVEC and not to exceed two (2%) percent of the outstanding shares of stock of any other corporation which engages in a related business if such shares are available to the general public on a national securities exchange or NASDAQ..
6. Term of agreement.
(a) This Agreement shall be for a period of three years commencing on December 1, 1997 unless terminated or canceled as provided herein.
(b) The term of any right or licenses under proprietary rights granted to TORVEC as a result of or related to this Agreement shall be for the full term of such proprietary rights.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

7. Warranties and representations. Consultant warrants and represents that:
(a) The Work Product is original work developed pursuant to this Agreement;
(b) The Work Product was created by the Consultant;
(c) The Work Product, in whole or in part, does not, upon information and belief, infringe any patents, copyrights, trade secrets or other proprietary rights of third parties and Consultant has received no claims or charges of such infringement by the Work Product or any portion thereof, and Consultant has no reason to believe that the Work Product, in whole or in part, may infringe the patents, copyrights, trade secrets or other proprietary rights of third parties;
(d) Consultant has the authority to enter into this Agreement and to perform all obligations, hereunder, including, but not limited to, the grant of rights and licenses to the Work Product and Background Rights and all proprietary rights therein or based thereon; and
(e) Consultant has not granted any rights or licenses to third parties under Work Product or any portion thereof.
8. Indemnities. Consultant shall indemnify and hold TORVEC harmless against any loss or liability to person or property arising out of the performance of Consultant under this Agreement
9. Disability waiver. TORVEC recognizes that Consultant's past association with TORVEC has created unique goodwill to TORVEC. TORVEC desires to retain Consultant's services and prevent them from being used by its competitors, even though Consultant may become disabled or incapacitated. Accordingly, it is expressly understood that Consultant's inability to render Services to TORVEC because of absences, or temporary or permanent illness, disability, or incapacity, or for any other reasonable cause, shall not constitute a failure to perform his obligations hereunder and shall not be deemed a breach or default by him.
10. Death benefit. Should Consultant die during the term of this Agreement, the Agreement shall terminate as of the last day of the month of his death. TORVEC shall, for a period of twelve (12) months after Consultant's death, pay to his legal representatives, or to his surviving widow (provided that Consultant has so instructed TORVEC in writing prior to his death) the sum of $12,500.00, monthly to be paid on the last day of each month during the twelve
(12) month period. If Consultant dies during the last year of this Agreement, however, the $12,500.00 monthly payments

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

to his legal representatives or widow, as the case may be, shall not in any case be made after the termination date set forth in this Agreement.
11. Termination/Cancellation.
(a) This Agreement may be terminated or canceled by either party upon the occurrence of any of the following events, and neither party shall have any liability to the other party for the exercise of such right.
(1) By either party, if the other party has breached a covenant, obligation or warranty under this Agreement and such breach remains uncured for a period of 30 days after notice thereof is sent to such other party;
(2) By either party, if the other party ceases to conduct business.
(b) In the event either party terminates or cancels this Agreement pursuant to this Paragraph 11, TORVEC shall have no further liability to Consultant, except to pay Consultant a pro-rata share of the compensation of Paragraph 4 for that portion of the Work Product performed through the date of termination/cancellation.
12. Arbitration. Any controversy or claim arising out of or relating to this Agreement shall be settled by arbitration in accordance with the Rules of Commercial Arbitration of the American Arbitration Association. Any judgment upon the award rendered in such arbitration may be entered in any court of competent jurisdiction. Notwithstanding the provisions of this paragraph, TORVEC shall have the right to seek enforcement of the provisions of paragraph 5 above by a court proceeding for an injunction.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

13. General.
(a) This Agreement is the sole and entire agreement between the parties relating to the subject matter hereof and the Work Product and the Background Rights, and supersedes all prior understandings, agreements, and documentation relating to the subject matter hereof other than prior assignments and transfers of ownership by Consultant to Torvec which assignments and transfers remain in full force and effect. This Agreement may be amended only by an instrument executed by the authorized representatives of both parties.
(b) Any termination, cancellation or expiration of this Agreement notwithstanding, provisions which are intended to survive and continue shall so survive and continue, including, but not limited to, the provisions of Paragraphs 3, 5, 7, 8, 9,10 11 and 12.
(c) This Agreement shall be interpreted in accordance with the substantive law of the State of New York. IN WITNESS WHEREOF the parties hereto have caused this Agreement to be executed by their duly authorized representatives and to be effective as of the date first above written.

TORVEC, INC.

By:____________________    ____________________________________
Title:                     Vernon Gleasman
Date: ___________________  Date:_______________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

STOCK OPTION AGREEMENT

THIS STOCK OPTION AGREEMENT MADE as of this 1st day of December, 1997 between TORVEC, INC., a New York business corporation (herein referred to as the "Company"), and VERNON E.GLEASMAN (herein referred to as the "Optionee");

WITNESSETH:

1. The Company hereby grants to the Optionee an Option (hereinafter referred to as "Option") to purchase an aggregate of 25,000 shares of the $.01 par value Common Stock of the Company (herein referred to as the "Shares") at an exercise price of $5.00 per Share to be paid by the Optionee with cash, a certified check or a bank cashier's check made payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, the Optionee may pay for the Shares, either in whole or in part, by the delivery of Common Stock of the Company already owned by him which will be accepted as payment for the Shares, based upon such Common Stock's fair market value on the date of exercise. In addition, provided the Board of Directors shall approve the specific transfer, payment for the Shares, either in whole or in part, may be made by delivery of Common Stock acquired by the Optionee under any of the Company's stock option plans, provided, however, that if this Option is exercised in part, Shares acquired by such partial exercise may not be used as payment for additional Shares to be acquired under this Agreement. In order for the Optionee to so use shares of Common Stock previously acquired under any of the Company's stock option plans as payment for the Shares either in whole or in part, the transfer of such previously acquired Common Stock as payment for all or a portion of the exercise price under this Agreement must occur more than two years from the date of the grant and one year from the date of exercise of the prior option pursuant to which the Optionee acquired such Common Stock.
2. The term during which the Option shall be exercisable shall commence on December 1, 1997 and expire on the close of business November 30, 2007, subject to earlier termination as provided in the Torvec, Inc. 1998 Stock Option Plan (herein referred to as the "Plan"). The Option to purchase the number of Shares granted under this Agreement vest on the 1st day of each of the five years of the Option Term on a cumulative basis, in accordance with the following schedule:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

                         VESTED      NON-VESTED

12/1/97 - 11/30/98        20%           80%
12/1/98 - 11/30/99        40%           60%
12/1/99 - 11/30/2000      60%           40%
12/1/2000 - 11/30/2001    80%           20%
12/1/2001 - 11/30/2002   100%            0%

provided however, that to the extent the Optionee shall fail to exercise or, due to the above limitation, be prohibited from exercising his Option in any year during the Option period, such annual right to exercise this Option shall not expire, but shall be cumulative and carry over into and be exercisable in any subsequent year during which the Option is outstanding.
This Option may be exercised by the Optionee in accordance with its terms during the Option Term even though, at the time of such exercise, whether in whole or in part, the Optionee is no longer an consultant of the Company.
3. Notwithstanding the limitation upon immediate exercise set forth in Section 2 hereof, this Option shall be exercisable in full immediately upon the occurrence of a change in control of the Company. For this purpose, the term "change in control of the Company" shall generally include a change in the ownership or effective control of the Company or in the ownership of a substantial portion of the assets of the Company. Specifically, the term shall include (i) the purchase or other acquisition by any person, entity or group of persons, within the meaning of Section 13(d) or 14(d) of the Securities Exchange Act of 1934, or any comparable successor provisions, of the beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Act) of more than 50% of either the outstanding shares of common stock or the combined voting power of the Company's then outstanding voting securities entitled to vote generally, or (ii) the approval by the shareholders of the Company of a reorganization, merger, or consolidation with respect to which, in such case, persons who were shareholders of the Company immediately prior to such reorganization, merger, or consolidation do not immediately thereafter, own more than 50% of either the outstanding shares of common stock or the combined voting power of the reorganized, merged or consolidated Company's then outstanding voting securities entitled to vote generally or
(iii) the liquidation and/or dissolution of the Company.
4. The Option is not transferable by the Optionee other than by Will or the laws of descent and distribution and is exercisable, during his lifetime, only by the Optionee. In the event that the right to exercise the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

Option passes to the Optionee's estate, or to a person to whom such right devolves by reason of the Optionee's death, then the Option shall be non transferable in the hands of the Optionee's Executor or Administrator or of such person, except that the Option may be distributed by the Optionee's Executor or Administrator to the distributees of the Optionee's estate as a part thereof.
5. In order for the Option to be exercised, in whole or in part, the notice by the Optionee to the Company in the form attached hereto must be accompanied by payment in full of the option price for the Shares being purchased. In addition, the Optionee agrees to tender to the Company an additional amount, in cash, certified check, cashier's check or bank draft, equal to the amount of any taxes required to be collected or withheld by the company in connection with the exercise of his Option.
6. The Company agrees that it will use its best efforts to register the sale of the Shares to be issued upon the exercise of the Option with the Securities and Exchange Commission under the Securities Act of 1933. Upon the effectiveness of the Registration Statement covering the Shares, the Optionee shall be able to sell the Shares in "open market transactions" free of Federal Securities Law restrictions, provided that at the time of sale, or within the three month period immediately prior to such sale, he is not nor has he been an "affiliate" of the Company. The Optionee further understands that, in accordance with applicable Commission rules governing controlling persons of public companies, members of the board of directors of a public company, and/or persons who hold significant policy-making positions with a public company, such as the Company, are deemed to be "affiliates" during their term of office. The Optionee, therefore, agrees that he will consult with the Company's counsel as to any Securities Law restrictions, including a limitation on the number of Shares which may be sold at any one time, on his ability to sell the Shares prior to any sale thereof.
7. The Company agrees to provide the Optionee with a copy of the Prospectus prepared by the Company in connection with the Registration Statement filed to register the Shares, together with its exhibits, and the Company hereby acknowledges its obligation to provide the Optionee with all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year of the Company and all updates thereof. The Optionee agrees that prior to exercise, either in whole or in part of the Option granted to him hereunder, he shall have read such materials, including the most recent annual and quarterly reports to shareholders, and shall have received, if requested, and read all the documents incorporated by reference in the Prospectus and Registration Statement filed with the Securities and Exchange Commission.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

8. The Optionee understands that except as provided in Paragraph 6 above, the Company has not agreed to register either the issuance or the resale of the Shares in accordance with the provisions of the Securities Act of 1933 or to register either the issuance or the resale of the Shares under any applicable State Securities Laws. Hence, the Optionee agrees that by virtue of the provision of certain rules respecting "restricted securities" promulgated under such Federal and/or State Laws, unless the resale of the Shares is registered as provided in Paragraph 6 above, and until the registration of such Shares in accordance with Paragraph 6 above shall have been declared effective by order of the Commission, the Shares which the Optionee shall purchase upon the exercise of this Option must be held indefinitely and may not be sold, transferred, pledged, hypothecated, or otherwise encumbered for value, unless and until a secondary distribution and/or resale of such Shares is subsequently registered under such Federal and/or State Securities Laws, or unless an exemption from registration is available, in which case the Optionee still may be limited as to the amount of the Shares that may be sold, transferred, pledged and/or encumbered for value. The Optionee therefore agrees that, until the registration of such Shares shall have been declared effective by order of the Commission, the Company may affix upon any certificate representing the Shares, a legend that such Shares may not be transferred in violation of Section 5 of the Securities Act of 1933.
9. The Optionee understands and agrees that the Shares to be acquired upon the exercise of the Option may not be sold, transferred, exchanged, hypothecated, encumbered, pledged or otherwise disposed of for value for a period of six (6) months from the date of the grant of this Option.
10. The Optionee understands that the Company has established certain policies and procedures governing trading in the Company's securities, including the Shares to be acquired upon the exercise of this Option, while in possession of material, inside information regarding the Company and/or any of its subsidiaries, receipt of which is hereby acknowledged. The Optionee agrees that upon exercise of this Option, either in whole or in part, he will comply with all of the terms and conditions of such policy, including the procedures and guidelines established for its implementation. In particular, the Optionee agrees that where required under such guidelines and procedures, he will obtain permission of the Company's Clearinghouse Committee composed of senior management prior to effectuating any sale or other transfer for value of the Shares to be acquired by virtue of the exercise of this Option.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

11. All the terms and provisions of the Plan, duly adopted at a meeting of the Company's Board of Directors on _______________ and approved by a majority vote of the Company's shareholders either in person or by proxy at a duly called meeting of such shareholders held on _______________ and as amended to date, are hereby expressly incorporated into this Stock Option Agreement and made a part hereof as if printed herein and the Optionee, by the Optionee's signature hereon, acknowledges receipt of a certified copy of said Plan. If there shall be any conflict between this Agreement and the Plan, the provisions of the Plan shall control.
12. In accordance with certain terms and conditions of the Plan, the aggregate number and kind of shares that may be purchased pursuant to the grant of the Option under this Agreement shall be proportionately adjusted for any increase, decrease or change in the total number of the outstanding shares of the Company resulting from a stock dividend, stock-split or other corporate reorganization which would result in or have the effect of the Optionee being treated differently (but for the adjustment) than he would be treated had he been the beneficial owner of the Shares subject to the Option on the record date for such dividend, split or reorganization, as the case may be.
13. The Optionee understands that the Option granted hereunder constitutes a "nonqualified stock option" for federal, and if applicable, state income tax purposes. Consequently, the Optionee understands that under current provisions of federal tax law, for

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

regular as well as for purposes to the federal alternative minimum income tax, no gain or loss generally is recognized to the Optionee upon the grant of the Option. In addition, the Company will receive no business expense deduction as a result of the grant of the Option.
For federal income tax purposes, upon the exercise of the Option, the difference between the exercise price and the fair market value of the Shares on the date of exercise constitutes ordinary income to the Optionee and is taxed to the Optionee at normal, ordinary tax rates, except to the extent the Shares are not transferable and are subject to a substantial risk of forfeiture. To the extent such difference is required to be included as income by the Optionee, the Company is entitled to a business expense deduction. Upon the later sale of the Shares, long or short term capital gain or loss will be recognized by the Optionee, depending upon the holding period (eighteen months for long term capital gain or loss) and the extent to which the selling price exceeds or is less than the Optionee's basis in the stock. The amount of gain will be taxed at normal, ordinary tax rates, with a maximum rate of 20% if the Shares are held for a period of at least eighteen months. If the Shares are held for a period of at least twelve months, the maximum rate on any gain from their sale will be taxed at 28%.
The Optionee also understands that the provisions of federal tax law described herein are subject to change and, consequently, the Optionee agrees to consult with his or her own tax advisor with respect to the tax treatment to be accorded the grant of the Option herein, the exercise of such Option, and the disposition of the Shares.
14. Consistent with the provisions of the Plan, this Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and to any executor, administrator, legal representative, legatee, or distributee entitled by law to the Optionee's right hereunder.
15. Except insofar as an interpretation of federal securities law otherwise is required, or is controlling, this Agreement shall be governed by and construed in accordance with the laws of the State of New York. IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Optionee has hereunto set his hand, as of the day and year first above written.
TORVEC, INC.
By: ____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a


Vernon E. Gleasman, Optionee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

NOTICE OF EXERCISE OF STOCK OPTION
AND
RECORD OF STOCK TRANSFER

Torvec, Inc.
3740 Route 104
Williamson, New York 14587
Gentlemen:
I hereby exercise my Stock Option granted to me by Torvec, Inc. under a Stock Option Agreement dated _______________, subject to all the terms and provisions thereof and of the Torvec, Inc. 1998 Stock Option Plan referred to therein and notify you of my desire to purchase Shares of the $.01 par value Common Stock of the Company which were offered to me pursuant to the Stock Option Agreement. Enclosed is my payment in the sum of in full payment of such Shares.
I understand that a Registration Statement covering the Shares to be issued to me pursuant to this exercise of the Option granted to me was filed with the Securities and Exchange Commission on _______________. The Registration Statement became effective on _______________. Consequently, I understand that unless I am an "affiliate" of the Company, the Shares I am acquiring are freely tradeable and may be sold by me in "open market" transactions. If I am an "affiliate" of the Company, however, or have been one during the three month period prior to sale, I recognize that I may not sell freely on the open market and therefore agree that I will consult the Company's counsel as to the securities law restrictions on my ability to sell the Shares.
I also understand that under the Plan, and in accordance with the terms of the Stock Option Agreement, I may not sell, assign, alienate, pledge, encumber or otherwise transfer for value the Shares unless a period of six (6) months has elapsed from the date of the grant of the Option to me.
I acknowledge that I am aware that the Company has established a policy with respect to trading in its securities while in possession of material inside information regarding the Company and/or its subsidiaries, and that, in accordance with certain guidelines and procedures designed to implement such policy, I may be required to obtain permission from a Clearinghouse Committee, composed of Senior Management, prior to any sale or other transfer for value of the Shares hereby acquired.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

I also acknowledge that I have received and have read the Prospectus dated _______________ prepared by the Company in connection with the grant of the Option contained herein, together with its exhibits, and all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year and all quarterly and current updates thereof. I acknowledge that I have received all documents incorporated by reference in the Prospectus and the Registration Statement filed with the Securities and Exchange Commission that I requested and have read the same. I acknowledge that I have had the opportunity to ask questions of and receive answers from the Company's management concerning the information set forth in such Prospectus, reports and updates and have been satisfied with the answers provided regarding the same.
Finally, I acknowledge that there are significant federal income tax consequences resulting from my exercise of this Option, that I have consulted with and received advice from qualified tax counsel both as to the nature of such tax consequences and their impact upon my own personal income tax situation as the result of such exercise, and that I fully understand such impact and have planned accordingly.

DATED: ____________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a

Receipt is hereby acknowledged of the delivery to me by Torvec, Inc. on , 19 of stock certificates for shares of $.01 par value common stock purchased by me pursuant to the terms and conditions of the Torvec, Inc. 1998 Stock Option Plan referred to above.

DATED: ______________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-6.x2a


EXHIBIT NUMBER 6.7

TORVEC, INC.
1998 Stock Option Plan

ARTICLE I - GENERAL

1.01. Purpose

The purposes of the 1998 Stock Option Plan (the "Plan") are to: (1) closely associate the interests of the management of Torvec, Inc. (the "Company") with the shareholders by reinforcing the relationship between participants' rewards and shareholder gains; (2) provide management with an equity ownership in the Company commensurate with Company performance, as reflected in increased shareholder value; (3) maintain competitive compensation levels; (4) provide an incentive to management for continuous employment with the Company; and (5) provide key consultants and/or advisors of the Company with an equity interest commensurate with Company performance, as reflected in increased shareholder value.
1.02. Administration

(a) The Plan shall be administered by The Board of Directors.
(b) The Board shall have the authority, in its sole discretion and from time to time to:
(i) designate the employees and/or consultants and advisors or classes

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

of the same eligible to participate in the Plan;
(ii) grant Options provided in the Plan in such form and number as the Board shall determine;
(iii) impose such limitations, restrictions and conditions upon any such Option as the Board shall deem appropriate, consistent with the purposes of the Plan; and
(iv) interpret the Plan, adopt, amend and rescind rules and regulations relating to the Plan, and make all other determinations and take all other action necessary or advisable for the implementation and administration of the Plan.

(c) Decisions and determinations of the Board on all matters relating to the Plan shall be in its sole discretion and shall be conclusive. No member of the Board shall be liable for any action taken or decision made in good faith relating to the Plan or any Option granted hereunder.
1.03. Eligibility for Participation

Participants in the Plan shall be selected by the Board from the executive officers, key employees, and consultants and advisors of the Company who occupy responsible managerial or professional positions and who have the capability of making a substantial contribution to the success of the Company. In making this selection and in determining the form and amount of Options, the Board shall consider any factors deemed relevant, including the individual's functions, responsibilities, value of services

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

to the Company and past and potential contributions to the Company's profitability and sound growth.
1.04. Types of Options Under the Plan

Options under the Plan may be in the form of any one or more of the following:
(i) Stock Options, as described in Article II;
(ii) Incentive Stock Options, as described in Article III; and
(iii) Reload Options, as described in Article IV.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

1.05. Aggregate Limitation on Options

Shares of stock which may be issued under the Plan shall, in the discretion of the Board of Directors of the Company, consist either in whole or in part of authorized but unissued shares or treasury shares of the $.01 par value common stock of the Company ("Shares"). The maximum number of Shares which may be issued under the Plan shall be 2,000,000. Any Shares subject to a Stock Option, Incentive Stock Option, or Reload Option which for any reason is terminated unexercised or expires shall again be available for issuance under the Plan.
1.06. Effective Date and Term of Plan

(a) The Plan's Effective Date is January ______, 1998, the date on which it was adopted by the Board of Directors of the Company, subject to the authorization and approval by a majority vote of the outstanding number of shares of the Company present in person or by proxy at a special meeting of the shareholders of the Company duly called and held on January ______, 1998.
(b) No Options shall be granted under the Plan after the last day of the Company's fiscal year ended January ______, 2008 provided, however, that the Plan and all Options made under the Plan prior to such date shall remain in effect until such Options have been exercised or lapsed in accordance with the Plan and the terms of such Options.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

1.07. Amendment and Termination of Plan

The Board of Directors of the Company, without further approval of the shareholders of the Company, may at any time suspend or terminate the Plan or may amend it from time to time in any manner; provided, however, that no amendment shall be effective without prior approval of the shareholders of the Company which would (i) except as provided by the anti-dilution provisions of this Plan, increase the maximum number of Shares which may be issued under the Plan, (ii) change the eligibility requirements for individuals entitled to receive awards under the Plan, (iii) cause Incentive Stock Options issued under the Plan to fail to meet the requirements of incentive stock Options as defined in Section 422 of the Internal Revenue Code of 1986 ("Code"), (iv) require prior approval of a majority vote of shareholders of the Company under the applicable provisions of the Business Corporation Law of New York State, or (v) materially increase the benefits accruing to participants under the Plan within the meaning of Rule 16b-3 of the Securities Exchange Act of 1934, as amended.
1.08. Reservation of Shares

The Company shall be under no obligation to reserve shares of its $.01 par value common stock to meet its obligations under the Plan but it may do so. The grant of Options or the issuance of Shares to employees hereunder shall not be construed to constitute

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

the establishment of a trust with respect to such Options or Shares. The Company shall be deemed to have complied with the terms of the Plan if, at the time of issuance and delivery of Shares pursuant to the Plan, it has a sufficient number of shares of its $.01 par value common stock authorized and unissued or in its treasury which may then be appropriated and issued for purposes of the Plan, irrespective of the date when such shares were authorized.
1.09. Application of Proceeds

The proceeds of the issuance of Shares by the Company under the Plan will constitute general funds of the Company and may be used by the Company for any business purpose.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

1.10. General Restrictions

Each Option granted under the Plan shall be subject to the requirement that, if at any time the Board shall determine that (i) the consent or approval of any governmental regulatory body, or (ii) an agreement by the Optionee of an Option with respect to the disposition of the Shares is necessary or desirable as a condition of, or in connection with, the granting of such Option or the issue or purchase of Shares thereunder, such Option may not be exercised in whole or in part unless such consent, approval or agreement shall have been effected or obtained free of any conditions not acceptable to the Board.
1.11. Withholding Taxes

Whenever the Company proposes or is required to issue or transfer Shares under the Plan, the Company shall have the right to require the Optionee with respect to an exercised Option to remit to the Company an amount sufficient to satisfy any Federal, state and/or local withholding tax requirements prior to the delivery of any certificate or certificates for such Shares. Alternatively, the Company may issue or transfer such Shares net of the number of shares sufficient to satisfy the withholding tax requirements. For withholding tax purposes, the Shares shall be valued on the date the withholding obligation is incurred.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

1.12. Right to Terminate Employment

Nothing in the Plan or in any agreement entered into pursuant to the Plan shall confer upon any employee the right to continue in the employment of the Company or effect any right which the Company may have to terminate the employment of such employee.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

1.13. Non-Uniform Determinations

The Board's determinations under the Plan (including without limitation determinations of the persons to receive Options, the form, amount and timing of such Options, the terms and conditions of such Options and the agreements evidencing the same) need not be uniform and may be made by it selectively among persons who receive, or are eligible to receive, Options under the Plan, whether or not such persons are similarly situated.
1.14. Leaves of Absence

The Board shall be entitled to make such rules, regulations and determinations as it deems appropriate under the Plan in respect of any leave of absence taken by the recipient of any Option. Without limiting the generality of the foregoing, the Board shall be entitled to determine (i) whether or not any such leave of absence shall constitute a termination of employment within the meaning of the Plan and
(ii) the impact, if any, of any such leave of absence on Options under the Plan theretofore made to any recipient who takes such leave of absence.
1.15. Anti-Dilution Provision

(a) The Exercise Price and the number and character of the Shares which are the subject of Stock Options granted under this Plan shall be subject to adjustment, as follows:
1. In case the Company shall at any time pay a dividend in shares of its common stock or subdivide its

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

outstanding shares of common stock into a greater number of shares, the Shares purchasable upon exercise of outstanding Stock Options immediately prior to the record date established for such dividend or subdivision shall be proportionately increased, and conversely, in case the outstanding shares of common stock of the Company shall be combined into a smaller number of shares, the Shares purchasable upon exercise immediately prior to the record date established for such combination shall be proportionately reduced.
2. In case of any reclassification, capital reorganization or other organic change of outstanding shares of common stock of the Company, or in case of any consolidation or merger of the Company into another corporation (other than a merger with a wholly owned subsidiary in which merger the Company is the continuing corporation and which does not result in any reclassification, capital reorganization or other change of outstanding shares of common stock of the class issuable upon exercise of outstanding Stock Options) or in case of any sale or transfer to another corporation of the property of the Company as an entirety or substantially as an entirety, the Company shall, as a condition precedent to such transaction cause effective provision to be made that the Optionee shall have the right thereafter, by exercising his Stock Option, to purchase the kind and amount of shares of stock (and other securities and property, as the case may

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

be) receivable upon such reclassification, capital reorganization or other change, consolidation, merger, sale or transfer by the Optionee as if he had been a shareholder owning a beneficial interest in the number of Shares immediately prior to the record date, or other similar date established for such reclassification, capital reorganization or other change, consolidation, merger, sale or transfer. Any such provision shall include provision for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for with respect to outstanding Stock Options. This subparagraph (a)2 shall similarly apply to any successive reclassification, capital reorganization and other organic change of shares of Common Stock and to successive consolidations, mergers, sales or transfers. In the event that at any time, as a result of an adjustment made pursuant to this subparagraph (a)2, the Optionee shall become entitled to purchase upon exercise of his Stock Option, shares of stock, evidences of indebtedness, or other securities or assets (other than shares of Common Stock) then, wherever appropriate, all references herein to shares of Common Stock shall be deemed to refer to and include such shares of stock, evidences of indebtedness, other securities or assets; and thereafter the number of such shares of stock, evidences of indebtedness, or other securities or assets shall be subject to adjustment from time to time in a manner and upon terms as nearly

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

equivalent as practicable to the provisions contained in this subparagraph 2.
3. In case the Company shall declare a dividend upon shares of common stock payable otherwise than out of earnings, retained earnings, or earned surplus or otherwise than in shares of common stock, the Optionee shall, upon exercise of his Stock Option in whole or in part, be entitled to purchase, in addition to the number of Shares deliverable upon such exercise against payment of the Exercise Price therefor, but without further consideration, the cash, stock or other securities or property which the Optionee would have received as dividends (otherwise than out of such earnings, retained earnings, or earned surplus and otherwise than in shares of common stock) if he had been a shareholder owning a beneficial interest in the number of Shares of common stock immediately prior to the record date established for such declaration. For purposes of this subparagraph (a)3, a dividend payable otherwise than in cash or otherwise than in shares of common stock shall be considered to be payable out of earnings, retained earnings, or earned surplus only to the extent that such earnings, retained earnings, or earned surplus shall be charged in an amount equal to the fair value of such dividends as determined by the Board of Directors.
4. Upon each adjustment of the number of Shares purchasable, the Optionee shall thereafter (until another such adjustment) be entitled to purchase, at a new Exercise

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

Price, up to such number of Shares, calculated to the nearest full share. Such new Exercise Price shall be calculated by multiplying the number of Shares immediately prior to such adjustment by the Exercise Price in effect immediately prior to such adjustment and dividing the product so obtained by the new number of Shares.
(b) Whenever the Exercise Price shall be adjusted as required by the provisions of the foregoing paragraph (a)4, the Company shall forthwith file in the custody of its Secretary or an Assistant Secretary at its principal office, and with its transfer agent, if any, a certificate from its independent certified public accountants showing the new exercise price, determined as there provided, setting forth in reasonable detail the facts requiring the adjustment of such price, including a statement of the number of additional shares of common stock, if any, and such other facts as shall be necessary to show the reason for and the manner of computing such adjustment. Each such accountants' certificate shall be made available at all reasonable times for inspection by the Optionee and the Company shall, forthwith after each such adjustment mail a copy of such certificate to the Optionee.
(c) So long as Stock Options granted under the Plan shall be outstanding,
(i) if the Company shall pay any dividend or make any distribution upon its Common Stock; or
(ii) if the Company shall offer to the beneficial owners of its Common Stock for subscription or purchase

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

by them any shares of stock of any class or any other rights; or

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

(iii) if any capital reorganization of the Company, reclassification of the Common Stock of the Company, consolidation or merger of the Company into another corporation, sale or transfer of all or substantially all of the property and assets of the Company to another corporation, or any voluntary or involuntary dissolution, liquidation or winding up of the Company shall be effected;

then, in any such case, the Company shall cause to be mailed to the Optionee at least ten (10) days prior to the earliest date hereinafter specified, a notice containing a brief description of the proposed action and stating the anticipated date on which (1) a record is to be taken for the purpose of such dividend, distribution or rights, or (2) such reclassification, reorganization, consolidation, merger, sale or transfer, dissolution, liquidation or winding up is to take place and the anticipated date, if any, that is to be fixed, as of which the beneficial owners of the common stock shall be entitled to exchange their shares of common stock for securities or other property deliverable upon such reclassification, reorganization, consolidation, merger, sale or transfer, dissolution, liquidation or winding up. After any such notice shall be given, the Company shall give the Optionee copies of all future notices sent to the Company's stockholders with respect to the same transaction.
1.16. Rights as a Shareholder

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

The Optionee shall have no rights as a Shareholder with respect to the Shares purchased by him pursuant to the exercise of a Stock Option under this Plan until the Company has received full payment therefor and has issued a Stock Certificate(s) to him representing such Shares. Except as provided in paragraph 1.15 above, no adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property), for distributions or for rights of

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

any other kind with respect to Shares for which the record date for such dividends or distributions or rights is prior to the date of the issuance to the Optionee of a Certificate(s) for the Shares.
1.17. Registration

The Company shall use its best efforts to register the Shares issuable under this Plan with the Securities and Exchange Commission under the provisions of the Securities Act of 1933 in order to facilitate the resale of the Shares acquired by non-affiliates of the Company under the Plan without federal securities law restrictions.
1.18. Acceleration of Options in Certain Events

Notwithstanding any provisions to the contrary in this Plan or in any Stock Option Agreement evidencing Stock Options granted hereunder, all Stock Options then currently outstanding shall become immediately exercisable in full and remain exercisable until their expiration in accordance with their respective terms upon the occurrence of either of the following events:
(i) the first purchase of the Company's common stock pursuant to a tender or exchange offer (other than a tender or exchange offer made by the Company) or
(ii) approval by the Company's Shareholders of a (A) merger or consolidation of the Company with or into another corporation (other than a merger or consolidation in which the Company is the surviving corporation and which does not result in any reclassification or

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

reorganization of the Company's then outstanding common stock), (B) sale or disposition of all or substantially all of the Company's assets, or (C) plan of liquidation and/or dissolution of the Company.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

ARTICLE II - STOCK OPTIONS

2.01. Award of Stock Options

The Board may from time to time, and subject to the provisions of the Plan and such other terms and conditions as the Board may prescribe, grant to any eligible employee, consultant and/or advisor one or more Options to purchase for cash or shares the number of Shares ("Stock Options") allotted by the Board. The date a Stock Option is granted shall mean the date selected by the Board as of which the Board allots a specific number of Shares to an employee pursuant to the Plan.
2.02. Stock Option Agreements

The grant of a Stock Option shall be evidenced by a written Stock Option Agreement, executed by the Company and the holder of a Stock Option (the "Optionee"), stating the number of Shares subject to the Stock Option evidenced thereby, and such Stock Option Agreement shall be in such form as the Board may from time to time determine. Each Agreement shall contain provisions consistent with this Plan, including a provision prohibiting the sale, assignment, exchange, alienation, pledge, encumbrance or other similar form of transfer for value of any Shares acquired pursuant to the exercise of any Stock Option granted under this Plan until after the date that is six (6) months from the date of grant of the Stock Option and including, in the discretion of the Board, a waiting period

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

following the grant of any Stock Option during which all or any part thereof may not be exercised.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

2.03. Terms and Conditions of Options

Each Stock Option granted by the Board shall be subject to the following terms and conditions:
(a) Price. Each Stock Option shall state the number of

Shares subject to the Stock Option and the Stock Option price, which, unless the Board, in its absolute discretion, otherwise determines, shall be not less than the fair market value of the Shares with respect to which the Option is granted at the time of the granting of the Stock Option ("Exercise Price"). The Board is explicitly authorized under this Plan to grant Stock Options the Exercise Price per Share of which is less than the fair market value of the Shares at the time of grant, but said Exercise Price per Share shall in no event be less than the par value thereof.
For purposes of this paragraph 2.03(a), the fair market value per Share shall be the closing price for the common stock of the Company as quoted by the National Association of Securities Dealers, Inc. on the business day immediately preceding the day the Stock Option is granted.
(b) Term. The term of each Stock Option shall be

determined by the Board. The Board and an Optionee may at any time by mutual agreement terminate or modify the term of any Stock Option granted to such Optionee under this Plan.
(c) Exercise. Each Stock Option, or any installment

thereof, shall be exercised, whether in whole or in part,

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

by giving written notice to the Company at its principal office, specifying the number of Shares purchased, the purchase price being paid, and accompanied by the payment of the purchase price. An Optionee may pay for the Shares subject to the Stock Option with cash, a certified check or a bank cashier's check payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, he may pay for the Shares, in whole or in part, by the delivery of common stock of the Company already owned by him which will be accepted in payment for Shares at the fair market value of such common stock on the date of exercise. For this purpose, fair market value per share of common stock shall be the closing price for the common stock of the Company as quoted by the National Association of Securities Dealers, Inc. on the business day immediately preceding the day the common stock is mailed or otherwise delivered to the Company. Certificates representing the Shares purchased by the Optionee shall be issued by the Company as soon as reasonably practicable after the Optionee has complied with these provisions.
(d) Restriction Upon Exercise. Notwithstanding any

other provision of this Plan, and subject to the following limitations, Shares obtained upon the exercise of any Stock Option or Incentive Stock Option (within the meaning of
Section 422 of the Code) under this or any other stock Option plan of the Company, may be used in satisfaction of any part of the Exercise Price for Shares subject to Stock

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

Options granted under this Plan. However, Shares obtained upon the exercise of a given Stock Option may not be used to acquire additional Shares under that same Stock Option. In addition, shares acquired through the exercise of an Incentive Stock Option may be used only if the transfer of such previously acquired shares takes place two years from the date of the grant of the prior Incentive Stock Option and one year from the date of exercise of the prior Incentive Stock Option.
The Board may, from time to time, impose such restrictions and/or conditions upon the vesting and/or the subsequent transferability of any Shares to be issued or transferred by the Company upon the exercise of any Stock Options granted pursuant to this Plan as it may deem advisable for the orderly, secondary transfer of such Shares.
The Stock Option Agreements utilized in connection with the grant and exercise of Stock Options granted under this Plan shall alert the Optionee as to the existence of the Company's policy regarding trading in the Company's securities while in possession of material, inside information regarding the Company as well as the guidelines and procedures designed to implement such policy. In particular, such documents shall state that the Optionee may be required, under the Company's policy and procedures, to obtain permission of the Company's Clearinghouse Committee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

prior to any sale or transfer for value of the Shares to be acquired under Stock Options granted under the Plan.
2.04. Non-Assignment/Non-Transferability

Unless the Board, in its discretion shall otherwise determine with respect to the grant of a specific Option(s) during the lifetime of the Optionee, Stock Options issued pursuant to this Plan shall be exercisable only by him and shall not be assignable or transferable by him, whether voluntarily or by operation of law or otherwise, and no other person shall acquire any rights therein.
2.05. Death of the Optionee

In the event that an Optionee shall die while he is an employee of the Company and prior to his complete exercise of Stock Options granted to him under this Plan, any such remaining Stock Option may be exercised in whole or in part only: (i) by the Optionee's estate or by or on behalf of such person or persons to whom the Optionee's rights pass under his Will or by the laws of descent and distribution,
(ii) to the extent that the Optionee was entitled to exercise the Stock Option at the date of his death, and subject to all of the conditions and restrictions contained in this Plan, and (iii) prior to the expiration of the term of the Stock Option.
2.06. Termination of Employment

Unless the Board in its discretion shall otherwise determine with respect to the grant of a specific Option, a

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

Stock Option shall be exercisable, during the lifetime of the employee to whom it is granted, only while he is an employee of the Company and has been an employee continuously since the date the Stock Option was granted. In addition, no Stock Option shall be exercisable after the expiration of the term thereof.

ARTICLE III - INCENTIVE STOCK OPTIONS

3.01. Award of Incentive Stock Options

The Board may, from time to time and subject to the provisions of the Plan and such other terms and conditions as the Board may prescribe, grant to any eligible employee one or more "incentive stock options", intended to qualify as such under the provisions of Section 422 of the Code ("Incentive Stock Options") to purchase for cash or shares the number of shares of Common Stock allotted by the Board. The date an Incentive Stock Option is granted shall mean the date selected by the Board as of which the Board allots a specific number of Shares pursuant to the Plan.
3.02. Annual Limitation

The aggregate fair market value (determined as of the time the Incentive Stock Option is granted) of the Shares with respect to which Incentive Stock Options are exercisable for the first time by any individual during any calendar year (under this Plan and all other incentive stock Option plans of the Company, any parent of the Company and

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

any of its subsidiaries) shall not exceed $100,000.00. For purposes of the application of this rule, Incentive Stock Options shall be taken into account in the order in which they were granted.
3.03. Incentive Stock Option Agreements

The grant of an Incentive Stock Option shall be evidenced by a written Incentive Stock Option Agreement, executed by the Company and the holder of an Incentive Stock Option (the "Optionee"), stating the number of Shares subject to the Incentive Stock Option evidenced thereby, and such Incentive Stock Option Agreement shall be in such form as the Board may from time to time determine. Each Agreement shall contain provisions consistent with this Plan, including a provision prohibiting the sale, assignment, exchange, alienation, pledge, encumbrance or other similar form of transfer for value of any Shares acquired pursuant to the exercise of any Incentive Stock Option granted under this Plan until after the date that is six (6) months from the date of grant of the Incentive Stock Option and including, in the discretion of the Board, a waiting period following the grant of any Incentive Stock Option during which all or any part thereof may not be exercised.
3.04. Terms and Conditions of Options

Each Incentive Stock Option granted by the Board pursuant to this Plan shall be subject to the following terms and conditions:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

(a) Price. Each Incentive Stock Option shall state the

number of Shares subject to the Incentive Stock Option and the Incentive Stock Option price, which shall be not less than the fair market value of the Shares with respect to which the Incentive Stock Option is granted at the time of the granting of the Incentive Stock Option. If an Incentive Stock Option is granted to any person who, at the time the Incentive Stock Option is granted, owns stock possessing more than ten (10) percent of the total combined voting power of all classes of stock of the Company and/or its subsidiaries (hereinafter referred to as a "Ten Percent Shareholder"), the Incentive Stock Option price shall be not less than one hundred ten (110) percent of the fair market value of the Shares with respect to which the Incentive Stock Option is granted at the time of the granting of the Incentive Stock Option to the Ten Percent Shareholder. For purposes of the foregoing limitation, the rules of Section 424(d) of the Code (relating to attribution of stock ownership) shall apply in determining share ownership, provided, however, Shares that an Optionee may purchase under outstanding Incentive Stock and/or Stock Options shall not be treated as stock owned by the individual.
For purposes of this paragraph 3.04(a), the fair market value per Share shall be the closing price for the common stock of the Company as quoted by the National Association of Securities Dealers, Inc. on the day the Incentive Stock Option is granted.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

(b) Term. The term of each Incentive Stock Option

shall be determined by the Board, but in no event shall an Incentive Stock Option be exercisable either in whole or in part after the expiration of ten (10) years from the date on which it is granted. In no event shall an Incentive Stock Option granted to a Ten Percent Shareholder be exercisable either in whole or in part after the expiration of five (5) years from the date on which it is granted. The Board and an Optionee may at any time by mutual agreement terminate or modify the term of any Incentive Stock Option granted to such Optionee under this Plan provided that any modification of the term of any Incentive Stock Option granted under this Plan shall meet the requirements of this paragraph.
(c) Exercise. Each Incentive Stock Option, or any

installment thereof, shall be exercised, whether in whole or in part, by giving written notice to the Company at its principal office, specifying the number of Shares purchased and the purchase price being paid, and accompanied by the payment of the purchase price. An Optionee may pay for the Shares subject to the Incentive Stock Option with cash, a certified check or a bank cashier's check payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, he may pay for the Shares, in whole or in part, by the delivery of common stock of the Company already owned by him which will be accepted in payment for such Shares at the fair market

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

value of such common stock on the date of exercise. For this purpose, fair market value per share of common stock shall be the closing price for the common stock of the Company as quoted on the National Association of Securities Dealers, Inc. on the business day immediately preceding the day the stock is mailed or otherwise delivered to the Company. Certificates representing the Shares purchased by the Optionee shall be issued by the Company as soon as reasonably practicable after the Optionee has complied with these provisions.
(d) Restriction Upon Exercise. Notwithstanding any

other provision of this Plan, and subject to the following limitations, Shares obtained upon the exercise of any Stock Option or Incentive Stock Option (within the meaning of
Section 422 of the Code) under this or any other stock Option plan of the Company, may be used in satisfaction of any part of the Exercise Price for Shares subject to Incentive Stock Options granted under this Plan. However, Shares obtained upon the exercise of a given Incentive Stock Option may not be used to acquire additional Shares under that same Incentive Stock Option. In addition, Shares acquired through the exercise of an

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

Incentive Stock Option may be used only if the transfer of such previously acquired shares takes place two years from the date of the grant of the prior Incentive Stock Option and one year from the date of exercising the prior Incentive Stock Option.
The Board may, from time to time, impose such restrictions and/or conditions upon the vesting and/or the subsequent transferability of any Shares to be issued or transferred by the Company upon the exercise of any Incentive Stock Options granted pursuant to this Plan as it may deem advisable for the orderly, secondary transfer of such shares.
The Incentive Stock Option Agreements utilized in connection with the grant and exercise of Options granted under this Plan shall alert the Optionee as to the existence of the Company's policy regarding trading in the Company's securities while in possession of material, inside information regarding the Company and/or its subsidiaries, as well as the guidelines and procedures designed to implement such policy. In particular, such documents shall state that the Optionee may be required, under the Company's policy and procedures, to obtain permission of the Company's Clearinghouse Committee prior to any sale or transfer for value of the Shares to be acquired under Incentive Stock Options granted under the Plan.
3.05. Non-Assignment/Non-Transferability

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

Unless the Board in its discretion shall otherwise determine with respect to the grant of a specific Option, during the lifetime of the Optionee, Incentive Stock Options issued pursuant to this Plan shall be exercisable only by him and shall not be assignable or transferable by him, whether voluntarily or by operation of law or otherwise, and no other person shall acquire any rights therein.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

3.06. Death of the Optionee

In the event that an Optionee shall die while he is an employee of the Company and prior to his complete exercise of Incentive Stock Options granted to him under this Plan, any such remaining Incentive Stock Option may be exercised in whole or in part only: (i) by the Optionee's estate or by or on behalf of such person or persons to whom the Optionee's rights pass under his Will or by the laws of descent and distribution, (ii) to the extent that the Optionee was entitled to exercise the Incentive Stock Option at the date of his death, and subject to all of the conditions and restrictions contained in this Plan, and
(iii) prior to the expiration of the term of the Incentive Stock Option.
3.07. Termination of Employment

Unless the Board in its discretion shall otherwise determine with respect to the grant of a specific Option, an Incentive Stock Option shall be exercisable, during the lifetime of the employee to whom it is granted, only while he is an employee of the Company and has been an employee continuously since the date the Incentive Stock Option was granted. In addition, no Incentive Stock Option shall be exercisable after the expiration of the term thereof.

ARTICLE IV - RELOAD OPTIONS

4.01. Authorization of Reload Options

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

Concurrently with the award of Stock Options and/or the award of Incentive Stock Options, the Board may authorize reload Options ("Reload Options") to purchase for cash or shares a number of shares of common stock. The grant of a Reload Option will become effective upon the exercise of the underlying Stock Option or Incentive Stock Option if the Optionee uses shares of common stock of the Company to purchase, either in whole or part, the underlying Stock or Incentive Stock Option. The number of Reload Options shall equal the number of shares of common stock used to exercise the respective underlying Option.
4.02. Reload Option Agreement

Each Stock Option Agreement and Incentive Stock Option Agreement shall state whether the Board has authorized Reload Options with respect to the underlying Stock Options and/or Incentive Stock Options. Upon the exercise of the underlying Stock Option or the underlying Incentive Stock Option, the Reload Option will be evidenced by an amendment to the underlying Stock Option Agreement or Incentive Stock Option Agreement, which amendment shall set forth the number of Reload Options, the Reload Option Price and such other terms and conditions governing the Reload Option.
4.03. Reload Option Price

The Option price per share of Shares deliverable upon the exercise of a Reload Option generally shall be the fair market value of a share of common stock on the date the

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

grant of the Reload Option becomes effective, that is, the date on which the underlying Stock Option and/or Incentive Stock Option shall have been exercised. For this purpose, the fair market value per Share shall be the closing price for the common stock of the Company as quoted by the National Association of Securities Dealers, Inc. on the business day immediately preceding such date. Notwithstanding the general rule regarding fair market value, in the case of a Reload Option granted where the Exercise Price of the underlying Stock Option constituted a given percentage of the then fair market value, in the Board's discretion, the Reload Option Price with respect to such Reload Option, may be at the same percentage of the fair market value on the date of the Reload Option's effectiveness.
4.04. Terms and Conditions

Each Reload Option granted by the Board pursuant to this Plan shall constitute a Stock Option if authorized with respect to underlying Stock Options or an Incentive Stock Option if authorized with respect to underlying Incentive Stock Options and consequently, each such Reload Option shall be governed generally by the same terms and conditions, set forth in Article II or III of this Plan respectively, as govern the underlying Stock Options or Incentive Stock Options, as the case may be. The Board may impose additional terms and conditions and/or restrictions on the exercise of Reload Options that, in its absolute

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a

discretion, it deems advisable to carry out the purpose of the Reload Option feature of this Plan. To this end, the Board may expressly limit the consideration payable upon the exercise of a Reload Option to cash, or may permit such consideration to consist of shares of common stock of the Company which the Optionee has held for at least 12 months. Further, the Board may, in its discretion, grant successive Reload Options if the granting of such successive Reload Options is, in the Board's judgment, in accordance with and in furtherance of the purposes of this Plan.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-7.x2a


EXHIBIT NUMBER 6.8

INCENTIVE STOCK OPTION AGREEMENT

THIS INCENTIVE STOCK OPTION AGREEMENT MADE as of this ______ day of ___________, 19__ between TORVEC, INC., a New York business corporation (herein referred to as the "Company"), and ______________________________ (herein referred to as the "Optionee");

WITNESSETH:

1. The Company hereby grants to the Optionee an Option (hereinafter referred to as "Option") to purchase an aggregate of ____________ shares of the $.01 par value Common Stock of the Company (herein referred to as the "Shares") at a price of $___________ per Share to be paid by the Optionee with cash, a certified check or a bank cashier's check made payable to the order of the Company. Alternatively, provided the Board of Directors shall approve the specific transfer, the Optionee may pay for the Shares, either in whole or in part, by the delivery of Common Stock of the Company already owned by him which will be accepted as payment for the Shares, based upon such Common Stock's fair market value on the date of exercise. In addition, provided the Board of Directors shall approve the specific transfer, payment for the Shares, either in whole or in part, may be made by delivery of Common Stock acquired by the Optionee under any of the Company's stock option plans, provided, however, that if this Option is exercised in part, Shares acquired by such partial exercise may not be used as payment for additional Shares to be acquired under this Agreement. In order for the Optionee to so use shares of Common Stock previously acquired under any of the Company's stock option plans as payment for the Shares either in whole or in part, the transfer of such previously acquired Common Stock as payment for all or a portion of the exercise price under this Agreement must occur more than two years from the date of the grant and one year from the date of exercise of the prior option pursuant to which the Optionee acquired such Common Stock.
2. The term during which the Option shall be exercisable shall commence on _______________ and expire on the close of business _______________, subject to earlier

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

termination as provided in the Torvec, Inc. 1998 Stock Option Plan (herein referred to as the "Plan"). The Option to purchase the number of Shares granted under this Agreement may not be exercised by the Optionee for a period of one year immediately following the date of grant (that is, until _______________) and then may be exercised each year during the Option term after such initial one year period only to the extent of the greater of 2,500 Shares or 25% of the number of Shares subject to this Option, provided, however, that to the extent the Optionee shall fail to exercise or, due to the above limitation, be prohibited from exercising his Option in any year during the Option period, such annual right to exercise this Option shall not expire, but shall be cumulative, and carry over into and be exercisable in any subsequent year during which the Option is outstanding.
However, this Option may be exercised only if the Optionee is and has been continuously an employee of the Company or its subsidiaries for a period beginning on the date of grant and ending on the day three months before the date of exercise. If the Optionee terminates employment due to permanent and total disability, the three month period referred to in the preceding sentence shall be one year.
3. The Option is not transferable by the Optionee other than by Will or the laws of descent and distribution and is exercisable, during his lifetime, only by the Optionee. In the event that the right to exercise the Option passes to the Optionee's estate, or to a person to whom such right devolves by reason of the Optionee's death, then the Option shall be non transferable in the hands of the Optionee's Executor or Administrator or of such person, except that the Option may be distributed by the Optionee's Executor or Administrator to the distributees of the Optionee's estate as a part thereof.
4. In order for the Option to be exercised, in whole or in part, the notice by the Optionee to the Company in the form attached hereto must be accompanied by payment in full of the option price for the Shares being purchased.
5. The Company agrees that it will use its best efforts to register the sale of the Shares to be issued upon the exercise of the Option with the Securities and Exchange Commission under the Securities Act of 1933. Upon the effectiveness of the Registration Statement covering the Shares, the Optionee shall be able to sell the Shares in "open market transactions" free of Federal Securities Law restrictions, provided that at the time of sale, or within the three month period immediately prior to such sale, he is not nor has he been an "affiliate" of the Company. The

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

Optionee further understands that, in accordance with applicable Commission rules governing controlling persons of public companies, members of the board of directors of a public company, such as the Company, are deemed to be "affiliates" during their term of office. The Optionee, therefore, agrees that he will consult with the Company's counsel as to any Securities Law restrictions, including a limitation on the number of Shares which may be sold at any one time, on his ability to sell the Shares prior to any sale thereof.
6. The Company agrees to provide the Optionee with a copy of the Prospectus prepared by the Company in connection with the Registration Statement filed to register the Shares, together with its exhibits, and the Company hereby acknowledges its obligation to provide the Optionee with all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year of the Company and all updates thereof. The Optionee agrees that prior to exercise, either in whole or in part of the Option granted to him hereunder, he shall have read such materials, including the most recent annual and quarterly reports to shareholders, and shall have received, if requested, and read all the documents incorporated by reference in the Prospectus and Registration Statement filed with the Securities and Exchange Commission.
7. The Optionee understands that except as provided in Paragraph 5 above, the Company has not agreed to register either the issuance or the resale of the Shares in accordance with the provisions of the Securities Act of 1933 or to register either the issuance or the resale of the Shares under any applicable State Securities Laws. Hence, the Optionee agrees that by virtue of the provision of certain rules respecting "restricted securities" promulgated under such Federal and/or State Laws, unless the resale of the Shares is registered as provided in Paragraph 5 above, and until the registration of such Shares in accordance with Paragraph 5 above shall have been declared effective by order of the Commission, the Shares which the Optionee shall purchase upon the exercise of this Option must be held indefinitely and may not be sold, transferred, pledged, hypothecated, or otherwise encumbered for value, unless and until a secondary distribution and/or resale of such Shares is subsequently registered under such Federal and/or State Securities Laws, or unless an exemption from registration is available, in which case the Optionee still may be limited as to the amount of the Shares that may be sold, transferred, pledged and/or encumbered for value. The Optionee therefore agrees that, until the registration of such Shares shall have been declared effective by order of the Commission, the Company may affix upon any certificate representing the Shares, a legend that such Shares may not

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

be transferred in violation of Section 5 of the Securities Act of 1933.
8. The Optionee understands and agrees that the Shares to be acquired upon the exercise of the Option may not be sold, transferred, exchanged, hypothecated, encumbered, pledged or otherwise disposed of for value for a period of six (6) months from the date of the grant of this Option.
9. The Optionee understands that the Company has established certain policies and procedures governing trading in the Company's securities, including the Shares to be acquired upon the exercise of this Option, while in possession of material, inside information regarding the Company and/or any of its subsidiaries. The Optionee agrees that upon exercise of this Option, either in whole or in part, he will comply with all of the terms and conditions of such policy, including the procedures and guidelines established for its implementation. In particular, the Optionee agrees that where required under such guidelines and procedures, he will obtain permission of the Company's Clearinghouse Committee composed of senior management prior to effectuating any sale or other transfer for value of the Shares to be acquired by virtue of the exercise of this Option.
10. All the terms and provisions of the Plan, duly adopted at a meeting of the Company's Board of Directors on _______________, 1998 and approved by a majority vote of the Company's shareholders either in person or by proxy at a duly called meeting of such shareholders held on _______________, 1998 and as amended to date, are hereby expressly incorporated into this Agreement and made a part hereof as if printed herein and the Optionee, by the Optionee's signature hereon, acknowledges receipt of a certified copy of said Plan. If there shall be any conflict between this agreement and the Plan, the provisions of the Plan shall control.
11. In accordance with certain terms and conditions of the Plan, the aggregate number and kind of Shares that may be purchased pursuant to the grant of the Option under this Agreement shall be proportionately adjusted for any increase, decrease or change in the total number of the outstanding shares of the Company resulting from a stock dividend, stock-split or other corporate reorganization which would result in or have the effect of the Optionee being treated differently (but for the adjustment) than he would be treated had he been the beneficial owner of the Shares subject to the Option on the record date for such dividend, split or reorganization, as the case may be.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

12. The Optionee understands that the Option granted hereunder constitutes an "incentive stock option" within the meaning of Section 422 of the Internal Revenue Code. Consequently, under current provisions of federal tax law, if the holding periods set forth in this paragraph are observed, no income or gain shall be recognized for regular income tax purposes to the Optionee upon either the grant of the Option or upon his exercise of all or a portion of the Option granted hereunder. Upon the disposition of the Shares of the Company acquired pursuant to exercise, long or short term capital gain or loss will be recognized by the Optionee, depending uon the holding period (eighteen months for long term capital gain or loss) and the extent to which the seling price exceeds or is less than the Optionee's basis in the Shares. The amount of gain will be taxed at normal, ordinary tax rates, with a maximum rate of 20% if the Shares are held for a period of at least eighteen months. If the Shares are held for a period of at least twelve months, the maximum rate on any gain from their sale will be taxed at 28%. To achieve this favorable income tax treatment, the Optionee understands that he cannot dispose of any Shares acquired pursuant to the exercise of the Option granted hereunder for a period of two (2) years from the date of the grant of this Option and for a period of one
(1) year from the date of exercise. The Optionee also understands that for purposes of the federal alternative minimum income tax calculation, the difference between the exercise price and the fair market value of the Shares on the date of exercise shall be includible as an item of gross income for the taxable year of exercise except to the extent that such Shares are not transferable and are subject to a substantial risk of forfeiture. The Optionee also understands that the provisions of federal tax law described herein are subject to change and, consequently, the Optionee agrees to consult with his or her own tax advisor with respect to the tax treatment to be accorded the grant of the Option herein, the exercise of such Option, and the disposition of the Shares.
13. Consistent with the provisions of the Plan, this Agreement shall be binding upon and inure to the benefit of any successor or assignee of the Company and to any executor, administrator, legal representative,

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

legatee, or distributee entitled by law to the Optionee's right hereunder.
14. Except insofar as an interpretation of federal securities law otherwise is required, or is controlling, this Agreement shall be governed by and construed in accordance with the laws of the State of New York. IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer and the Optionee has hereunto set his hand, as of the day and year first above written.
TORVEC, INC.

By:____________________ ____________________, ,Optionee

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

NOTICE OF EXERCISE OF STOCK OPTION
AND
RECORD OF STOCK TRANSFER

Torvec, Inc.
3740 Route 104
Williamson, New York 14587
Gentlemen:
I hereby exercise my Incentive Stock Option granted to me by Torvec, Inc. under an Incentive Stock Option Agreement dated _______________, subject to all the terms and provisions thereof and of the Torvec, Inc. 1998 Stock Option Plan referred to therein and notify you of my desire to purchase Shares of the $.01 par value Common Stock of the Company which were offered to me pursuant to the Incentive Stock Option Agreement. Enclosed is my payment in the sum of in full payment of such Shares.
I understand that a Registration Statement covering the Shares to be issued to me pursuant to this exercise of the Option granted to me was filed with the Securities and Exchange Commission on _______________. The Registration Statement became effective on _______________. Consequently, I understand that unless I am an "affiliate" of the Company, the Shares I am acquiring are freely tradeable and may be sold by me in "open market" transactions. If I am an "affiliate" of the Company, however, or have been one during the three month period prior to sale, I recognize that I may not sell freely on the open market and therefore agree that I will consult the Company's counsel as to the securities law restrictions on my ability to sell the Shares.
I also understand that under the Plan, and in accordance with the terms of the Incentive Stock Option Agreement, I may not sell, assign, alienate, pledge, encumber or otherwise transfer for value the Shares unless a period of six (6) months has elapsed from the date of the grant of the Option to me.
I acknowledge that I am aware that the Company has established a policy with respect to trading in its securities while in possession of material inside information regarding the Company and/or its subsidiaries, and that, in accordance with certain guidelines and procedures designed to implement such policy, I may be required to obtain permission from a

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

Clearinghouse Committee, composed of Senior Management, prior to any sale or other transfer for value of the Shares hereby acquired.
I also acknowledge that I have received and have read the Prospectus dated _______________ prepared by the Company in connection with the grant of the Option contained herein, together with its exhibits, and all proxy and other shareholder communications, including the annual report to security holders, for the most recently completed fiscal year and all quarterly and current updates thereof. I acknowledge that I have received all documents incorporated by reference in the Prospectus and the Registration Statement filed with the Securities and Exchange Commission that I requested and have read the same. I acknowledge that I have had the opportunity to ask questions of and receive answers from the Company's management concerning the information set forth in such Prospectus, reports and updates and have been satisfied with the answers provided regarding the same.
Finally, I acknowledge that there are significant federal income tax consequences resulting from my exercise of this Option, that I have consulted with and received advice from qualified tax counsel both as to the nature of such tax consequences and their impact upon my own personal income tax situation as the result of such exercise, and that I fully understand such impact and have planned accordingly.

DATED: __________________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a

Receipt is hereby acknowledged of the delivery to me by Torvec, Inc. on , 19 of stock certificates for shares of $.01 par value common stock purchased by me pursuant to the terms and conditions of the Torvec, Inc. 1998 Stock Option Plan referred to above.

DATED: ______________________

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-8.x2a


EXHIBIT NUMBER
6.9

-AFFIDAVIT-

Re: Assignment of Gleasman Patents to Torvec, Inc.

5
   State of New York   )
                       ) Ss.
   County of Monroe    )

10 Morton A. Polster, being duly sworn deposes and says:
1. I am an attorney registered to practice before the United States Patent and Trademark Office ("USPTO"); and I have been acting as patent attorney for Vernon, Keith, and James Gleasman (the
15 Gleasmans") since 1989 and am presently an Officer and Director of Torvec, Inc.
2. Attached hereto are Assignments (both of which have been recorded at the USPTO) transferring all right and title to listed 20 patent properties from the Gleasmans to Torvec, Inc.
3. 1 have personal knowledge that each of the listed U.S. Patents was issued to the Gleasmans; that the two listed U.S. Patent Applications have both matured into U.S. Patents and have since issued to the
25 Gleasmans; that all of these U.S. Patents are now owned by Torvec, Inc.; that the two International Patent Applications have each been filed in the European Patent Office as well as in seven other countries; and that all of those non-U.S. filings have been made in the name of Torvec, Inc.

30
s/Morton A. Polster

35

Sworn to before me this 29th day of January, 1988.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-9.x2a

S/Pamela J. Knapp
Notary Public

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-9.x2a

UNITED STATES DEPARTMENT
OF COMMERCE

                                   Patent and Trademark
                                   Office
                                   Assistant Secretary and
                                   Commissioner
                                   of Patents and Trademarks
                                   Washington, D.C.  20231
   FEBRUARY 24, 1997

   PTAS

   EUGENE STEPHENS & ASSOCIATES
   MORTON A. POLSTER
   56 WINDSOR STREET
   ROCHESTER, NY 14605
          UNITED STATES PATENT AND TRADEMARK OFFICE
            NOTICE OF ACCREDATION OF ASSIGNMENT DOCUMENT
THE ENCLOSED DOCUMENT HAS BEEN RECORDED BY THE ASSIGNMENT
DIVISION OF THE U.S. PATENT AND TRADEMARK OFFICE.  A
COMPLETE MICROFILM COPY IS AVAILABLE AT THE ASSIGNMENT
SEARCH ROOM ON THE REEL AND FRAME NUMBER REFERENCED BELOW.
PLEASE REVIEW ALL INFORMATION CONTAINED ON THIS NOTICE.  THE
INFORMATION CONTAINED ON THIS RECORDATION NOTICE REFLECTS
THE DATA PRESENT IN THE PATENT AND TRADEMARK ASSIGNMENT
SYSTEM.  IF YOU SHOULD FIND ANY ERRORS OR HAVE QUESTIONS
CONCERNING THIS NOTICE, YOU MAY CONTACT THE EMPLOYEE WHOSE
NAME APPEARS ON THIS NOTICE AT 703-308-9723.  PLEASE SEND
REQUEST FOR CORRECTION TO: U.S. PATENT AND TRADEMARK OFFICE,
ASSIGNMENT DIVISION, BOX ASSIGNMENTS, NORTH TOWER BUILDING,
SUITE 1OC35, WASHINGTON, D.C. 20231.
RECORDATION DATE: 11/22/1996          REEL/FRAME: 8268/0844
   NUMBER OF PAGES: 5
BRIEF:   ASSIGNMENT OF ASSIGNOR'S INTEREST (SEE DOCUMENT FOR
DETAILS).
ASSIGNOR:
   GLEASMAN, VERNON E.                DOC DATE: 09/30/1996
ASSIGNOR:
   GLEASMAN, KEITH E.                 DOC DATE: 09/30/1996
ASSIGNOR:
   GLEASMAN, JAMES A.                 DOC DATE: 09/30/1996

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-9.x2a

ASSIGNEE:
   TORVEC, INC.
   11 PONDVIEW DRIVE
   PITTSFORD, NEW YORK 14534
SERIAL NUMBER: 08252743               FILING DATE: 06/02/1994
PATENT NUMBER:                        ISSUE DATE:
SERIAL NUMBER:  08410235              FILING DATE: 03/241995
PATENT NUMBER: 5613914                ISSUE DATE: 03/25/1997

8268/0844 PAGE 2
SERIAL NUMBER: 06668313               FILING DATE: 11/05/1984
PATENT NUMBER: 4732053                ISSUE DATE: 03/22/1988
SERIAL NUMBER: 07027748               FILING DATE: 03/19/1987
PATENT NUMBER: 4776235                ISSUE DATE: 10/11/1988
SERIAL NUMBER: 07027741               FILING DATE: 03/19/1987
PATENT NUMBER: 4776236                ISSUE DATE: 10/11/1988
SERIAL NUMBER: 07255663               FILING DATE: 10/11/1988
PATENT NUMBER: 4895052                ISSUE DATE: 01/23/1990
SERIAL NUMBER: 07768399               FILING DATE: 09/12/1991
PATENTNUMBER: 5186692                 ISSUE DATE: 02/16/1993
SERIAL NUMBER: 07936842               FILING DATE: 08/27/1992
PATENT NUMBER: 5440878                ISSUE DATE: 08/15/1995
SERIAL NUMBER: 08274220               FILING DATE: 07/13/1994
PATENT NUMBER: 5513553                ISSUE DATE: 05/07/1996
SERIAL   NUMBER:                      FILING DATE:
PATENT NUMBER:                        ISSUE DATE:
PCT NUMBER: US9506538
SERIAL NUMBER:                        FILING DATE:
PATENT NUMBER:                        ISSUE DATE:
PCT NUMBER: US9508732

SHARMALLA SIMPSON, EXAMINER
ASSIGNMENT DIVISION

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-9.x2a

OFFICE OF PUBLIC RECORDS

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-9.x2a


EXHIBIT NUMBER 6.10

SERVICE AND SPACE AGREEMENT

THIS AGREEMENT, made the _____ day of _________________, 1997 by and JOSEPH L. NERI, SR., 3740 Rte. 104, Williamson, New York 14589 (the _Owner_), JOSEPH NERI CHEVROLET- OLSMOBILE-PONTIAC, INC., a New York Corporation with offices at 3740 Rte. 104, Williamson, New York 14589 (the _Provider_) and TORVEC, INC., a New York Corporation with offices at 11 Pondview Drive, Pittsford, New York 14534 (_Torvec_).

W I T N E S S E T H :

WHEREAS, Owner is the owner of Premises located at 3740 Rte. 104, Williamson, New York consisting of eight acres of land on which there is located a building of approximately 17,000 square feet (the _Premises_), and WHEREAS, the Provider occupies the Premises as an automobile dealership and fully equipped repair department and body shop (the _Facility_), and
WHEREAS, Torvec is a development company engaged in the development of patented products which will be utilized as components of motor vehicles and as a new type of vehicle, and in multiple other applications, and

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-10.x2a

WHEREAS, the Parties desire that the Provider make the Facility available to Torvec and utilize Provider's personnel to construct, assemble and install Torvec's products into vehicles,

NOW THEREFORE, it is agreed as follows:
1. The Owner and the Provider warrant and represent that they are the sole owners of the Facility as it is above described and agree that Torvec shall have the use of so much of the Facility as is required by Torvec from time to time to store goods of Torvec and to permit the Provider to construct, assemble and install Torvec's products into vehicles, including but not limited to the FasTrack.
2.Provider warrants and represents that equipment at the Facility includes a computer system, service department, specialized equipment and tools with above-ground lifts (D.E.C. approved), one of which has a 28,000 pound capacity for trucks and buses, and an eight bay body shop complete with paint room and Kansas Jack straightening machine and a two floor parts department. Provider further warrants and represents that its staff consists of thirty members, including sales managers, office staff, mechanics and a computer programmer, all of whose services will be employed by Provider in fulfilling its obligations under this Agreement.
3.Provider agrees:

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-10.x2a

(A)To provide office space as needed to Torvec, not to exceed ____________ square feet.


(B)To provide all utilities, including a telephone

system with an after-hour answering service.
(C)To construct, assemble and install the Company's products into various vehicles, including the FasTrack, and to devote so much of the space at the Facility and as many of its personnel as are required to promptly meet the reasonable needs of Torvec. (D)To maintain the Facility and keep it in good repair. (E)To designate Torvec as an additional insured on Provider's general liability insurance. (F)To take all reasonable actions to secure the Facility against theft of Torvec's products or technology.
4.Torvec agrees:


(A)To provide the designs for all products being

constructed or installed by Provider.
(B)To provide the inventory for all products, which inventory shall, at all stages of assembly or production remain the property of Torvec.
(C)To provide the training required by Provider's personnel to properly render the services which Provider is obligated to render under this Agreement, it being understood that initially Mr. Keith Gleasman will provide such training but Torvec shall have the right to designate one or more additional individuals to provide.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-10.x2a

5.The parties agree that Provider is an independent contractor and neither Provider nor his employees shall be an employee, agent, servant or representative of Torvec. Provider shall have no authority to transact business, enter into agreements or otherwise make commitments on behalf of Torvec. Provider shall be responsible for the payment of all taxes, worker's compensation benefits and other fringe benefits of the employees of Provider who are engaged in fulfilling Provider's obligations under this Agreement.
6.Provider and Owner have been advised that Torvec is a development company engaged in the development of commercial applications of new patented products. Provider and owner have agreed that all patents, designs and technology relating to the Products, as well as all marketing plans, customer and supplier lists are confidential proprietary information of Torvec (Confidential Information). Neither Owner nor Provider will claim any ownership interest in any such proprietary and Confidential Information and agree to use such Information as is provided to them for the sole purpose of performing their obligations under this Agreement. They will limit dissemination of this Confidential Information to only those employees who have a need to know to perform the limited tasks assigned to them. Such Confidential Information will not be copied and will be returned to Torvec upon expiration of this Agreement. The parties have agreed that Torvec would be irreparably harmed

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-10.x2a

by a violation of this paragraph of this Agreement and that an action for damages may not be an adequate remedy and that Torvec may seek an injunction in addition to any other remedies available at law to enforce this Article 6 of this Agreement.
7.Owner represents and warrants that he has a binding and irrevocable option to purchase 80 acres of land adjacent to the Premises and fronting on Rte. 104, which acreage contains ponds, swamps and woods suitable for testing vehicles containing products of Torvec. One year from the effective date of this Agreement, Owner will transfer and convey said 80 acre parcel to Torvec free of liens and encumbrances for the sum of $350,000.00 which Torvec agrees to pay. Owner warrants and represents that use of said 80 acre parcel to test Torvec's vehicles will not violate any zoning law or restriction running with the land.
8.For services and space to be provided by Provider and Owner pursuant to this agreement, Torvec agrees to pay Provider the sum of $630,000.00 in twelve equal monthly installments. The first and last monthly payments have been paid and Owner and Provider acknowledge that fact by executing this Agreement. Owner and Provider acknowledge that they have been advised that pursuant to the Securities Act of 1933 Torvec is seeking to complete an initial public offering of its stock and this Agreement shall become effective on the date on which the proceeds of such public offering are distributed to Torvec. The initial term of

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-10.x2a

this Agreement shall be one (1) year. Torvec shall have the option on four separate occasions to extend this Agreement on the same terms for additional periods of one year each, provided that Provider is given notice in writing of the exercise of this option no less than ninety (90) days prior to the date on which the original term of this Agreement or any extension thereof would terminate.
9.Any dispute arising out of or relating to this Agreement other than disputes pursuant to Article 6 above shall be settled by arbitration. Such arbitration shall be governed by the rules of commercial Arbitration of the American Arbitration Association and shall be conducted at Rochester, New York. Any award granted in such arbitration shall be final and binding upon the parties and may be enforced in accordance with Article 75 of the Civil Practice Law and Rules of the State of New York. 10.This Agreement has been entered into in the State of New York and its validity and interpretation shall be governed by and in accordance with the laws of that State. 11.This Agreement shall be binding upon and inure to the benefit of the parties hereto and their successors but neither party shall have the right to assign or transfer any right or obligation under this agreement to any third party without the prior written consent of the others. A combination of Torvec with another entity shall not be deemed an assignment.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-10.x2a

IN WITNESS WHEREOF, the parties hereto have entered into this Agreement on the date first above written.


Joseph L. Neri, Sr., Owner

JOSEPH NERI
CHEVROLET-OLDSMOBILE-
PONTIAC, INC.

By:____________________________
Provider

TORVEC, INC.

By:____________________________
Torvec

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-10.x2a


EXHIBIT NUMBER
6.11
INFINITELY VARIABLE TRANSMISSION

The term of this Agreement will begin on its Effective Date, January 24, 1997, and will expire on January 23, 1998, unless extended by mutual consent of the parties, This Agreement is between Ford Motor Company, a Delaware corporation, having a place of business at The American Road, Dearborn, Michigan, (hereinafter "Ford"), and Torvec Inc., having a place of business at 11 Pondview Drive, Pittsford, New York, 14534 (hereinafter "Torvec"). Torvec has developed an Infinitely Variable Transmission (IVT) and desires to install the IVT in a motor vehicle and demonstrate the performance and operation of the IVT in the motor vehicle.
To protect certain Confidential Information to be disclosed for the purposes set forth in this Agreement, the parties agree as follows:
1. The parties', representatives for disclosing or receiving Confidential Information are:

FORD  Mr. E. J. DeVincent    TORVEC:       Mr. James Gleasman:
      Ford Motor Company                   Torvec Inc.
      6800 Plymouth Road                   11 Pondview Drive
      Livonia, Michigan 48150              Pittsford, New York
                                           14534

2. Confidential Information means proprietary information, data, sketches and drawings of Ford, and includes (but is not limited to) Ford production drawings of AX4N automatic transmission, drawings of the AX4N transmission case, an outline or package drawing, and a torque converter layout.
3. Ford shall disclose Confidential Information to Torvec, as deemed necessary in the sole judgment of Ford, for Torvec to adapt the IVT for installation into a Taurus vehicle.
4. Torvec shall use Confidential Information only for the purpose of developing an IVT adapted for use in a Taurus vehicle, installing such IVT into a Taurus vehicle, and

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-11.x2a

demonstrating performance of the Taurus vehicle with the IVT installed.
5. Torvec's duty to protect Confidential Information disclosed under this Agreement extends for a period of ten years from the date of each first disclosure of confidential information.
6. Torvec shall protect Confidential Information by using the same degree of care as Torvec uses to protect its own confidential information of a like nature, but no less than a reasonable degree of care, to prevent publication and dissemination of Confidential Information to third parties, and to prevent use of Confidential Information for any purpose other than the purpose of Article 4 hereof.
7. This Agreement imposes no obligation upon Torvec with respect to Confidential Information which (a) was in Torvec's possession before receipt from Ford, (b) is or becomes a matter of public knowledge through no fault of Torvec, (c) is rightfully received by Torvec from a rightfully possessing third party without a duty of confidentiality, or (d) is required to be disclosed by court order or other lawful governmental action, but only to the extend so ordered, and provided that if Torvec is so ordered Torvec shall notify Ford so that Ford may attempt to obtain a protective order.
8. Torvec shall make no copies of the Confidential Information. All materials bearing, containing, disclosing or relating to Confidential Information shall remain the property of Ford. Upon receipt of written request from Ford, Torvec shall return all writings and other materials in its possession or control that contain Confidential Information received from Ford under this Agreement.
9. Torvec shall adhere to the U.S. Export Administration Laws and Regulations and shall not export or re-export any technical data or products received from Ford or the direct product of such technical data to any proscribed country listed in the U.S. Export Administration Regulations unless properly authorized by the U.S. Government.
10. If a dispute arises between the parties relating to this Agreement, the following procedure shall be implemented before either party pursues other available remedies except that each party may seek injunctive relief from a court where appropriate in order to maintain the status quo while this procedure is being followed:
a. The parties shall hold a meeting promptly, attended by persons with decision making authority regarding the dispute, to attempt in good faith to negotiate a resolution of the dispute; provided,

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-11.x2a

however, that no such meeting shall be deemed to vitiate or reduce the obligations and liabilities of the parties hereunder or be deemed a waiver by a party hereto of any remedies to which such party would otherwise be entitled hereunder, and further provided that all such statements made at such meeting shall be strictly off the record and shall not be admissible in any court or arbitration proceeding.
b. If, within 30 days after such meeting, the parties have not succeeded in negotiating a resolution of the dispute, they agree to submit the dispute to mediation in accordance with the then current Model Procedure for Mediation of Trademark and Unfair Competition Disputes of the CPR Institute for Dispute Resolution and to bear equally the costs of the mediation.
c. The parties will jointly appoint a mutually acceptable mediator, seeking assistance in such regard from the CPR Institute for Dispute Resolution if they have been unable to agree upon such appointment within 20 days from the conclusion of the negotiation period.
d. The parties agree to participate in good faith in the mediation and negotiations related thereto for a period of 30 days. If the parties are not successful in resolving the dispute through the mediation, then the parties agree to submit the matter to binding arbitration or a private adjudicator, or either party may seek an adjudicated resolution through the appropriate court.
e. Mediation or arbitration shall take place at a mutually convenient site in the State of Michigan to be agreed to by the parties. The substantive and procedural law of the State of Michigan shall apply to the proceedings. Equitable and compensatory remedies shall he available in any arbitration. Punitive damages, costs and attorneys fees shall not be awarded. This Article of this Agreement is to be governed by the Federal Arbitration Act, 9 U.S.C.A.'1 et seq. Judgment upon the award rendered by an Arbitrator, if any, may be entered by any court having jurisdiction thereof.
11. Torvec warrants and represents that as of the date of this Agreement, it has not granted to any party a license or

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-11.x2a

rights to a license that would preclude Torvec from granting Ford a license to make, have made, use and sell IVTs.
12. Torvec shall demonstrate the Taurus vehicle having the IVT installed to Ford before Torvec demonstrates the vehicle to any third party.
13. Torvec shall provide to Ford, at no cost or obligation to Ford, any performance data and analysis developed during operation of the IVT in the Taurus vehicle or derived from information pertaining to such operation.
14. Upon successful demonstration of the IVT, Ford shall determine its interest in obtaining for itself and/or its associated companies a license under Torvec technology and patents related to the IVT.
15. For a period of one year after the effective date of this Agreement, Torvec shall provide Ford an opportunity to enter with Torvec a license agreement, pursuant to which Torvec would grant to Ford under Torvec property rights in the IVT a right to make, have made, use, sell and lease IVTs.
16. In the event that a license is not concluded by the parties on or before one year after the effective date of this Agreement, or Ford determines in its sole judgment not to incorporate the IVT into its vehicles, and either party is unwilling to extend this Agreement, this Agreement will terminate and neither party will have any further obligation or liability to the other party except as specified in this Agreement. This Agreement does not impose on Ford any obligation to enter into any agreement or business relationship with Torvec.
17. Neither party has an obligation under this Agreement to purchase any service or item from the other party.
18. No agency or partnership relationship is created between the parties by this Agreement. 19, All modifications to this Agreement must be made in writing and must be signed by representatives of both parties.
20. This Agreement is made under and shall be construed according to the laws of the State of Michigan without giving effect to principles of conflict of laws.
21. Under the terms of this Agreement, the obligations accruing to Torvec shall also accrue to Torvec affiliates and subsidiaries, if any. This Agreement shall not be assignable.

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-11.x2a

                                    FORD MOTOR COMPANY
   TORVEC Inc.

By:____________________________     By:___________________________
   (Authorized Signature)           (Authorized Signature)

   ______________________________   Ernest J. DeVincent
   (Printed Signatory's Name)

   ______________________________   Advanced and Pre-Program
   (Printed Signatory's Title)      Auto. Trans. Engrg.  Manager

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-11.x2a

FIRST AMENDMENT OF
CONFIDENTIAL DISCLOSURE AGREEMENT

This FIRST AMENDMENT is effective January 23, 1998 between Torvec Inc. (hereafter "Torvec"), and FORD (defined as Ford Motor Company and its affiliated companies, hereinafter referred to as 'FORD").
WHEREAS, Torvec and FORD have entered into a CONFIDENTIAL DISCLOSURE AGREEMENT effective January 24, 1997 (hereinafter "AGREEMENT") and wish to amend that AGREEMENT to revise its expiration date. Accordingly, the parties agree as follows:
1. The parties modify the first paragraph in the preamble of such AGREEMENT to read:
"The term of this Agreement will begin on its Effective Date, January 24, 1997, and will expire on January 23, 1999, unless extended by mutual consent of the parties."
2. The AGREEMENT, as amended by this FIRST AMENDMENT, remains in full force and effect.

                  FORD MOTOR COMPANY            TORVEC INC-
                                 11 Pondview Drive
                                 Pittsford, NY 14534

By                               By
s/Ernest J. DeVincent            s/Keith E. Gleasman
(Authorized Signature)           (Authorized Signature)
Ernest DeVincent                 Keith E. Gleasman
(Printed Signatory's Name)       (Printed Signatory's Name)

Dept. Mgr., Ford Advanced Trans.President
(Printed Signatory's Title)      (Printed Signatory's Title)

\\cdog1\sys\depts\adm\wpfiles\sec\ex6-11.x2a


EXHIBIT 12.1

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below hereby severally constitutes and appoints Robert Oppenheimer, Esq. and Richard B. Sullivan, Esq. and each of them, his true and lawful attorneys-in-fact and agents, each acting alone, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and all documents relating thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys -in-fact and agents, each acting alone full power and authority to do and perform each and every act and thing necessary or advisable to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys -in- fact and agents, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this Registration Statement and power of attorney have been signed by the following persons in the capacities and on the dates indicated:

       Signature               Title                   Date

 /s HERBERT H. DOBBS    Chairman of the Board        4 May 1998
 -------------------    of Directors                ------------
 Herbert H. Dobbs

/s KEITH E. GLEASMAN    Director; President and        5-1-98
 -------------------    Consultant to Torvec, Inc.  -----------
 Keith E. Gleasman

/s LEE E. SAWYER        Director                       5-1-98
 -------------------                                -----------
 Lee E. Sawyer

/s MORTON A. POLSTER    Director;                     4/30/98
 -------------------    Secretary of Torvec, Inc.   -----------
 Morton A. Polster

\\cdog1\sys\depts\adm\wpfiles\sec\ex12-1.x2a

EXHIBIT 12.1

/s JAMES A. GLEASMAN     Director, Consultant         5/1/98
 -------------------     of Torvec, Inc.            ----------
 James A. Gleasman

/s SAMUEL M. BRONSKY     Chief Financial Officer     4/30/98
 -------------------                                ----------
 Samuel M. Bronsky

\\cdog1\sys\depts\adm\wpfiles\sec\ex12-1.x2a


EXHIBIT NUMBER
12.2

ALFRED STATE
SUNY College of Technology

Associate in Applied Science Department of Mechanical Engineering Technology

Bachelor of Science   Alfred, New York 14802
                     Office (607) 587-4617
                      FAX: (607) 587-4615
October 24, 1997

Ms. Judy Greenwald
White House Climate Change Task Force 734 Jackson Place Northwest
Washington, D.C. 20503
Dear Ms. Greenwald:
Mr. James Gleasman, of TORVEC, Inc., has asked me if I could update you regarding the first phase of testing of the TORVEC IVT (Infinitely Variable Transmission). In this connection, it is our great pleasure to report our observations and the results thus far.
The tests were conducted at our Internal Combustion Engineering (ICE) laboratory using a 3-liter, 145 HP, 168 ft. lb. torque, V-6 gasoline engine as a power source. A 250 HP Eddy Current Dynamometer was used to provide torque resistance along with a Lebow Torque Sensor and Daytronic Data Acquisition System 10 to measure and record the data. In general, we were very impressed with tile function and operation of this IVT. Duriil(, the tests, we observed tile transmission consistently changed its torque output and speed ratios very smoothly and quickly. Numerous demonstrations showed that the engine RPM ran at what would be defined as "steady-state." The transmission was much lighter than the production A4LD transmission by almost 40 lbs., in addition to being smaller (17 /" in comparison to the A4LD, which measures 35" in length). These tests were designed to provide data on the operation, function, torque flow, practicality and the performance of IVT. We are very pleased to learn that TORVEC Inc. intends to proceed with the next phase of testing also in our laboratory. According to TORVEC, the second phase of testing will be to produce two new transmissions that are design-specific. The first one will be for a 200 HP, gasoline automobile transaxle (FWD) and the second will be

\\cdog1\sys\depts\adm\wpfiles\sec\ex12-2.x2a

for a 6.5 liter, V-8 diesel from a HMMWV (Hummer). Both will be tested for performance, fuel economy and emissions. We are presently working with TORVEC, Inc. to outline this phase of the program and its cost.
I assure you, all of us at SIJNY, College of Technology at Alfred including our President William D. Rezak , faculty and students are extremely excited about being involved with this project because of the promising results from the first phase of testing. We believe that this transmission has the potential for a major positive impact on vehicle fuel economy and emission levels. This is achieved because of its ability to run a power source at a "steady-state" with a variable load demand.
Further, if we can be of any assistance, please feel free to contact us.
Thank you very much.
Yours Sincerely,

s/Yogendra B. Jonchhe, Professor
Department of Mechanical Engineering Technology

CC:   Mr. James Gleasman, TORVEC Inc.
   Dr. William D. Rezak, President, SUNY College of
Technology at Alfred
   Mr. Craig R. Clark, Acting Dean, School of Engineering
Technology
   Mr. Robert E. Rees, Chair, Mechanical Engineering
Technology Dept.

\\cdog1\sys\depts\adm\wpfiles\sec\ex12-2.x2a


EXHIBIT NUMBER
12.3
KIA MOTORS

Date: March 12,1998
To: Mr. Keith Gleasman
President, TORVEC Inc.
11 Pond View Drive
Pittsford, NY 14534
cc: Mr. Min Dokko -Kia Motors America Mr. Lee Sawyer -Kia Motors America Subject: TORVEC FasTrack/K2700 Program We are glad to provide you with our products, code name K2700, for the feasibility study of TORVEC FasTrack program. Regarding the 2 units of prototype vehicle for TORVEC, KMC will build those units with following specifications; -Standard Cab with K/Cab box -V-Belt type PTO
Full Option (i. e. Tilting Cab., A/C. P/S, Power door lock & window. Audio.
Tachometer, Heater, box brim cover etc.) The prototype vehicles will be produced by the end of April and shipped to Newark port where we have used for our Sephia and Sporrage, We will update you on the detailed schedule. As K2700 annual production capacity is 80,000 units a year, we are able to supply sufficient volume.

Please let us know if you have any question.

Best Regards,

s/J.U.Koo
Manager, Overseas Sales Dept. 1
Kia Motors Corp.
Tel: 82-2-788-1826
Fax: 82-2-788-1841
                                             EXHIBIT NUMBER
                                             12.3
                                             KIA MOTORS



\\cdog1\sys\depts\adm\wpfiles\sec\ex12-3.x2a



Date: March 12,1998
To:   Mr. Keith Gleasman
      President, TORVEC Inc.
      11 Pond View Drive
      Pittsford, NY 14534
cc:   Mr. Min Dokko    -Kia Motors America
      Mr. Lee Sawyer   -Kia Motors America
Subject:   TORVEC FasTrack/K2700 Program
We are glad to provide you with our products, code name
K2700, for the feasibility study of TORVEC FasTrack program.
Regarding the 2 units of prototype vehicle for TORVEC, KMC
will build  those units with following specifications;
       -Standard Cab with K/Cab box
       -V-Belt type PTO
       Full Option (i. e. Tilting Cab., A/C.  P/S, Power
       door lock & window.  Audio.
          Tachometer, Heater, box brim cover etc.)
The prototype vehicles will be produced by the end of April
and shipped to Newark port where we have used for our Sephia
and Sporrage, We will update you on the detailed schedule.
As K2700 annual production capacity is 80,000 units a year,
we are able to supply sufficient volume.

Please let us know if you have any question.

Best Regards,

s/J.U.Koo
Manager, Overseas Sales Dept. 1
Kia Motors Corp.
Tel: 82-2-788-1826
Fax: 82-2-788-1841

\\cdog1\sys\depts\adm\wpfiles\sec\ex12-3.x2a